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Abstract 
Malaria control strategies are often targeted at individuals who suffer most morbidity, 
not at those driving transmission. This is in part due to our limited understanding, 
described in Chapter 1, of the human infectious reservoir of falciparum malaria – i.e. 
individuals responsible for human-to-mosquito transmission of Plasmodium 
falciparum parasites in endemic areas. This work, whose objectives are listed in 
Chapter 2, assessed the prevalence of infectiousness in naturally exposed human 
populations during dry and wet seasons. Exposure to Anopheles mosquitoes, a 
measure of transmission opportunities, was also quantified; and to determine the value 
of infectiousness-reducing interventions, the use of primaquine to block transmission 
from infectious individuals was investigated. 
Experimental infections of mosquitoes were performed to determine malaria 
infectivity of randomly selected individuals in two villages in Burkina Faso. Molecular 
assays were used to quantify parasite, including gametocyte, densities. Less than 10% 
of the population was infectious to mosquitoes. These results are presented in a 
manuscript that included data from other study sites (Chapter 3). 
To assess exposure to malaria vectors, bloodfed mosquitoes were collected indoors in 
one of the study villages in Burkina Faso. A multiplex PCR assay targeting nine human 
microsatellites and a gender-specific marker was used to identify the human sources 
of mosquito blood meals. Although there was substantial variation in the number of 
mosquito bites each individual received (Chapter 4), on average adults received more 
mosquito bites than children. This suggests that, despite their lower infectiousness, 
adults are major contributors to malaria transmission in endemic areas. 
An efficacy trial of single low dose primaquine was performed in Burkina Faso and 
pre- and post-treatment infectiousness were quantified by mosquito feeding 
experiments to assess primaquine’s infectiousness-reducing activity (Chapter 5). 
Individuals receiving primaquine cleared gametocytes faster than individuals who 
received artemether-lumefantrine alone. Feeding assays, however, suggest that 
artemether-lumefantrine blocks most parasite transmission after treatment 
administration.  
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In Chapter 6, these findings, and how they can inform future control strategies, are 
discussed.  
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Chapter 1, Malaria Transmission 
 
Few human infections have their name derived from their transmission mechanism – 
mala aria, ‘bad air’, is one of them. Of the five malaria parasite species infecting 
humans, two, Plasmodium vivax and Plasmodium falciparum, are arguably major 
public health problems [1, 2], causing hundreds of millions of clinical cases each year 
[3]. This work focuses on the more virulent species, P. falciparum, and its transmission 
in endemic settings. 
 
The complexity of malaria transmission 
 
A new era of malaria control, focused in reducing contact between humans and malaria 
vectors, started when the key events of transmission were elucidated [4]. Indeed, 
shortly after Alphonse Laveran’s observation of what we now know as exflagellation 
[5], the hypothesis that mosquitoes were the source of parasites causing human malaria 
infection was proposed by Laveran himself and Sir Patrick Manson. By the end of the 
nineteenth century, Sir Ronald Ross, working in India, had shown that mosquitoes 
were responsible for transmitting avian malaria [6], and the Italian zoologist Battista 
Grassi had demonstrated that humans acquire their infections from mosquitoes: a 
healthy individual living in a non-endemic region became infected with malaria 
parasites after being exposed to experimentally-infected mosquitoes [7, 8]. 
 
Today, more than a century later, our knowledge of these transmission events is much 
more detailed, although far from complete. We now know that there is a non-
replicating transmission blood stage, gametocyte, that develops from asexual stage 
parasites – these crescent-shaped gametocytes need to be ingested by Anopheles 
mosquitoes for transmission to occur. In Figure 1, the steps of the parasite life cycle 
involved in human-to-mosquito transmission and the factors believed to influence 
transmission potential of infected individuals are schematized. Of note, the only 
naturally-occurring exception to vector-mediated transmission is congenital malaria 
[9], which is thought to be rare in highly endemic areas and will not be discussed in 
this document. 
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The long process leading to human infectiousness to mosquitoes starts at the moment 
exo-erythrocytic schizonts in the liver burst and merozoites invade red blood cells: 
this is the beginning of the blood stage of the malaria infection, responsible for both 
morbidity and infection propagation. Falciparum parasites in these newly infected 
erythrocytes replicate their genome several times and 48 hours after invasion a new 
generation of merozoites is produced by schizogony. At each replication cycle, a 
subset of these erythrocytic schizonts will generate sexually-committed merozoites. 
Indeed, Bruce and colleagues used monoclonal antibodies that distinguish sexual and 
asexual blood stage parasites to study the progeny of single falciparum schizonts and 
their in vitro work suggested that all merozoites from a single schizont become either 
replicating asexual stage parasites or gametocytes [10]. Nearly ten years later, another 
study using red blood cell monolayers and gametocyte-specific antibodies showed that 
sibling gametocytes derived from a single schizont are all either male or female [11]. 
The molecular events underlying this commitment to transmission have only recently 
started to be elucidated. The ap2-g gene, a transcription factor epigenetically silenced 
in asexual stage parasites, is essential to initiate formation of P. falciparum 
gametocytes and thought to control transcription of early gametocyte genes [12]. Other 
genes that have been linked to the early steps of the sexual development include Nima-
related kinase (Pfnek4) and P. falciparum gametocyte development 1 (Pfgdv1): the 
latter was identified by comparative genomic analysis of gametocyte-producing and -
deficient parasite lines [13]; the former was shown not to be gametocyte-specific 
although Pfnek4-expressing schizonts generated more gametocytes than schizonts that 
did not express this gene [14]. The identification of these and other early markers of 
gametocytogenesis [15] is relevant not only for future studies of gametocyte formation 
in experimental systems but potentially for field studies of malaria transmission that 
aim to predict future infectiousness by quantifying levels of sexually-committed 
parasites. 
 
Although these studies revealed some of the molecular steps of gametocytogenesis 
(recent findings were reviewed by Josling and Llinás [16]), what determines the 
“decision” of a parasite or a population of parasites to invest in transmission or to 
produce replicating parasites remains controversial. In the late 1970s, Carter and 
Miller [17] showed, by manipulating falciparum parasites cultures, that the 
microenvironment (i.e. human blood) to which malaria parasites are exposed 
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influences the commitment rate, also called conversion rate, of asexual to sexual stage 
parasites. Indeed, evidence [18] accumulated over the last three decades suggests that 
changes in conversion rates might be an adaptive response to signs of stress or to the 
effects of stress on the parasite population. Stress is often linked to changes in 
haematological parameters [19] including age of red blood cells and anaemia and to 
competition for host resources (number of circulating falciparum clones). Factors 
directly related to parasite clearance, such as human immunity [20] and antimalarials 
[21-23], have also been associated with enhanced or decreased commitment to 
gametocytogenesis. Interestingly, microvesicles, thought to be a means of 
communication between parasites circulating in the same human host, influence 
gametocytogenesis [24, 25] and could be responsible for one of the mechanisms that 
control transmission investment. To my knowledge, the only non-stress-related factor 
that has been postulated to influence commitment to gametocytogenesis is exposure 
to saliva of uninfected Anopheles mosquitoes at the beginning of the wet season in 
areas with seasonal transmission [26] – such mechanism could explain the observation 
that in some endemic areas gametocyte prevalence is higher at beginning versus peak 
of wet seasons [27]. Despite the long list of factors believed to modulate malaria 
parasite conversion rates, no study has attempted to quantify the contribution of these 
different stress signals to the establishment of gametocyte populations and for all we 
know, for an individual parasite commitment to sexual development seems to be the 
outcome of a stochastic process.   
 
Commitment to gametocytogenesis does not fully determine the contribution of an 
asexual stage parasite to future transmission.  The sex ratio of circulating gametocytes 
is another key factor that influences the capacity of human hosts to infect mosquitoes 
[28]. As with commitment, sexual determination in gametocytes remains a mystery 
and although animal model studies have linked host factors to changes in gametocyte 
sex ratio during the course of malaria infections [19, 29, 30], the mechanism behind 
this plasticity continue to elude us. 
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Figure 1.  Factors that influence the transmission of malaria parasites from humans to mosquitoes. Abbreviations: RBC, red blood cell; 
TBI, transmission blocking immunity.                                     
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Red blood cell invasion by sexually-committed merozoites is followed by a maturation 
period that lasts approximately one week [31] and involves five morphologic stages 
[32]. Gametocytes in the initial stages of this maturation process (stages II – IV) are 
not observed in the peripheral circulation, although stage III – IV specific transcripts 
have been detected in the peripheral blood [33]. In a field study in The Gambia, 
Smalley and colleagues biopsied children with falciparum infections and observed that 
immature gametocytes accumulate in the bone marrow [34]. A recent autopsy study 
of children with fatal malaria [35] and an epidemiological study of children with 
severe anaemia that included bone marrow biopsy [33] confirmed this observation that 
young gametocytes accumulate in the bone marrow, more specifically in the extra-
vascular compartment of this organ [36]. Changes in red blood cell membrane rigidity 
[37], rather than cytoadherence [38], have been implicated in both accumulation of 
immature gametocytes in the bone marrow and migration of mature gametocytes back 
to peripheral circulation.  
 
After stage V gametocytes leave maturation sites, our knowledge of what happens 
with these parasites in the blood is limited. Evidence from malariotherapy studies [39] 
suggests that stage V gametocytes are not necessarily infectious when they enter 
circulation and few more days might be necessary for these parasites to fully mature. 
Furthermore, it is a well-known fact that gametocytes represent only a small 
proportion of all circulating parasites [40]. This could be explained by at least two 
mechanisms: low commitment rate (estimated [31] to be ~1%); and the 8-to-12 day 
lag between commitment and circulation of mature gametocytes means that, if 
exponential growth of parasites persists during this period, the asexual parasite 
population when a cohort of gametocytes enters circulation is up to 105 times larger 
than the asexual parasite population at the time of commitment of the same gametocyte 
cohort (10 represents the approximate effective parasite multiplication in each cycle, 
as estimate by controlled human malaria infections [41]).  
 
Low gametocytes densities during infections contrast with the success of falciparum 
parasites in sustaining transmission. Several strategies are believed, with varying 
supporting evidence, to facilitate the ingestion of gametocytes by malaria vectors: 
circadian changes in gametocyte infectiousness (also known as Hawking phenomenon 
named after Frank Hawking), gametocyte aggregation in peripheral blood, and 
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gametocyte sequestration in skin capillaries. In 1971, Hawking and colleagues [32] 
observed that exflagellation activity of P. falciparum parasites had periodicity of 48 
hours, and more recently a study in Tanzania showed that gametocytes densities might 
peak early at night [42] – however in the same study, the time of peak gametocytaemia 
did not coincide with the time of peak mosquito biting activity. Evidence of 
gametocyte aggregation comes from the observation that the distribution of 
gametocytes in mosquito blood meals does not appear to be random but rather highly 
heterogeneous, with few mosquitoes ingesting very high quantities of gametocytes; in 
statistical terms, the number of gametocytes in mosquito blood meals is overdispersed 
and seems to follow a negative binomial, rather than a Poisson, distribution [43]. To 
my knowledge, no other studies have been performed that support or refute this 
finding. Finally, the accumulation of gametocytes in the skin is an obvious and yet 
difficult-to-test mechanism of maximising the transmission probability of circulating 
gametocytes. There is limited evidence for this parasite strategy from studies using 
skin scarification to test for presence of gametocytes in the skin [44]. The fact that 
mosquito skin feeding experiments, where Anopheles mosquitoes feed directly on the 
skin of volunteers, result in higher proportions of infected mosquitoes compared to 
membrane feeding assays [45, 46] indicates that preferential accumulation of 
gametocytes in the skin may occur however it is not possible to rule out that other 
factors, including changes in parasite fertility linked to venous sampling, are 
responsible for this observation.  
 
Once inside the mosquito, male gametocytes, which represent ~20% of the total 
gametocyte population in natural infections [28], exflagellate and generate eight 
microgametes each. Two factors have been proposed to trigger this process: 
xanthurenic acid [47] in mosquito midgut and drop in temperature. Each female 
gametocyte produces only one macrogamete. A zygote is formed from the fertilisation 
of a macrogamete by a male gamete and differentiates into a motile ookinete. The 
migration of ookinetes towards the midgut epithelium and the subsequent invasion are 
followed by a transformation into immotile oocysts. Of note, this process is associated 
with substantial reductions in parasite numbers, with more than 90% of the initial 
parasite population (gametocytes ingested) being lost up to the oocyst stage, most of 
this loss occurring in the gametocyte-to-zygote step (which involves both 
gametogenesis and fertilisation) (reviewed in [48]). Roughly two weeks after 
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gametocyte ingestion, sporogonic development is complete and sporozoites 
developing inside oocysts migrate to salivary glands rendering the mosquito infectious 
to humans. 
 
Transmission in endemic areas 
 
This highly plastic transmission strategy developed by falciparum parasites explains 
why malaria is so widespread in tropical regions. Indeed, the basic reproductive 
number or R0 (the number of secondary infections generated by a single infectious 
individual in an immunologically naive population) of malaria is estimated to be 115 
(median, interquartile range 30 – 815) in endemic areas [49], which is considerably 
higher compared to infections caused by pathogens with direct transmission 
mechanism. As with other vector-borne infections, this potential to cause secondary 
cases depends not only on the number of mosquitoes each individual infects but also 
on the number of individuals each infected mosquito infects. Knowing that anopheline 
mosquitoes are abundant in most endemic areas, it is easy to understand why R0 
estimates for malaria reach values as high as ~3,000.  
 
For an infectious individual, the factors that determine the number of mosquito 
infections he or she will generate can be broadly categorised as factors that influence 
infectivity, duration of infectious period and exposure to anopheline vectors. The sub-
sections discussing these factors were in part based on a review by Stone and 
colleagues [50], particularly where previous malaria xenodiagnostic studies and 
studies that assessed age-specific exposure to mosquitoes are described. This review 
is included in the Appendix for reference.  
 
Infectiousness 
 
Logic and intuition suggest that the probability of mosquito infection after a single 
blood meal is directly linked to total parasite burden in the human host, as asexual 
parasites generate the sexual stage parasites. However, the time necessary for the 
maturation of P. falciparum gametocytes means that circulating gametocytes densities 
might only loosely correlate with concomitant asexual parasitaemia. An alternative 
approach to estimate the infectiousness of infected individuals is to quantify their 
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gametocyte densities. Transmission studies where mosquitoes were fed on blood or 
skin of volunteers suggest a positive correlation between the density of gametocytes 
in the blood and the risk of mosquito infection [51-53]. Predictions of mosquito 
infection rates (i.e., proportion of mosquitoes acquiring infection in feeding assays) 
based solely on gametocyte density data are however complicated by the shape of this 
relationship, which is sigmoidal, not linear, and seems to be dependent on how we 
quantify gametocytes in the peripheral blood [52]. The decades-old observations [54, 
55] that individuals with submicroscopic densities of gametocytes can infect 
mosquitoes, and that some individuals with high gametocytaemia fail to produce 
mosquito infections confirm that gametocyte density, although important, is not the 
only determinant of host infectivity. Several studies (reviewed in [56]) have shown 
that some but not all individuals living in endemic areas acquire immunity that reduces 
infectiousness in mosquito feeding assays. Other host factors, such as genetics might 
influence gametocyte levels [57, 58] and infectivity [59] as well as mosquito survival 
after feeding experiments [60]. 
 
This multitude of factors modulating the infectiousness of malaria-infected individuals 
suggests that to determine how many mosquitoes an individual can infect all these 
different parameters need to be measured. A more direct approach to estimate 
infectivity is to let female Anopheles mosquitoes feed on infected human blood or on 
the skin of volunteers. This procedure was called xenodiagnostic by the French 
parasitologist Émile Brumpt, studying Chagas disease, who described this type of 
assay as “une culture naturelle du parasite chez des hôtes favorables” [61]. 
 
Identifying the individuals who drive malaria transmission in endemic areas and 
quantifying the contributions of children and adults to local epidemiology are the 
ultimate goals of using these transmission assays. Sixty years ago, the xenodiagnostic 
method was used in a first attempt to quantify infectiousness at a population level [62]. 
Changing the focus from individuals to entire populations was a major development. 
This initial survey was performed in an area with endemic transmission in Liberia; 
individuals were enrolled in the study regardless of parasite status and mosquitoes 
were fed on their skin to assess infectivity. Approximately 10% of the population were 
capable of infecting mosquitoes and although young children were more often 
infectious, all different age groups contributed similar numbers of infectious 
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individuals to the local malaria transmission reservoir. After this first study, few other 
xenodiagnostic surveys were performed [63-67]. In all these surveys, except one in 
Burkina Faso where the prevalence of infectiousness was 48%, only a small 
percentage (< 15%) of naturally exposed individuals contributed to local transmission 
(Figure 2). Recent epidemiological studies using molecular methods to detect malaria 
parasites indicate that even in low transmission areas significant proportions of 
populations are infected with malaria parasites [68]. The findings of xenodiagnostic 
surveys suggest that the majority of these infected individuals are, at least temporarily, 
non-infectious, possibly due to relatively low gametocyte densities.  
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Figure 2. Xenodiagnostic surveys. Infectiousness (infection of at least one mosquito 
in feeding experiments) prevalences are presented in the y-axis. Previous assessments 
of the malaria infectious reservoir are listed in the x-axis [62-67]. The proportions of 
infectious individuals from different age groups are indicated. Surveys in Burkina 
Faso and Senegal did not include children aged 5 years or younger and infectiousness 
prevalences in older children (aged between 5 and 15 years) were used for both age 
groups. Demographic data from World Population Prospects (United Nations) were 
used to calculate age-adjusted prevalences of infectiousness. 
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All population-wide malaria xenodiagnostic studies were cross-sectional surveys and 
consequently were not able to assess duration of infectivity. In endemic areas, children 
are more likely to develop symptoms that require treatment compared to adults. Since 
effective antimalarials limit the duration of gametocyte circulation [69] and 
consequently of infectivity, older children and adults, who acquired immunity that 
protects against clinical malaria and might remain asymptomatic for several weeks or 
months, might carry gametocytes for longer periods of time after a new infection is 
established. Blood stage immunity that clears asexual stage infection might also 
influence the duration of infectiousness, especially in chronic asymptomatic 
infections. To determine the range of durations of malaria infectiousness in naturally 
acquired infections, longitudinal studies enrolling randomly selected individuals and 
repeatedly assessing infectiousness at regular intervals would be necessary. 
 
Transmission opportunities 
 
The number of mosquito bites a malaria-infected individual receives has a direct 
impact on his or her contribution to local transmission (Box 1). This number depends 
on local vector density, and on the degree of anthropophily (proportion of all mosquito 
blood meals originating from humans) of mosquitoes: while Anopheles gambiae sensu 
stricto and Anopheles funestus are predominantly anthropophylic, another important 
malaria vector species, Anopheles arabiensis, presents some degree of zoophily [70]. 
These factors determine the average exposure to malaria vectors in a community; 
however, different individuals of the same community are not equally exposed to 
mosquitoes and several studies [71-73] indicate that there is substantial variation in 
human attractiveness to Anopheles mosquitoes.  
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Box 1. Exposure to Anopheles mosquitoes determines contribution to local 
transmission. In the figure below, malaria transmission in two hypothetical households 
is presented. Household A is located near a mosquito breeding site and individuals 
living in this house are exposed to higher vector densities compared to individuals in 
household B. Adults are represented by large circles and are assumed to be more 
attractive to mosquitoes than children (smaller circles). Individuals sleeping under bed 
nets were placed in hatched areas. Relative mosquito exposure is represented by the 
number of mosquitoes linked to each resident of these houses. Coloured circles 
correspond to infected individuals, and the colours of the circles in the right panel of 
the figure represent the source of the infections: for example, the infected adult in 
household A was the source of most human infections detectable few weeks later.   
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Studies that quantified age-specific exposure to mosquitoes by direct observation or 
by ABO typing of blood meals indicate that adults are more attractive than children to 
Anopheles mosquitoes [74-77]. This age pattern in vector exposure seems to be related 
to differences in body weight and surface area [77]. Additional factors that may 
influence host attractiveness include body temperature and chemical cues [78-80]. 
Behaviour that prevents mosquitoes from feeding after alighting on the skin also seems 
to change with age [74]. The observation that individuals with gametocytes might be 
more attractive to mosquitoes [81] suggest that the parasite might modulate host 
attractiveness to vectors to maximise its transmission. Of note, a recent study 
identified a chemical compound produced by P. falciparum parasites that could 
mediate enhanced attractiveness of malaria-infected individuals to mosquitoes [82]. 
 
Human behaviour, including use of bed nets, also influences how often individuals are 
exposed to mosquitoes. In areas where nets are widely used, age-specific bed net 
coverage is highest among young children [83-86]. A reduction in availability of one 
group could divert mosquitoes to other demographic groups: in The Gambia, children 
were protected against malaria after insecticide-treated bed nets (ITN) were 
introduced; this protection was at least partially related to the diversion of mosquito 
bites to animals or adults [87]. Other behavioural practices, such as sleeping times and 
activities performed indoors or outdoors at night, influence availability to different 
mosquito populations. If children sleep earlier than their parents, they might be 
protected by bed nets for longer periods of time every night. On the other hand, if 
adults stay outdoors more often than children, they might be an important source of 
outdoor malaria transmission, even if they are less infectious. How different 
behavioural factors influence transmission will depend on local vector populations. 
 
Preventing human-to-mosquito transmission of falciparum parasites 
 
Malaria transmission events can be prevented by reducing the infectiousness of human 
hosts or by minimising the number of host-vector encounters. While the latter can be 
achieved by bed net use and indoor residual spraying of insecticides, infectivity 
reduction relies on drugs that target different steps of the malaria transmission process 
(Figure 1). This section will focus on how antimalarials influence human infectivity.  
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The clearance of asexual stage parasites by antimalarials limits production of 
gametocytes and consequently infectivity duration. Artemisinin-based combination 
therapies (ACTs), in addition to effectively clearing asexual parasites [88], also have 
activity against immature gametocytes [89], which explains the lower post-treatment 
infectivity associated with these drug combinations [90]. Mature gametocytes 
however seem to be only mildly affected by ACTs [89] and this has been associated 
with transmission after treatment initiation [91]. In areas approaching malaria 
elimination, where few additional infected mosquitoes might have a significant impact 
on the persistence of endemic transmission, antimalarials should completely sterilise 
parasites shortly after drug administration. Primaquine can accelerate clearance of 
circulating stage V gametocytes and has been recommended to reduce infectiousness 
of falciparum infections in combination with first-line antimalarials. Questions remain 
on which primaquine doses should be used in combination with different ACTs [92] 
and how primaquine should be deployed (e.g. mass drug administration campaigns). 
A better understanding of the malaria infectious reservoir is essential to inform 
chemotherapy-based approaches to interrupt transmission. 
 
Summary 
 
Human-to-mosquito malaria transmission is an intricate and robust process that allows 
falciparum parasites to propagate despite the wide range of host (peripheral blood) 
environments. At the community level, identifying individuals who contribute to 
malaria transmission requires data on human infectiousness to mosquitoes and 
estimates of mosquito exposure. Indeed, infectious individuals who are frequently 
exposed to anopheline vectors constitute the local human infectious reservoir of 
malaria. The aims of the work presented here were to quantify the infectiousness of 
individuals living in falciparum malaria endemic areas (Chapter 3), their exposure to 
Anopheles mosquitoes (Chapter 4) and the benefits of using primaquine as an 
infectiousness-reducing intervention (Chapter 5).  
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Chapter 2, Objectives 
 
The following chapters describe epidemiological (Chapter 3), entomological 
(Chapter 4) and clinical (Chapter 5) studies on falciparum malaria transmission. 
These different approaches were used to address interconnected questions related to 
the spread of malaria parasites in natural settings.  
 
Rationale 
 
Heterogeneity pervades various aspects of P. falciparum epidemiology – this now 
widely held view is supported by observations that few individuals suffer most clinical 
malaria episodes [1] and that relatively small areas concentrate most malaria burden 
of a community [2]. While these findings concern infection risk and disease 
susceptibility, human malaria transmission potential, the capacity of an infected 
individual to generate secondary mosquito infections, is also thought to be variable, 
although evidence supporting this comes from disconnected studies that determined 
either human infectiousness or attractiveness to mosquitoes (see Chapter 1). A 
realistic quantification of the variability in transmission potential would be 
informative for control programmes and allow optimal implementation of strategies 
that target the transmission process (e.g. administration of gametocytocidal drugs). 
 
Objective 
 
The research projects presented here had as general objective a better understanding 
of falciparum transmission at a community level, which could inform the deployment 
of infectiousness-reducing tools such as primaquine. These studies were 
complementary to each other in that quantifying the two parameters that influence 
malaria transmission from humans to mosquitoes (infectiousness and actual exposure 
to malaria vectors) required different methodologies.  
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Specific objectives 
 
Specific objectives are either related to more comprehensive descriptions of human 
transmission potential (first three objectives) or the direct evaluation of a drug that 
could interrupt infectiousness (fourth objective): 
-  To determine the infectiousness of individuals living in malaria endemic 
areas and how it relates to standard and molecular parasite diagnostics  
-  To estimate how often individuals are exposed to Anopheles mosquitoes and 
how vector exposure varies between individuals and over time 
- To quantify age-specific contributions to malaria transmission based on 
infectiousness and vector exposure estimates 
-  To assess the effect of primaquine on the infectiousness of individuals 
infected with falciparum parasites. 
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Chapter 3, The human infectious reservoir for Plasmodium 
falciparum malaria in areas of differing transmission 
intensity 
 
This chapter describes the results of xenodiagnostic surveys performed in two villages 
in Burkina Faso. This work, together with data from two other study sites (Mbita and 
Kilifi, both in Kenya), was submitted for publication. The version presented here is a 
revised version after initial comments from reviewers. In addition to the manuscript 
and the supplementary material, two new figures are included at the end of this 
chapter. 
 
In October 2017, this manuscript was published in Nature Communications 
(https://doi.org/10.1038/s41467-017-01270-4).   
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Abstract 
 
Detailed understanding of the human infectious reservoir is essential to rationally 
target malaria transmission-reducing interventions. We report on the first multi-region 
study to assess population-wide malaria transmission potential based on 1,209 
mosquito feeding assays in endemic areas in Burkina Faso and Kenya. Overall, 39 
individuals were infectious; age-standardised prevalences of infectiousness in the 
study sites ranged from 0.9 to 6.4%, and the percentage of infected mosquitoes ranged 
from 0.05% (4/7,716) to 1.6% (121/7,749) and correlated positively with transmission 
intensity. In the high endemicity setting, most infectious individuals were identified 
by research-grade microscopy (92.6%; 25/27), whilst 1 of 3 infectious individuals in 
the lowest endemicity setting was detected by molecular techniques alone. Exposure 
to malaria vectors was estimated by genetically matching blood from 1,094 wild-
caught bloodfed mosquitoes with that from humans resident in the same houses. 
Although adults transmitted fewer parasites to mosquitoes than children, they received 
more mosquito bites, balancing their contribution to the infectious reservoir. 
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Introduction 
 
Heterogeneity in the transmission potential of individual hosts is a common feature of 
many infectious diseases, and the identification of individuals who disproportionally 
contribute to onward transmission has attracted much attention [1, 2]. For vector-borne 
infections, quantifying the contribution of individual humans to transmission (the 
infectious reservoir) requires the estimation of host infectivity with the pathogen and 
assessment of the effective contact rate, the frequency with which individual hosts are 
sampled by the vector population. Malaria due to Plasmodium falciparum remains a 
major cause of morbidity and mortality worldwide, despite marked recent declines in 
disease burden [3, 4]. Initiatives to further reduce the burden of malaria, as well as 
efforts to contain the spread of artemisinin resistant malaria parasites in Southeast Asia 
[5], require a thorough understanding of the human infectious reservoir for malaria, 
which would allow interventions to be targeted to individuals who are most important 
for the transmission of infection to mosquitoes. The need to resolve uncertainties in 
identifying these individuals is further necessitated by accumulating evidence that a 
considerable proportion of those infected have very low parasite densities, only 
detectable by sensitive molecular assays. This need is particularly acute in low malaria 
transmission settings and areas threatened by artemisinin resistance [6, 7].  
 
Few epidemiological studies have assessed malaria infectiousness at a population level 
by directly quantifying human infectivity using mosquito feeding experiments [8-12]. 
In these experiments, malaria vectors are fed directly on the skin or on blood through 
a membrane and later dissected for parasite development assessment (e.g., oocyst 
detection). Only one of these studies, conducted in an area of intense malaria 
transmission in Burkina Faso, concurrently quantified asexual stage parasites and the 
transmissible sexual stage parasites (gametocytes) by molecular assays and concluded 
that up to 17% of mosquito infections are caused by submicroscopic parasite carriage 
in humans [12]. In contrast, in Cambodia a hospital-based study involving 
uncomplicated malaria cases reported much lower infectivity of submicroscopic 
infections [13]. The findings of these studies highlight the need for more extensive 
assessments of infectivity to mosquitoes across a range of endemicities. Such 
xenodiagnostic surveys select individuals regardless of parasite carriage, incorporate 
concurrent assessments of parasite and gametocyte densities by molecular assays, 
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which could provide insights into the mechanisms responsible for the variation in 
human-to-mosquito infectiousness, and take into account that individuals are not 
equally bitten by mosquitoes and consequently have different numbers of opportunities 
to transmit [14]. Both infectiousness and exposure to mosquito bites are needed to be 
able to quantify an individual’s contribution to malaria transmission.  
 
In this study, we determined the proportions of mosquito infections originating from 
different demographic groups in areas with low, moderate and high malaria 
transmission intensity. For this, we integrated infectivity data from xenodiagnostic 
surveys, molecular parasite quantification and data on actual exposure to malaria 
vectors, which were generated by blood meal analysis of wild-caught bloodfed 
mosquitoes in study sites in East and West Africa. 
 
Results 
 
Xenodiagnostic surveys were performed in four areas selected to represent three 
different malaria endemicities (Table 1): in Burkina Faso, the villages of Laye and 
Balonghin, sampled during the low intensity season (from here on ‘dry season’) of 
2013 and the peak intensity season (from here on ‘wet season’) of 2014 respectively, 
are both characterised by intense seasonal transmission; malaria transmission in 
Mbita, Kenya, is seasonal with moderate intensity; in Kilifi, also located in Kenya, 
low transmission occurs throughout the year but is higher during the wet season 
months. Membrane feeding experiments were used to quantify infectivity of study 
participants to locally reared Anopheles gambiae mosquitoes [12, 15]. 
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Table 1. Xenodiagnostic surveys. In Mbita, 142 individuals participated in both dry and wet season surveys. 
 
  
Laye Balonghin Mbita Mbita Kilifi Kilifi 
(Burkina Faso) (Burkina Faso) (Kenya) (Kenya) (Kenya) (Kenya) 
Transmission      
  
Intensity High Moderate Low 
Season Dry Wet Dry Wet Dry Wet 
Number of Participants 200 200 202 202 
 
139a 
 
274 
Start Date May – 2013 Oct – 2014 Feb – 2014 May – 2014 Jan – 2014 May – 2014 
End Date Jun – 2013 Nov – 2014 Apr – 2014 Jul – 2014 Apr – 2014 Dec – 2014 
      
  
  N (%) N (%) N (%) N (%) N (%) N (%) 
Age categories (in years)     
  
< 5  50 (25.0) 49 (24.6) 41 (20.3) 50 (24.7) 16 (11.5) 66 (24.1) 
5 - 15  100 (50.0) 100 (50.2) 59 (29.2) 51 (25.2) 33 (23.7) 76 (27.7) 
> 15  50 (25.0) 50 (25.1) 102 (50.5) 101 (50.0) 90 (64.7) 132 (48.2) 
      
  
Gender     
  
Male 98 (49.7) 114 (57.3) 69 (34.2) 86 (42.6) 43 (30.9) 108 (39.4) 
Female 99 (50.2) 85 (42.7) 133 (65.8) 116 (57.4) 96 (69.1) 166 (60.6) 
       
a35 participants were recruited in January – February 2015 
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A total of 1,075 individuals were recruited regardless of their parasitological status, 
including 142 who participated in both dry and wet season surveys in Mbita (Table 
1), with a total of 1,216 parasitological observations. As expected, infection with P. 
falciparum was more prevalent in high (Burkina Faso) versus moderate (Mbita) and 
low (Kilifi) transmission settings (Figure 1a). While parasite positivity was higher 
during wet versus dry season in Burkina Faso (83.8% [166/198] and 50.5% [100/198] 
by 18S qPCR, respectively), in Kilifi, P. falciparum prevalence was similar in both 
seasons (37.4% [52/139] versus 38.3% [105/274] by 18S qPCR during dry and rainy 
seasons, respectively). Molecular detection and quantification of malaria parasites 
failed for samples collected in Mbita due to local electricity issues resulting in an 
unknown number and duration of freeze-thaw cycles. Based on microscopy results, 
the prevalences of asexual stage parasites in the two Mbita surveys were also similar 
(25.7% [52/202] versus 28.2% [57/202] during dry and wet seasons, respectively). In 
all sites, children aged between 5 and 15 years had higher parasite prevalence than 
individuals older than 15 years (Figure 1a). The detectability of infections by 
microscopy was associated with qPCR parasite density (Figure S1); the median 
(interquartile range [IQR]) parasite densities estimated by 18S qPCR in 
microscopically subpatent and patent infections were 4.9 (1.0 – 32.6) and 387.3 (95.1 
– 1,244.5) parasites per µL, respectively. In Balonghin, Laye, Kilifi wet season and 
Kilifi dry season the percentages of infections that were detectable by 18S qPCR but 
negative by microscopy (i.e. submicroscopic infections) were 37.9, 49.5, 58.1 and 
82.7%, respectively (Figure 1b). The distributions of parasite densities estimated by 
18S qPCR suggest that the tails of undetectable infections (infections with densities 
below 0.01 parasites per μL) are negligible for all settings except in Kilifi dry season 
and may be interpreted as evidence that our assays detected the majority of malaria 
infections [6]. 18S qPCR parasite densities were lower in adults compared to children 
living in the same study area (P < 0.001). 
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Figure 1. Age-specific asexual stage parasites prevalence by microscopy (a) and 
distributions of parasite densities (b) by study site. In a, 95% exact binomial 
confidence intervals are presented for microscopy-based parasite prevalence 
estimates. In b, parasite densities quantified by DNA-based 18S qPCR are presented 
(log10 scale) for both patent and subpatent infections. This panel only includes 18S 
qPCR-positive samples (100, 166, 52 and 105 in Burkina Faso dry and wet season 
surveys, and Kilifi dry and wet season surveys, respectively). 
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A small percentage (6.2% [75/1213]) of samples had microscopically detectable levels 
of gametocytes. As expected, Pfs25 mRNA quantitative nucleic acid sequence-based 
amplification (QT-NASBA) identified gametocytes in a much larger percentage of the 
study population (353/809 [43.6%] participants in Burkina Faso and Kilifi surveys). 
Overall, 76.6% (324/423) of all 18S qPCR parasite positive individuals were also 
Pfs25 mRNA QT-NASBA gametocyte positive. Pfs25 mRNA QT-NASBA identified 
more gametocyte carriers in the wet compared to the dry season in both high-endemic 
Burkina Faso (75.2% [149/198] versus 49.5% [98/198]) and low-endemic Kilifi 
(29.6% [81/274] versus 18.0% [25/139]). Similarly, gametocyte densities estimated 
by Pfs25 mRNA QT-NASBA were higher during wet compared to dry season in Kilifi 
and in Burkina Faso (P < 0.001). As with asexual stage parasites, schoolchildren were 
more frequently gametocytaemic than adults (63.0 versus 34.0% in dry-season Laye 
[P = 0.001], 86.9 versus 78.0% in wet-season Balonghin [P = 0.16], and 44.7 versus 
26.5% in Kilifi during the wet season [P = 0.007], respectively), except in Kilifi during 
the dry season (12.1 versus 21.1%, respectively [P = 0.26]).  
 
Exposure to mosquitoes is dependent on age and setting 
 
To generate realistic quantification of the transmission potential of individuals, we 
measured exposure to anopheline vectors to determine the likely frequency with which 
potentially infectious individuals are sampled by mosquitoes. We analysed a total of 
1,874 blood meals from fed mosquitoes (1,066 from Balonghin and 808 from Mbita) 
collected in households in the study villages to estimate human host age-specific 
exposure to malaria vectors. Sampling bloodfed mosquitoes in the low endemic area 
in Kilifi was abandoned when 2 months of sampling yielded only 31 bloodfed 
mosquitoes, which was insufficient for meaningful assessments of mosquito exposure 
by age groups. Molecular typing of blood meals to identify the human blood source 
using a short tandem repeat multiplex PCR assay was successfully performed for 966 
and 689 mosquitoes collected in Burkina Faso and Kenya, respectively. Blood was 
taken from 99.2% (126/127) and 86.7% (163/188) of all household members in 
Balonghin and in Mbita, respectively, to link to mosquito blood meals. 
 
666 and 428 mosquito blood meals were matched to single individuals living in the 
same household where they were collected in Balonghin and Mbita, respectively. Since 
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the association between mosquito exposure and age varied with study site (P = 0.001, 
Figure 2a, c and d), we performed separate analyses for the two sites. In Burkina Faso, 
adults (incidence rate ratio [IRR] 20.9 95% confidence interval [CI] 7.7 – 57.4) and 
children aged 5 to 15 years (IRR 7.7 95% CI 2.9 – 20.8) were more often bitten by 
Anopheles mosquitoes than younger children (< 5 years). In Mbita, although children 
aged < 5 years received relatively fewer bites compared to the other age groups, there 
was no statistically significant difference: IRR 2.3 (95% CI 0.8 – 6.2) for children aged 
5 – 15 years versus younger children (reference group) and IRR 2.1 (95% CI 0.7 – 5.7) 
for adults relative to children aged < 5 years. In Balonghin, weight and height data 
were collected and used to estimate body surface area. In this setting, higher body 
surface area was correlated with age and was associated with more frequent mosquito 
exposure (Figure 2b).  
 
 
  
  
 50 
Figure 2. Mosquito exposure by age and body surface area. In a, the number of 
mosquito bites for each age group and survey is presented; each circle represents a 
study participant, and the mean number of mosquito bites per individual by age group 
is represented by horizontal black lines. In b-d, fractional polynomials were used to 
determine the models that best describe the relationships between mosquito bites and 
age in Mbita (c) and Balonghin (d) and mosquito bites and body surface area 
calculated using Dubois equation (b, data from Balonghin). The lines in panels b-d 
represent predicted numbers of mosquito bites per individual based on selected models 
(see Methods section). The green (b) and purple (c, d) areas represent 95% confidence 
intervals.  
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In both study sites, a non-negligible percentage of mosquito blood meals (15.8% 
[153/966] in Balonghin and 12.6% [87/689] in Mbita) had multiple human DNA 
sources, indicative of mosquitoes feeding on two or more individuals the night before 
collection. Since it was not possible to unequivocally determine the sources of human 
alleles in these blood meals, mosquitoes with multiple human blood sources were not 
included in the statistical analyses. We assessed whether these mosquitoes with 
unknown multiple blood meal sources may have affected our estimations of age-
specific biting patterns. For this, we identified alleles (N=125) that were unique to 
single individuals at the household level based on data from Balonghin, Burkina Faso. 
Fourteen of these unique alleles were in children aged < 5 years living in households 
where at least one multiply fed mosquito was collected. None of these unique alleles 
in young children were present in multiple-source blood meals. To further assess the 
sensitivity of our outcomes to biting preferences of mosquitoes with multiple human 
blood sources, we re-analysed our data assuming 1) that multiple-source meals were 
single blood meals equally allocated to study participants living in the household where 
they were collected, or 2) that individuals who had the lowest genetic distances to the 
genotypes present in these meals were blood sources: under these different 
assumptions, adults were still seven to eleven times more likely to be bitten by 
mosquitoes than young children in Balonghin (see Supplementary Information). 
 
Infectivity to mosquitoes by setting, season and age 
 
Overall, 1,209 mosquito feeding assays were performed to assess infectivity of study 
participants; 39/1,209 (3.2%) individuals infected at least one mosquito (Table 2). No 
mosquitoes (0/3,046) became infected in feeding experiments performed in Kilifi 
during the dry season. In the other surveys, the percentages of mosquitoes that became 
infected ranged from 0.05% (4/7,716) to 1.6% (121/7,749) and was highest in 
Balonghin. Children aged 5 to 15 years had similar infectivity compared to younger 
children (odds ratio [OR] 1.02, 95% CI 0.48 – 2.20, P = 0.95) and were more often 
infectious to mosquitoes than adults, albeit not statistically significantly (OR 2.07, 
95% CI 0.88 – 4.91, P = 0.10; Table 3 and Figure S2). In Burkina Faso, where the 
number of infectious individuals was highest, nearly all infectious individuals (25/27, 
92.6%) had falciparum parasites, asexual or sexual stages, detected by intensive, 
research quality, microscopy effectively screening 200 fields, which is equivalent to 
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~4,000 white blood cells (Figure S3). In Kilifi and Mbita, 2/3 (66.7%) and 7/9 (77.8%) 
infectious individuals, respectively, had microscopically detectable falciparum 
parasites. 6/9 infectious individuals in Mbita surveys had patent Plasmodium malariae 
infections; in Laye, 1/14 infectious individual only had patent P. malariae infection 
(see Supplementary Information, Table S1). Among all 31/39 infectious individuals 
without evidence of co-infection with non-falciparum malaria parasites, P. falciparum 
gametocytes were detected by microscopy in 61.3% (19/31) and by Pfs25 mRNA QT-
NASBA in 100.0% (28/28). Gametocyte densities by Pfs25 mRNA QT-NASBA were 
positively associated with parasite densities by 18S qPCR (Figure 3a; Spearman’s 
rank correlation coefficient for samples with positive 18S qPCR result 0.35, P < 0.001) 
and positively associated with mosquito infection rates (Figure 3b). Mosquito 
infections were mostly observed when feeding on blood containing estimated 
gametocyte densities ≥10 gametocytes per μL (25/28 infectious feeds). The infection 
burden in mosquitoes (oocyst density) was positively associated with the proportion 
of infected mosquitoes (Figure 3c), as previously reported for experiments with 
cultured gametocytes [16, 17] and natural infections with Plasmodium vivax [18]. 
High oocyst counts (10 or more oocysts per midgut) were observed in a subset 
(29/231) of infected mosquitoes in Burkina Faso while in Kilifi all infected mosquitoes 
had oocyst counts below 5. 
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Table 2. Membrane feeding assays.  
 
 
Study Site Season 
Number of 
participants 
Number of 
mosquitoes 
dissected 
Number of 
infectious 
individuals 
Number of 
infected 
mosquitoes 
Number of 
mosquitoes 
dissected per 
participanta 
Proportion of 
infected 
mosquitoes per 
participantb 
Median 
oocyst count 
(range) 
Burkina 
Faso 
Dry 
198 
17,231 14 110 
91 (79 – 97) 
0.04 (0.01 – 
0.27) 
2 (1 – 22) 
 
Wet 
196 
7,749 13 121 
41 (35 – 46) 
0.23 (0.02 – 
0.50) 
3 (1 – 71) 
Mbita, 
Kenya 
Dry 
202 
7,071 7 28 
30 (28 – 49) 
0.02 (0.02 – 
0.57) 
4 (1 – 197) 
 Wet 200 6,842 2 5 30 (27 – 46) 0.07, 0.8 2 (1 – 4) 
Kilifi, 
Kenya 
Dry 
139 
3,046 0 0 
17 (11 – 31) - 
- 
 
Wet 
274 
7,716 3 4 
28 (19 – 35) 
0.04 (0.03 – 
0.07) 
2 (1 – 4) 
aMedian (interquartile range); bMedian (range), only data from infectious individuals included. 
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Table 3. Age-specific contributions to local malaria transmission. For the high (Burkina Faso) and moderate (Mbita, Kenya) transmission 
settings, local age-specific exposure to mosquitoes was quantified and used to estimate the contribution of different age groups to the pool 
of infected mosquitoes. For Kilifi estimates, age-specific mosquito exposure determined in Mbita was used. Estimates in this table include 
P. falciparum mono-infections and mixed or non-falciparum infections. 
  
Prevalence of infectiousness % 
(number of infectious 
individuals/total number of 
participants) 
% of infected mosquitoes (number of 
infected mosquitoes/number of dissected 
mosquitoes) 
Contribution to the pool of 
infected mosquitoes before 
adjustment for mosquito 
exposure (%) 
Contribution to the pool of 
infected mosquitoes after 
adjustment for mosquito 
exposure (%) 
 Age (in years) 
  
< 5   5 - 15 > 15  < 5   5 - 15 > 15  < 5   5 - 15 > 15  < 5  5 - 15 > 15 
                    
  Dry  
8.3 
(4/48) 
9.0 
(9/100) 
2.0 (1/50) 
 0.7 
(29/4,263) 
0.8 
(74/8,707) 
0.2 
(7/4,261)  
25.8 52.5 21.7 2.9 45.8 51.3 
Burkina 
Faso 
                  
  Wet 
6.7 
(3/45) 
7.0 
(7/100) 
6.0 (3/50) 
 2.2 
(40/1,832) 
1.8 
(73/3,979) 
0.4 
(8/1,893)  
32.9 45.0 22.1 3.9 41.1 55.0 
                    
  Dry 
4.9 
(2/41) 
5.1 
(3/59) 
2.0 (2/102) 
 0.1 
(2/1,468) 
0.9 
(21/2,292) 
 0.1 
(5/3,311) 
6.3 69.3 24.4 2.9 73.5 23.6 
Mbita                    
  Wet 0 (0/49) 
2.0 
(1/50) 
1.0 (1/101) 
 0 
(0/1,937) 
0.2 (3/1,674) 
0.06 
(2/3,231)  
0 57.5 42.5 0 59.7 40.3 
                    
Kilifi Wet 
3.0 
(2/66) 
0 (0/76) 0.8 (1/132) 
0.2 
(3/1,850)  
0 (0/2,024)  
 0.03 
(1/3,842) 
64.1 0 35.9 46.0 0 54.0 
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Figure 3. Associations between gametocyte and parasite densities, gametocyte density 
and infectivity, and mosquito infection prevalence and infection burden. In a, the 
association between gametocyte and parasite densities is shown; the y axis is on log10 
scale and parasite (18S qPCR) and gametocyte (Pfs25 mRNA QT-NASBA) densities 
were set to 0.01 parasites (or gametocytes) per µL for negative samples to be included 
in this panel. In b, the proportion of mosquitoes infected in individual feeding 
experiments (y axis) and gametocytes densities (x axis) are shown. Data from all 
surveys are presented: gametocytes densities were quantified by Pfs25 mRNA QT-
NASBA in samples collected in Burkina Faso and Kilifi, and by microscopy for Mbita 
participants. Green circles correspond to samples with patent gametocytes. Both the x 
axis and the segment of the y axis that ranges from 0.01 to 1 are in log10-scale. 
Individuals who did not infect mosquitoes are presented in a separate segment of y 
axis that only includes the 0 y-coordinate. One infectious individual from Mbita who 
infected 4/60 mosquitoes had no gametocytes detected by microscopy and no available 
sample for molecular assays and is therefore not represented in the graph. In c, mean 
and maximum (vertical line) oocyst counts per assay in experiments with at least one 
mosquito infection are presented. The dotted line represents the hypothetical situation 
if all infected mosquitoes in an experiment would have exactly one oocyst. In b and c, 
feeding experiments where participants had evidence of non-falciparum malaria 
infections were excluded.
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At community level, the proportion of individuals who were able to infect mosquitoes 
was related to transmission intensity: prevalences of infectiousness in Laye, 
Balonghin, Mbita dry season, Mbita wet season, and Kilifi wet season were 4.9, 6.4, 
3.3, 1.1 and 0.9%, respectively, after age standardisation based on estimates for Sub-
Saharan Africa [19]. In Laye and Mbita, children younger than 15 years represented 
the majority of infectious individuals during dry season (76.7 and 65.8%, respectively), 
whereas during wet season, adults and children contributed similar numbers of 
infectious individuals to the local infectious reservoir. Estimations that consider age-
specific mosquito infection rates in feeding assays and demographic data indicate that 
children below 15 years of age were responsible for most (~78%) mosquito infections 
in the high endemicity setting in Burkina Faso (Table 3). The relatively high frequency 
of exposure to mosquitoes of adults indicates that, in Burkina Faso, adults, when 
infectious, have on average more opportunities to transmit infection compared to 
children. To estimate the proportion of all mosquito bites in a community on adults, 
population age structure and age-specific relative exposure to mosquitoes as estimated 
by our blood meal analyses were used. Age-specific probability of infection 
transmission in a single blood meal, determined in feeding experiments, was then used 
to calculate the proportion of human-to-mosquito transmission events that starts in 
infected adults. In Burkina Faso, this adjustment for mosquito exposure resulted in a 
marked change in age-specific contributions to infected mosquitoes with adults 
contributing ~50% of all transmission events (Table 3). 
 
Infectivity to mosquitoes in relation to diagnostic performance 
 
In our research settings, expert microscopy alone was sufficiently sensitive to detect 
infections in most infectious individuals (34/39 for all positive feeding assays and 
28/31 when excluding non-falciparum [co-] infections). In routine practice, the lowest 
parasite densities detectable by routine microscopy and rapid diagnostic tests (RDTs) 
are estimated as 100 and 200 parasites per μL, respectively. When expressing the 
contribution to the infectious reservoir incorporating these theoretical limits of 
detection, our findings suggest that routine microscopy and RDT would detect 
infections in nearly half of all infectious individuals in the different settings studied 
(Table S2). The proportion of infected mosquitoes is the transmission endpoint that is 
of more relevance to public health. Before adjusting for mosquito exposure, 19.6 – 
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52.1% of P. falciparum infected mosquitoes became infected from individuals with P. 
falciparum parasite densities below 100 parasites per μL by microscopy, including 
individuals who had subpatent parasites detectable by PCR (Figure 4, top panels). 
After adjusting for mosquito exposure, these percentages increased to 45.4 – 77.3% 
(Figure 4, bottom panels). 
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Figure 4. Proportion of infected mosquitoes by parasite density. Age-specific 
prevalences of falciparum malaria parasites by microscopy and PCR and 
infectiousness prevalences by microscopy-defined parasite density were used to 
estimate the proportions of P. falciparum infected mosquitoes in each community; 
demographic age structure in Sub-Saharan Africa populations was used to standardise 
estimates. Individuals with evidence of non-falciparum malaria infections were 
excluded (N=2). The top panels represent the contributions of human infections with 
different parasite densities to local mosquito infections, after adjusting for population 
age structure and age-and-parasite density-specific probabilities of mosquito infection 
in feeding assays; in the bottom panels, age-specific relative mosquito exposure data 
were used. These calculations were based on 13, 12 and 3 infectious individuals and 
108, 104 and 4 infected mosquitoes in the Burkina Faso dry and wet season surveys 
and in the Kilifi wet season survey, respectively. Data from Mbita are not presented 
as most infectious individuals in this setting had P. malariae co-infections. 
 
 
Burkina Faso
Dry Season
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Discussion 
 
Quantifying the transmission potential of individuals infected with human pathogens 
is important to guide control strategies. Here, we report the first multi-region 
assessment of malaria transmission using a standardised mosquito feeding protocol and 
highly sensitive molecular assays for parasite and gametocyte quantification. We 
observed that only a small proportion of individuals living in malaria endemic areas 
are infectious to mosquitoes at a given time, and that this proportion decreases with 
decreasing transmission intensity. While children were more infectious than adults in 
most surveys, adults were more likely to get bitten by mosquitoes than children and 
consequently individuals aged > 15 years contributed considerably to falciparum 
infections in mosquitoes.  
 
We performed 1,209 mosquito membrane feeding experiments in 1,075 individuals of 
all ages in areas with transmission ranging from intense to low (microscopy-based P. 
falciparum parasite prevalence in participants aged 2 – 10 years of 34.0, 51.0, 40.0 and 
15.5% in Laye, Balonghin, Mbita during wet season, and Kilifi during wet season, 
respectively). Overall, we observed that between 1.0 and 7.1% of study participants 
were capable of infecting mosquitoes at the moment surveys were conducted. This is 
broadly in line with the limited data available on the human infectious reservoir [14] 
that are almost exclusively from areas of intense malaria transmission and used both 
membrane feeding and direct skin feeding assays to measure infectivity. The few 
studies directly comparing skin feeding versus membrane feeding, reviewed in  [20], 
were mostly based on microscopically detectable (high-density) gametocyte carriers 
and suggest that skin feeding is more sensitive. Higher infection rates in skin feeding 
assays are nevertheless strongly correlated with infection rates measured by membrane 
feeding [20]. Skin feeding is biologically attractive since it best reflects natural feeding 
but is ethically fraught due to discomfort, particularly in children. It is currently 
unknown what fraction of low-density infections may result in mosquito infections in 
skin feeding assays but not membrane feeding assays; this information may be of great 
relevance to translate assessments of transmission by membrane feeding assays to the 
natural situation. It is noteworthy that our estimates of the proportion of infectious 
individuals in Burkina Faso in 2013-2014 (4.9 and 6.4%) are lower than those 
previously estimated in the same setting in 2007-2008[12]. In the previous study, 
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transmission intensity was higher than in the current study with 83 – 94 % parasite 
prevalence by RNA-based methods and 11 – 21% of all participants carrying 
microscopically-detectable gametocytes. Lower prevalence and density of parasites 
will have contributed to the observed difference. Temporal variation in the 
susceptibility of the mosquito colony to P. falciparum may also have contributed.  One 
of the strengths of the current study was that we did not select individuals based on 
parasite status. Prior screening by molecular assays may have increased the proportion 
of study participants that was infectious to mosquitoes but would have left 
uncertainties about the transmission potential of undetected infections [6, 21]. We 
therefore recruited participants for feeding assays from the general population and 
successfully used molecular diagnostics in 3 of 4 study sites. In our surveys, all 
infectious individuals with molecular assays results available had parasites detected by 
18S qPCR and Pfs25 mRNA QT-NASBA, except one infectious individual believed 
to have transmitted P. malariae parasites. This suggests that these assays might be 
useful to exclude non-infectious individuals. However, it is currently unclear what the 
kinetics of parasite densities are in chronic submicroscopic infections and conceivable 
that some infections that are not detectable by these sensitive assays at one time-point 
may increase in density and likelihood of transmission in the future. 
 
There is accumulating evidence that in all endemicities substantial proportions of 
falciparum infections are subpatent, i.e. below the limit of detection of conventional 
field diagnostics [7]. In line with this, we detected a considerably larger number of 
infections with molecular assays than microscopy. In contrast to findings with high-
volume qPCR from a large epidemiological study in Southeast Asia [6], where the 
percentage of undetectable infections was estimated based on distributions of 
quantifiable parasite densities, we found no evidence for a significant number of 
infections being missed by 18S qPCR, as indicated by Figure 1b. There is considerable 
interest in quantifying the contribution of low density, submicroscopic, infections to 
onward transmission. Submicroscopic infections are defined as infections that are 
detectable by molecular methods but not by microscopy. In practice, this definition is 
influenced by the sensitivity of microscopy and molecular assays, both of which can 
vary between settings. In our two surveys in Burkina Faso, parasite densities below 
100 parasites per μL were detected by research quality microscopy in 35.2 and 41.5% 
of infectious individuals, who were responsible for 45.4 and 67.2% of infected 
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mosquitoes (Figure 4), suggesting that a non-negligible proportion of transmission 
events may be missed by routine microscopy but not necessarily by research 
microscopy where a larger number of microscopic fields are screened (200 – 400 fields 
in our study). Both parasite quantification by microscopy and qPCR have limitations 
[22, 23] and ultimately the detectability of the infectious reservoir may need to be 
judged against diagnostic practices that are relevant to guide interventions in the field. 
If transmissible low-density infections could be targeted by interventions using 
improved diagnostics, such as highly sensitive RDTs, or that include individuals 
irrespective of parasite status, transmission might be reduced more effectively and 
rapidly. Of note, in Kilifi, one individual of three who were infectious in feeding 
experiments did not carry patent parasites. Whilst we believe the low proportion of 
infectious individuals accurately reflects the low likelihood of transmission in this 
setting, numbers are limited to draw conclusions on the performance of different 
diagnostics to identify the human infectious reservoir for malaria. For this, the 
methodology for xenodiagnostic studies may need to be refined to include sensitive 
screening tools to identify potentially infectious individuals in low transmission areas 
and provide more robust estimates of population infectiousness.  
 
The probability of infecting at least one mosquito and the proportion of infected 
mosquitoes in successful feeding experiments were positively associated with 
gametocyte density [21, 24]. Among infectious individuals with P. falciparum mono-
infection, 61.3% were gametocyte positive by microscopy despite screening 200 
microscopic fields specifically for gametocytes, whilst 100.0% were gametocyte 
positive by Pfs25 mRNA QT-NASBA. In our surveys, mosquito infection rates were 
loosely associated with gametocyte densities [21, 24] and most infectious individuals 
had an estimated density of 10 or more gametocytes per µL by Pfs25 mRNA QT-
NASBA. Since children harbour the highest parasite and gametocyte densities, they 
are generally considered to constitute a large fraction of the infectious reservoir.  
 
Our observations also confirm that children are more likely to infect mosquitoes than 
adults. In the high endemicity setting in the current study, the proportion of mosquitoes 
acquiring malaria infection in feeding experiments was four-fold higher when feeding 
on blood from children below 15 years of age compared to older individuals (Table 
3). This is in broad agreement with previous findings from the same setting (five-fold 
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higher infection rates in children) [12]. In the lower endemicity settings in the current 
study, mosquito infections were rare and occurred from children and adults without 
any obvious age-dependency; however, in Kilifi the number of mosquitoes dissected 
per assay was comparatively low, particularly during the dry season survey, which 
could have prevented the identification of age-related patterns of infectiousness and 
may have resulted in a lower sensitivity to detect sporadic mosquito infections.  
 
One of the novel elements of our study is that we determined actual Anopheles 
mosquito exposure in areas where xenodiagnostic surveys were performed. Earlier 
field quantifications of human attractiveness to malaria vectors [25-27] utilised a series 
of different techniques, ranging from direct observation to blood meal typing using 
markers with limited polymorphism (e.g., ABO group). Our study expanded these 
observations by collecting mosquitoes in households with variable numbers of 
inhabitants in two different endemic settings. We were able to uniquely link 1,094 
mosquito blood meals to household occupants. We observed different patterns in 
mosquito feeding choices in Balonghin (Burkina Faso) versus Mbita (Kenya) that have 
consequences for our interpretation of the human infectious reservoir for malaria. In 
Balonghin, adults were twenty times more likely to be sampled by mosquitoes than 
children aged < 5 years; in Mbita, adults received twice as many bites compared to 
young children. The difference in mosquito feeding choices between the sites may be 
partially explained by differences in bed net use; in Mbita, adults reportedly slept under 
nets more often (87.7%) than children < 5 years (77.8%) and schoolchildren (63.8%), 
while in Burkina Faso, reported bed net usage was similar in all age groups (90.0, 87.1 
and 88.6% for young children, schoolchildren and adults). Differences in species 
composition of local vector populations is another possible explanation, although 
evidence for between-Anopheles species variation in feeding behaviour with regards 
to human hosts at the individual level is limited [28]. Although we also observed 
considerable variation in mosquito exposure between households, and ideally we 
would have been able to quantify mosquito exposure for every xenodiagnostic survey 
participant, our observations of mosquito feeding preferences in a selection of 
households allow a better interpretation of mosquito feeding experiments by 
extrapolating from standardised numbers of mosquitoes in feeding assays to actual 
mosquito sampling rates that are strongly age-dependent. When adjusting our estimates 
for mosquito exposure, the relative contribution of adults to the infectious reservoir 
  
 64 
nearly doubles in Burkina Faso and resulted in a more modest increase in the 
contribution of older individuals to the infectious reservoir in our Kenya sites. Taken 
together, our results highlight that even in highly endemic settings where children 
account for the vast majority of clinical malaria episodes, control interventions that 
target based on infectiousness may require inclusion of adults. 
 
Two unanticipated findings were the high proportion of P. malariae co-infections in 
Mbita and, to a lesser extent, in Burkina Faso and the high proportion of multiple-
human-source blood meals in wild-caught mosquitoes. We only determined non-
falciparum malaria co-infections based on microscopy. Screening for non-falciparum 
infections by molecular methods may have increased the estimates of the parasitaemic 
reservoir of P. malariae and Plasmodium ovale [29] (see Supplementary Information).  
 
Overall, 14.5% of all mosquito blood meals contained DNA from more than one 
human source, indicative of repeated (potentially interrupted) feeding during the night 
prior to sampling. This relatively high percentage of bloodfed mosquitoes with 
multiple human sources of blood is likely to impact comprehensive malaria 
transmission models [30]. Currently these do not explicitly account for multiple 
feeding behaviour, despite previous reports [31, 32]: if sporozoites are inoculated with 
every probing event, mosquito multiple feeding behaviour is likely to increase the risk 
of human malaria infection. A number of mosquito blood meals (14.4% in Balonghin 
and 25.2% in Mbita) could not be linked to residents of study houses. In Balonghin, 
nearly all household occupants provided a blood sample that allowed genetic matching 
to mosquito blood meals and this suggests indoor resting of mosquitoes that fed 
elsewhere. In Mbita however, the higher percentage of unmatched mosquitoes could 
be at least partially explained by the fact that 13.3% (25/188) of household occupants 
did not provide blood samples for matching. A limitation of our mosquito exposure 
estimates is that only malaria vectors resting indoors were collected and outdoor biting 
may account for a non-negligible proportion of mosquito exposure events. One might 
assume that outdoor mosquito exposure is associated with increasing age, reflecting 
sleeping patterns, and our finding of a disproportionate number of mosquito bites 
encountered by adults may thus be an underestimate of true differences in mosquito 
exposure between age groups.  
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Individuals recruited into the xenodiagnostic surveys, as with most community-based 
cross-sectional surveys, were primarily asymptomatic. One study subject in Laye 
developed acute malaria that required immediate treatment prior to feeding assay and 
was not sampled, whilst three study participants in Balonghin reported recent (within 
a week of enrolment) antimalarial treatment, including two individuals, one infectious 
and one non-infectious, with Plasmodium ovale co-infection. In Kilifi, five individuals 
had positive RDT results (parasite densities by microscopy, range 1,240 – 21,500 
parasites per µL) and body temperatures higher than 37.5ºC; one of these individuals 
infected mosquitoes in feeding assays, the others participated in feeding experiments 
but were non-infectious. Data on recent or current malaria symptoms were not 
collected for Mbita participants. Our observation that gametocyte carriage is common 
in asymptomatic infections, 44.2 – 90.0% by Pfs25 mRNA QT-NASBA in those 
individuals with 18S qPCR positive results in our surveys, together with evidence from 
a previous study in Mbita where asymptomatic gametocytaemic children were 
substantially more infectious than symptomatic gametocytaemic children [33], suggest 
that individuals without malaria symptoms are likely to contribute more to local 
transmission compared to symptomatic individuals. Acute symptomatic infections 
with high parasite densities are likely to be characterised by a shorter duration of 
infection and thus shorter time-window that allows gametocyte production compared 
to infections that are more chronic in nature[34]. Despite these considerations that 
support the importance of asymptomatic infections for the human infectious reservoir, 
it is of great relevance to directly compare onward transmission from symptomatic and 
asymptomatic infections in the same setting. Such studies require a design where 
participants are recruited from both local health facilities and the communities they 
serve.  
 
In summary, our study that combined actual mosquito exposure assessments and 
xenodiagnostic surveys indicates that approximately 45 – 75% of all mosquito 
infections are caused by individuals with total parasite densities below 100 parasites 
per μL but gametocyte densities above 10 gametocytes per μL. These densities are not 
generally detected by routine diagnostics. Because of their higher exposure to 
mosquitoes, adults contribute much more to local transmission in some settings than 
expected based on age-specific infectiousness prevalences and adjustments for 
population age structure. These findings highlight the potential roles for sensitive 
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diagnostics and interventions that target all age groups to reduce the transmission of 
malaria across different endemicities.  
 
Methods 
 
Infectivity studies - study areas and populations 
 
Our surveys were conducted in an area of intense malaria transmission in Burkina Faso 
and areas of low and moderate malaria transmission in Kenya. In Burkina Faso, the 
dry season survey was performed in the village of Laye and the wet season survey in 
nearby Balonghin. Both villages are characterized by intense seasonal transmission 
[12, 35]. In Kenya, dry and wet season surveys were performed in Mbita, on the shores 
of Lake Victoria in the Suba District in Western Kenya, an area characterised by 
moderate malaria transmission intensity [36]. In Kilifi, in coastal Kenya, malaria 
transmission occurs throughout the year, but peaks during the wet season [37]. Over 
the last 25 years, malaria incidence in this area has declined to very low levels [38]. 
Of note, health facilities, clinics, were available in all study villages, and artemisinin-
based combination therapy is used as first-line treatment of clinical cases in all sites. 
At the time of these surveys, seasonal malaria chemoprophylaxis for children under 5 
years of age was not part of national guidelines in Burkina Faso. 
 
In all xenodiagnostic surveys, children aged 2 years or older and adults were recruited 
regardless of their parasite status. Individuals with serious clinical conditions requiring 
immediate treatment were not eligible and were referred to the nearest health facility. 
Different population sampling strategies were adopted in different surveys. In Laye, 
recent census data were not available, and the random walk method [39] was used to 
select households (N=59); each selected household contributed 4 (median, IQR 3 – 4) 
study participants, children and adults. In Balonghin (Burkina Faso), a census list was 
used to randomly select households (N=81); individuals living in these households 
were randomly selected to participate in the study. For the cross-sectional study 
performed in Mbita during the dry season, a different sampling strategy was used: the 
study area was divided in sub-areas with ~10 households; the study team visited a sub-
area per day and randomly selected up to six subjects to membrane feeding 
experiments among those individuals willing to participate in the study. During the 
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following wet season, whenever possible, the same individuals that participated in the 
first Mbita survey were recruited. In Kilifi, individuals were invited to come to the 
study clinic and, as with the other study sites, were enrolled regardless of their parasite 
status.  
 
Infectivity studies - sampling strategy 
 
The objective of these surveys was to estimate the prevalence of infectiousness in 
different age groups and transmission settings. Due to logistical constraints related to 
mosquito husbandry and dissection capacity, we estimated that we would be able to 
perform on average 6 membrane feeding assays per day in the different study sites. 
Two hundred participants were recruited during each survey in Burkina Faso and 
Mbita; in Kilifi, seasonality is less marked and 413 individuals were recruited over a 
period of 14 months. Children aged 5 years or younger, schoolchildren (between 5 and 
15 years) and adults (15 years or older) were recruited in a 1 : 2 : 1 ratio in surveys 
performed in Burkina Faso; in Kilifi and Mbita, where adults were hypothesized to 
form a more important part of the parasitaemic reservoir, a ratio of 1 : 1 : 2 was 
targeted.  
 
Infectivity studies - Parasite detection  
 
Light Microscopy 
Malaria parasites (asexual and sexual stages) were quantified by microscopy. All 
slides were double-read and considered negative if no parasites were detected in 100 
(Burkina Faso and Kilifi) or 200 (Mbita) microscopic fields. Densities of falciparum 
and non-falciparum malaria parasites were determined by assuming 8,000 white blood 
cells per µL of blood. 
 
Molecular assays 
Finger prick blood samples collected in Laye, Balonghin and Mbita were stored in 
RNAprotect Cell Reagent® and had nucleic acids extracted using MagNAPure LC 
automatic extractor (Total Nucleic Acid Isolation Kit – High Performance, Roche 
Applied Science). All samples from Kilifi were collected by venipuncture: DNA was 
extracted from 100 L of whole blood using the Qiagen extraction method on an 
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automated Qiaxtractor (Qiagen); for RNA based assays, 100 L of whole blood was 
stored in the appropriate volume of Trizol (Invitrogen) and extracted using the phenol-
chloroform method. 18S rRNA quantitative nucleic acid sequence-based amplification 
(18S QT-NASBA) was used to detect all falciparum parasite stages. Nested PCR 
targeting the 18S rRNA gene was also performed to detect falciparum infections [40]; 
and quantitative PCR (18S qPCR) allowed estimation of P. falciparum parasite 
burden. The detection and quantification of mature P. falciparum gametocytes was 
performed by Pfs25 mRNA QT-NASBA according to the protocol described in [24]. 
 
Infectivity studies - assessment of infectiousness 
 
Venous blood samples collected in heparinized tubes were used for whole blood 
membrane feeding assays following an established protocol [41]. Immediately after 
venipuncture, 400-500 μL of blood were offered to female A. gambiae mosquitoes via 
an artificial membrane. After 20 minutes, fully fed mosquitoes were transferred to 
storage cups by aspiration and kept at 29°C on average for one week (6 – 8 days) with 
access to glucose solution prior to dissection and microscopical assessment for the 
presence of oocysts.  
Mosquito infections in Burkina Faso and Kilifi surveys were confirmed by molecular 
methods. Midguts of mosquitoes with at least one oocyst identified by microscopy 
were stored in 50 µL of RNAprotect Cell Reagent®. MSP2-based nested PCR [42] 
was used for mosquitoes infected in Burkina Faso feeding experiments. Genetic 
material (cDNA) of mosquitoes infected in Kilifi were tested with CSP-based PCR. 
We were not able to reliably confirm mosquito infection for Mbita feeding 
experiments due to technical issues with sample storage. 
 
Mosquito exposure quantification - indoor mosquito collections 
 
Mosquito collections were performed in Balonghin (Burkina Faso) and Mbita 
(Kenya). In Balonghin, mosquito collections were performed at three different 
timepoints: end of the 2013 wet season (November – December), and start (June 2014) 
and peak (September 2014) of the following wet season. Every week indoor mosquito 
collections were performed in five households. During the first entomological survey 
(2013), 40 randomly selected households were included; for each household, 
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mosquitoes were collected during seven days or until 30 blood fed mosquitoes were 
collected. In the second and third surveys, mosquitoes were collected over 5 days in 
20 households with highest mosquito exposure in the first survey and with no changes 
in the number of inhabitants. Demographic data are not available for 5 houses selected 
only for the 2013 survey and where no bloodfed mosquitoes were obtained; 
individuals living in these households are not included in the analysis presented here. 
In Mbita, mosquitoes were collected from 40 households during a single time-point 
from August to December 2015; mosquitoes were collected during seven days or until 
30 blood fed mosquitoes were collected. 
Mosquitoes were aspirated from walls and ceilings between 7 and 9 in the morning 
for a maximum of 15 minutes per house, transferred to paper cups, transported to the 
Centre National de Recherche et de Formation sur le Paludisme (CNRFP) in 
Ouagadougou or the International Centre of Insect Physiology and Ecology (ICIPE) 
in Mbita and processed immediately upon arrival to minimise DNA degradation. If 
blood fed, the abdomen of mosquitoes was squeezed onto a Whatman 3MM filter 
paper for later DNA extraction. To link mosquito blood meals to specific individuals, 
all permanent inhabitants of households selected for mosquito sampling were asked to 
provide a single finger prick blood sample into plastic K2EDTA BD Microtainer® for 
collection of 50 μL-blood samples in 250 μL of RNAprotect Cell Reagent® and onto 
a Whatman 3MM filter paper. 
 
Mosquito exposure quantification - identification of blood meal source 
 
Nucleic acids were extracted from filter papers with squeezed bloodfed mosquito 
abdomens and with human samples from Balonghin study participants using Boom 
extraction method [43]. Nucleic acids from human blood samples collected in Mbita 
in RNAprotect Cell Reagent® were extracted using MagNAPure LC automatic 
extractor (Total Nucleic Acid Isolation Kit – High Performance, Roche Applied 
Science).  
Molecular analysis of blood meals was performed using AuthentifilerTM PCR 
Amplification kit (Applied Biosystems®), which consists of a multiplex PCR assay 
with 9 microsatellite markers and one gender-determining marker (Amelogenin). 
Automated capillary electrophoresis was used to determine DNA profiles in mosquito 
blood meals. 88/1,066 and 72/808 mosquito samples collected in Balonghin and Mbita 
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respectively had no amplification. A small number of samples with amplification had 
less than 10 alleles detected (12 in Balonghin and 47 in Mbita) and were not included 
in our analysis. 153 mosquito samples from Balonghin and 87 from Mbita had 
evidence of multiple human DNA sources, i.e. more than two alleles in at least three 
loci (see Results section and Supplementary Information, including Tables S3 and 
S4). This conservative definition of multiple feeding was to avoid artefacts due to 
minor peaks in capillary electrophoresis resulting from variable amounts of human 
DNA. Of those mosquito blood meal samples that had a single human DNA source, 
139 and 174 in Balonghin and Mbita respectively were not matched to someone living 
in the same household where they were collected and for this reason were also 
excluded from our analysis; additionally 8 mosquitoes collected in Burkina Faso did 
not have identification data available.  
 
Statistical Analysis 
 
Statistical analyses were performed in Stata 14® (StataCorp LP, Texas, USA). 
Prevalences of falciparum parasites and gametocytes were estimated for each 
xenodiagnostic survey. Age-specific (< 5 years, 5 – 15 years and > 15 years) asexual 
stage parasite, gametocyte and infectivity prevalences were also calculated. We 
compared parasite levels between children and adults and gametocyte levels during 
wet season surveys versus dry season surveys using negative binomial regression. 
Logistic regression was used to assess the association between age and infectiousness 
(at least one infected mosquito in feeding experiments). In these models, estimates 
were adjusted for study site. In Figure 4, parasites densities in patent infections were 
defined based on microscopy results; the highest stage-specific density (asexual stage 
levels or gametocytaemia) in individual infections was used. In Figure 1, two 
participants of the Kilifi wet season survey had parasite densities above 100,000 
parasites per µL by 18S qPCR, ~10 – 30 times higher than microscopy-based 
estimates, and microscopy-defined densities were presented for these individuals. In 
Figure 2, fractional polynomials were used to determine the combinations of powers 
that best describe the associations between age or body surface area and number of 
mosquito bites; mixed effects negative binomial models with household as random 
effect were fitted. The lines in Figure 2 panels b-d correspond to the predicted number 
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of mosquito bites per individual; for Balonghin (panels b and d), this number 
represents mosquito exposure during peak wet season over five days.  
 
An algorithm was developed that quantified squared differences in allele sizes for each 
locus between human and mosquito samples and identified study participants with the 
lowest mean allelic distance to each mosquito blood meal. All blood meal samples 
from the Burkina Faso study and a subset of mosquito samples from Mbita had their 
matching result checked manually. The effect of age, as a categorical variable, on 
mosquito exposure (i.e., the number of singly matched mosquito blood meals to an 
individual) was assessed by mixed effects negative binomial regression. Initially, we 
fit a model that included data from both study sites and tested for interaction between 
age effects and study site effects. Since there was a significant interaction (P = 0.001) 
between study site and age effects, we present separate analyses for the different sites. 
For the entomological study in Balonghin, this analysis was adjusted for survey (fixed 
effect). To account for data correlatedness and household-level differences in vector 
abundance, the models for both sites had household as random effect. 
 
Age-specific contributions to transmission were estimated as (i) the proportion of 
infectious individuals from each age group and (ii) the proportion of infected 
mosquitoes acquiring infection from each age group.  
 
The relative contribution (Ci) of each age group i to the pool of infective individuals 
in each study site was calculated: 
 
                              [1] 
 
where di is the proportion of the population in age group i, pi is the age-specific 
prevalence of infectivity (at least one infected mosquito in feeding experiments), and 
n is the number of categories into which the population was divided. Values of pi are 
study site-specific. For this analysis three age categories were used (n = 3, < 5 years, 
5 – 15 years and > 15 years) and we used an age structure based on recent estimates 
for Sub-Saharan Africa [19].  
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To estimate the proportion of infected mosquitoes that acquire their parasites from a 
specific age group (Mi) (Table 3), the following formulas were used: 
 
                             [2] 
                         
                     [3] 
 
where bi is the proportion of all mosquito bites which occur on age group i, and ai 
represents the age-specific relative exposure to mosquitoes, which was calculated 
based on the results of mosquito blood meal analysis (for Burkina Faso study sites, a1 
= 1, a2 = 7.7, a3 = 20.9; for Mbita surveys, a1 = 1, a2 = 2.3, a3 = 2.1); wi corresponds 
to the probability of mosquito infection (number of mosquitoes infected divided by 
total number of mosquitoes dissected) in feeding assays involving individuals from 
age group i, regardless of their parasite status.  
 
We also determined the contribution to transmission of individuals with different 
parasite densities (Mj) (Figure 4). Equation 3 was modified by re-assigning mosquito 
bites by age and diagnostic status using age-specific prevalences of infections with 
different parasite levels (tij), where i corresponds to specific age groups and j to 
parasite density categories: 
 
                         [4] 
 
 
Here, m represents the number of different diagnostics categories: j = 1 (no patent 
parasites but PCR positive), j = 2 (patent infections with < 100 parasites per μL), j = 
3 (patent infections with 100 – 200 parasites per μL) or j=4 (patent infections with 
>200 parasites per μL). In this modified framework, wij represents the age (i) and 
parasite density category (j) specific probability of mosquito infection in feeding 
assays. 
 
Ethics  
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The study received ethical clearance from local and international ethical committees: 
xenodiagnostic and entomological studies in Burkina Faso were approved by the 
ethical review committees of the Ministry of Health of Burkina Faso and of the 
London School of Hygiene and Tropical Medicine (reference numbers 6271 and 
6447); xenodiagnostic surveys in Mbita and Kilifi, Kenya, were combined in one 
protocol and received clearance from the Kenya Medical Research Institute Scientific 
Ethics Research Unit (KEMRI-SERU SSC number 2574). Written informed consent 
was obtained from all participants or the parents/guardians. 
 
Data availability 
 
The datasets generated and analysed during the current study are available from the 
corresponding author on reasonable request. 
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Supplementary Information 
 
Quantification of parasites 
 
We observed a strong association between 18S qPCR parasite densities and 
microscopy parasite densities. Where both assays detected parasites, microscopy 
overestimated parasite densities compared to 18S qPCR (Figure S1). One possible 
explanation for this overestimation is the assumption made during microscopy-based 
quantification that white blood cells levels are equal to 8,000 cell per µL. In one of the 
study sites in Burkina Faso (Balonghin), 34.4% of children recruited to a recent 
primaquine trial had white blood cell counts per µL of blood below 6,000 at enrolment 
(Gonçalves, personal communication).  
 
Non-falciparum malarias and their potential infectiousness 
 
Microscopically-detectable non-falciparum malaria parasites were present in all study 
sites. Patent Plasmodium malariae infections were more common in Mbita (5.9 
[12/202] and 7.9 [16/202] % prevalence during dry and rainy seasons, respectively); 
only one individual in Kilifi had P. malariae co-infection. In Laye, three participants 
had patent malariae parasites, whilst in Balonghin one malariae infection was 
observed. Plasmodium ovale infections (N=4) were also detected during surveys in 
Balonghin and Mbita (wet season). In total, 29 individuals had more than one malaria 
species identified in blood smear. 
Overall, 8 of the 39 infectious individuals had patent non-falciparum malaria parasites 
(Table S1). In Laye, one individual who infected 2/77 mosquitoes had patent malariae 
gametocytes and no evidence of falciparum infection by microscopy or molecular 
assays. In Balonghin, one individual who infected 17/35 mosquitoes had both patent 
ovale and falciparum gametocytes. In Mbita, 5/9 infectious individuals carried both 
patent falciparum and malariae parasites and one, only malariae parasites, including 
gametocytes.  
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Sensitivity analysis on age-specific exposure to mosquitoes in Burkina Faso 
 
To assess whether the non-negligible number of mosquitoes with multiple human 
source blood meal could have influenced our results, we fit mixed effects negative 
binomial models similar to the model described in the Methods section under different 
assumptions. In one model, we evenly allocated mosquito bites with multiple human 
DNA sources to all individuals living in the households where they were collected. 
Under this conservative assumption, adults (incidence rate ratio [IRR] 7.7 95% 
confidence interval [CI] 3.8 – 15.7) and children aged 5 to 15 years (IRR 3.7 95% CI 
1.8 – 7.4) were more often bitten by Anopheles mosquitoes than younger children 
(Table S3). In a different analysis, we assumed that individuals who had the lowest 
genetic distances to the genotypes present in these meals were blood sources. As most 
(98%) singly matched meals involved mean squared allelic distances lower than 1, this 
cut-off was used. Using this approach, we linked 125 multiple-source blood meals to 
one or two individuals in the same household, and we observed that adults (IRR 10.9 
95% CI 4.6 – 25.8) and schoolchildren (IRR 4.6 95% CI 2.0 – 10.5) were more often 
exposed to anopheline vectors than children aged < 5 years. 
 
  
  
 79 
Figure S1. Parasite quantification by 18S rRNA gene qPCR and microscopy. To 
facilitate visualisation, y-axes (parasite densities quantified by 18S qPCR) are in log10 
scale. Samples from four individuals with patent asexual stage parasites (one sample 
from Burkina Faso dry season survey, and three from Kilifi wet season survey) did not 
have parasites detected by 18S qPCR and are not presented. The inset plots present 
parasitaemias when parasites were detected by both methods. 
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Figure S2. Age-specific prevalences of infectiousness by site and season.  
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Figure S3. Infectiousness to mosquitoes and infection detectability. The percentages 
(y-axes) of infectious individuals with parasites detected by different diagnostic 
methods (x-axes) are presented. 
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Table S1. Infectious individuals sorted study site survey, and 18S qPCR-based parasite density. 
Study Site Survey 
Proportion (n/N) 
infected 
mosquitoes 
Median 
(range) oocyst 
count 
Patent 
falciparum 
asexual  
Patent 
falciparum 
gametocytes 
P. malariae 
parasites 
P. ovale 
parasites 
Pfs25 
mRNA 
QT-
NASBA  
18S rRNA 
QT-
NASBA 
18S qPCR  
18S qPCR 
(parasites per 
µL) 
Pfs25 QT-NASBA 
(gametocytes per 
µL) 
Molecular confirmation of 
falciparum mosquito infection 
Laye Dry 0.03 (2/77) (1, 1) Negative Negative Positive Negative Negative Negative Negative 0.0 0.0 Negative 
Laye Dry 0.10 (7/71) 3 (1 – 4) Negative Positive Negative Negative Positive Positive Positive 0.4 110.1 All P. falciparum 
Laye Dry 0.27 (21/78) 2 (1 – 5) Negative Positive Negative Negative Positive Positive Positive 0.7 9.2 All P. falciparum 
Laye Dry 0.04 (3/73) 1 (1 – 1) Positive Positive Negative Negative Positive Positive Positive 1.0 7.2 All P. falciparum 
Laye Dry 0.05 (3/65) 1 (1 – 1) Negative Positive Negative Negative Positive Negative Positive 8.6 10.8 All P. falciparum 
Laye Dry 0.16 (16/98) 1 (1 – 5) Negative Negative Negative Negative Positive Positive Positive 11.9 10.9 All P. falciparum 
Laye Dry 0.02 (2/96) (1, 3) Positive Negative Negative Negative Positive Positive Positive 150.3 50.3 All P. falciparum 
Laye Dry 0.20 (14/71) 3.5 (1 – 11) Positive Negative Negative Negative Positive Positive Positive 200.9 88.1 All P. falciparum 
Laye Dry 0.28 (24/87) 2.5 (1 – 22) Positive Positive Negative Negative Positive Positive Positive 218.8 42.5 All P. falciparum 
Laye Dry 0.03 (3/88) 2 (1 – 2) Positive Positive Negative Negative Positive Positive Positive 281.2 11.0 All P. falciparum 
Laye Dry 0.01 (1/97) 1 Positive Negative Negative Negative Positive Positive Positive 399.0 24.1 All P. falciparum 
Laye Dry 0.02 (2/81) (1, 1) Positive Negative Negative Negative Positive Positive Positive 431.5 13.0 All P. falciparum 
Laye Dry 0.01 (1/76) 1 Positive Negative Negative Negative Positive Positive Positive 1119.4 21.4 All P. falciparum 
Laye Dry 0.13 (11/84) 2 (1 – 4) Positive Negative Negative Negative Positive Negative Positive 1782.4 54.3 All P. falciparum 
Balonghin Wet 0.03 (1/39) 1 Negative Positive Negative Negative Positive Positive Positive 0.4 21.2 All P. falciparum 
Balonghin Wet 0.05 (2/39) (1, 2) Negative Positive Negative Negative Positive Positive Positive 1.3 116.9 All P. falciparum 
Balonghin Wet 0.33 (14/43) 2 (1 – 5) Positive Positive Negative Negative Positive Positive Positive 15.1 106.2 All P. falciparum 
Balonghin Wet 0.05 (2/44) (2, 2) Positive Negative Negative Negative Positive Positive Positive 54.1 68.1 All P. falciparum 
Balonghin Wet 0.14 (5/35) 2 (1 – 5) Positive Positive Negative Negative Positive Positive Positive 114.3 89.9 All P. falciparum 
Balonghin Wet 0.03 (1/33) 1 Positive Positive Negative Negative Positive Positive Positive 356.5 32.7 All P. falciparum 
Balonghin Wet 0.34 (17/50) 3 (1 – 16) Positive Negative Negative Negative Positive Positive Positive 435.5 161.1 All P. falciparum 
Balonghin Wet 0.29 (15/51) 1 (1 – 15) Positive Positive Negative Negative Positive Positive Positive 450.8 144.5 All P. falciparum 
Balonghin Wet 0.49 (17/35) 4 (1 – 15) Positive Positive Negative Positive Positive Positive Positive 712.9 0.04 Negative 
Balonghin Wet 0.23 (8/35) 4 (2 – 13) Positive Positive Negative Negative Positive Positive Positive 1324.3 162.5 All P. falciparum 
Balonghin Wet 0.27 (12/45) 4 (1 – 9) Positive Positive Negative Negative Positive Positive Positive 2264.6 220.8 All P. falciparum 
Balonghin Wet 0.50 (24/48) 16 (1 – 71) Positive Positive Negative Negative Positive Positive Positive 4305.3 3228.5 All P. falciparum 
Balonghin Wet 0.07 (3/41) 8 (3 – 8) Positive Positive Negative Negative Positive Positive Positive 30478.9 144.9 All P. falciparum 
Mbita Dry 0.07 (4/60) 1 (1 – 1) Negative Negative Negative Negative - - - - - 1 mosq. P. falciparum 
Mbita Dry 0.02 (1/56) 1 Positive Negative Positive Negative - - - - - - 
Mbita Dry 0.57 (17/30) 8 (2 – 197) Negative Positive Positive Negative - - - - - 1 mosq. P. malariae 
Mbita Dry 0.02 (1/44) 3 Positive Positive Positive Negative - - - - - - 
Mbita Dry 0.02 (1/60) 1 Positive Positive Negative Negative - - - - - - 
Mbita Dry 0.02 (1/60) 1 Positive Positive Negative Negative - - - - - - 
Mbita Dry 0.05 (3/60) 1 (1 – 1) Positive Positive Positive Negative - - - - - 1 mosq. P. malariae 
Mbita Wet 0.07 (2/30) (1, 2) Negative Negative Positive Negative - - - - -   
Mbita Wet 0.08 (3/37) 2 (1 – 4) Positive Positive Positive Negative - - - - - - 
Kilifi Wet 0.07 (1/15) 1 Negative Negative Negative Negative Positive Positive Positive 30.7 2.0 Positive 
Kilifi Wet 0.04 (2/45) (1, 4) Positive Positive Negative Negative Positive Positive Positive 1361.4 266.1 Positive 
Kilifi Wet 0.03 (1/32) 3 Positive Negative Negative Negative Positive Positive Positive 5345.8 107.9 Positive 
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Table S2. Malaria diagnostics and contribution to the local population of infectious 
individuals.  
 
  
Contribution to the pool of infectious individuals 
(%) 
  
Laye Balonghin Kilifi (Wet Season)   
Diagnostics  
    
  
No patent parasites and PCR 
+ 5.7 0 46.5   
< 100 parasites per μL 
 
35.2 41.5 0.0   
100 - 200 parasites per μL 
 
0.0 4.3 0.0   
> 200 parasites per μL   59.0 54.1 53.5   
 
 
 
Table S3. Sensitivity analyses of age-specific mosquito exposure in Burkina Faso.  
 
  Incidence Rate Ratio (95% confidence interval) 
  
Excluding mixed 
blood meal 
mosquitoes* 
Including mixed blood 
meal mosquitoes and 
assuming equal 
exposure** 
Including mixed blood meal 
mosquitoes and matching to 
lowest genetic distance 
Age (in years)     
< 5 Reference Reference Reference 
5 – 15 7.7 (2.9 - 20.8) 3.7 (1.8 - 7.4) 4.6 (2.0 - 10.5) 
> 15 20.9 (7.7 - 57.4) 7.7 (3.8 - 15.7) 10.9 (4.6 - 25.8)  
*as reported in the main text; based on 666 uniquely matched mosquitoes 
**assuming equal exposure among age groups of mosquitoes with multiple blood meals. This analysis 
was based on 666 singly matched mosquitoes and 153 mosquitoes with multiple human DNA sources 
that were allocated evenly to all individuals living in the households where they were collected. 
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Table S4. Distribution of multiple source blood meals by number of loci with multiple 
alleles (three or more alleles per loci). 
 
 Study sites 
Number of loci with 
 multiple alleles (3 or more) 
Balonghin Mbita 
3 45 27 
4 29 13 
5 38 21 
6 28 8 
7 11 12 
8 2 2 
9 0 4 
10 0 0 
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Additional Figures 
Additional Figure 1. Distribution of gametocyte densities during dry (Laye) and wet 
(Balonghin) seasons. Only Pfs25 mRNA QT-NASBA results of individuals who had 
parasites detected by 18S qPCR are included in this graph. 57 and 48.2% of parasite-
positive individuals in Laye and Balonghin, respectively, had 10 or fewer gametocytes 
per μL. A total of 14 individuals had sexual stage parasites detected by QT-NASBA 
and negative 18S qPCR results and are not included in this figure. 
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Additional Figure 2. Distribution of parasites by households during the two 
xenodiagnostic surveys in Burkina Faso. Only households with four study participants 
were included in this graph (34 houses in Laye, 14 in Balonghin). The top panels 
represent household-specific prevalences (radial axes) of parasites (18S qPCR) and 
gametocytes (Pfs25 mRNA QT-NASBA). The bottom panels represent the mean 
densities (per µL) of parasites and gametocytes in different households; only 
individuals with parasites detected by molecular assays were included in the 
calculations of the means. The radial axes of the lower panels are in logarithmic scale 
(base 10). Of note, 2/27 infectious individuals, recruited in Balonghin, lived in the 
same house. 
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Chapter 4, Variation in natural exposure to anopheles 
mosquitoes and its effects on malaria transmission 
 
 
The number of mosquito bites a malaria-infected individual receives determines his or 
her contribution to onward malaria transmission. In this chapter, I present data on 
individual-level exposure to Anopheles mosquitoes in a village with endemic malaria 
transmission in Burkina Faso. This work was submitted for publication in October 
2017; an early draft is included in this chapter. An additional figure is also presented 
at the end of the chapter. 
 
A revised version (December 2017) of this manuscript, with modifications suggested 
by reviewers, as well as our answers to reviewers’ comments are included in the 
Appendix. 
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Abstract 
Variation in biting frequency by Anopheles mosquitoes can explain some of the 
heterogeneity in malaria transmission in endemic areas. In this study, we assessed 
natural exposure to mosquitoes by genotyping bloodfed resting mosquitoes and 
matching their blood meals with blood from residents of local households. We 
observed that the distribution of mosquito bites exceeded the Pareto rule (20/80) in 
two of the three surveys performed: 85.1, 76.0, and 95.5% of mosquito blood meals 
were matched to one fifth of the study population at the start, peak and end of the 
transmission season, respectively. Both between- and within-household differences in 
exposure contributed to the high number of individuals with no matched blood meals. 
The distribution of potential parasite inoculations (i.e., bites from mosquitoes with 
sporozoites detected by PCR) followed a similar pattern, with a small number of 
individuals receiving multiple potentially infectious bites over the period of a few 
days. Together, our findings indicate that some individuals are much more frequently 
sampled and infected by Anopheles mosquitoes than the rest of the population, which 
might explain heterogeneity in infection risk and suggests significant variation in 
malaria transmission potential.   
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Introduction 
 
Malaria epidemiology is doubly dependent on the frequency of contacts between 
human hosts and Anopheles mosquitoes, which links the number of mosquito 
infections caused by an infectious human host and the rate at which uninfected humans 
acquire infections. Describing the variability in the frequency of human sampling by 
malaria vectors is therefore essential to understand parasite transmission from and to 
humans. While at a local level vector density determines average mosquito exposure, 
even within the same locality individuals may not be equally likely to be bitten by 
Anopheles mosquitoes [1-4]. Exposure to malaria vectors is influenced by host 
availability (i.e., amount of time an individual remains unprotected against mosquito 
bites in an environment where anopheline mosquitoes are present) and attractiveness 
to mosquitoes [5]. Availability determines when and where individuals might be 
sampled by mosquitoes: a multicentre study in Africa that collected entomological and 
human behavioural data estimated that more than three quarters of human exposure to 
anopheline mosquito bites occur when individuals are indoors [6]. For individuals who 
are accessible to malaria vectors, age and body surface area [3, 7] are two major 
determinants of attractiveness to mosquitoes, although other factors also play a role 
[2].  
 
The multifactorial nature of mosquito exposure in malaria endemic areas indicates 
that, while experimental and quasi-experimental studies are valuable, they will not 
accurately capture inter-individual variation in actual exposure. Here, we describe the 
variability in real-life exposure to malaria vectors by linking, through DNA 
fingerprinting, blood meals of wild-caught mosquitoes to humans living in the 
households where they were collected. Previously we have shown that these 
mosquitoes fed more often on adults (Gonçalves et al, submitted). We now extend this 
analysis to assess whether mosquito bites are distributed evenly in the population or 
are concentrated in a few individuals and to determine the frequency of Anopheles 
species-specific mosquito bites, and potential parasite inoculations (i.e., sporozoite-
positive mosquito bites) per individual.  
 
Methods 
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Study area and mosquito collections 
 
This study was conducted in Balonghin (health district of Saponé, Burkina Faso), an 
area characterized by seasonal malaria transmission between August and December 
following rainfall between June and September [8]. Enrolment coincided with a 
malaria treatment trial that recruited asymptomatic parasite carriers [9], and all 
households where children participating in that trial lived were eligible for this study.  
 
Indoor mosquito collections were performed at the end of the 2013 transmission 
season (October – December), and at the start (July 2014) and peak (September 2014) 
of the following wet season. Every week mosquito collections were performed in five 
households. Forty households were included in the first survey and, for each 
household, mosquitoes were collected by mouth aspiration for seven days or until 30 
bloodfed Anopheles mosquitoes were collected. In 2014, mosquito collections were 
performed in 20 of these 40 initial households over 10 days (5 days in July, and 5 in 
September). Bloodfed mosquitoes had their head-thoraces stored for speciation and 
malaria infection assessment by PCR (see below), and their abdomens containing 
blood meal material squeezed on filter paper.  
 
Mosquito blood meal typing 
 
Genetic typing of these blood meal samples has been described in detail elsewhere 
(Gonçalves et al, submitted). Briefly, bloodfed mosquitoes’ abdomens were processed 
using Boom extraction method [10]. The AuthentifilerTM PCR Amplification kit 
(Applied Biosystems®), with nine human microsatellite markers and one gender 
marker, was used to compare human DNA in blood meals and in blood samples 
collected from study participants. Capillary electrophoresis was used to determine 
DNA profiles.  
 
Mosquito speciation assay and malaria parasite detection by PCR 
 
DNA was extracted from individual head-thoraces using the DNAzol procedure 
(Invitrogen). Mosquito speciation was performed using a single PCR-RFLP assay as 
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described by Fanello and colleagues [11], and nested PCR [12] was used for 
Plasmodium falciparum detection.  
 
Statistical analysis 
 
Stata version 14 (Stata Corporation, College Station, TX, USA) was used for statistical 
analysis. Demographic data were not available for five houses where no bloodfed 
mosquitoes were collected; study participants living in these households are not 
included in the analyses presented here. We used the number of bloodfed Anopheles 
mosquitoes collected per day per household when comparing different surveys. 
Wilcoxon signed-rank test was used to assess within-household changes in Anopheles 
abundance. A mixed effects logistic model was used to quantify the association 
between mosquito falciparum infection status and mosquito species; the analysis was 
adjusted for survey time (fixed effect), and household of collection was used as 
random effect.  
 
Mixed effects negative binomial models [13, 14] were used to assess overdispersion 
in exposure to mosquitoes, after adjustment for variability linked to age and survey 
time (fixed effects) and household-level variation (random effect). These models were 
also used in Anopheles species-specific analysis. Likelihood-ratio test compared 
mixed effects negative binomial models and mixed effects Poisson models. 
 
Ethics 
 
Ethical clearance was obtained from the London School of Hygiene & Tropical 
Medicine ethics committee (reference number 6447), and the ethics committee of the 
Centre National de Recherche et de Formation sur le Paludisme (Burkina Faso). 
 
Results 
 
Study households 
 
Thirty-five households were included in this analysis. The median number of 
individuals living in each study household was 3 (range, 2 – 5). We collected 325, 620 
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and 190 bloodfed Anopheles mosquitoes at the start (2014), peak (2014) and end 
(2013) of the transmission season, respectively (Table 1). During the 2013 survey, 
21/35 houses had at least one bloodfed mosquito collected; in 2014, 19/20 and 20/20 
households had fed mosquitoes collected at the start and peak of transmission season, 
respectively. The average number of bloodfed mosquitoes collected per day in each 
household was higher at the start (median 2.3, interquartile range [IQR] 0.7 – 5.5) and 
peak (median 3.9, IQR 2.1 – 8.5) compared to the end (median 0.1, IQR 0 – 0.6 
mosquitoes per day) of the transmission season (P = 0.001 and <0.001, respectively). 
There was no correlation between the average number of bloodfed mosquitoes 
collected per day and the number of individuals living in each household (Spearman’s 
rank correlation coefficients, 0.15, 0.03 and 0.06 for the first, second and third surveys 
respectively; all P > 0.05). Of note, at the end of 2013 transmission season, most 
mosquito collections performed after mid-November were unsuccessful, suggesting a 
village-wide reduction in mosquito abundance during this period (Supporting 
Information Figure S1). 
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Table 1. Study surveys. 
 
  First Survey Second Survey Third Survey 
     
Start Date October, 2013 June, 2014 September, 2014 
Number of sampling days 54 20 20 
     
Timing End of transmission season Start of transmission season Peak of transmission season 
     
Number of households 35* 20 20 
     
Number of participants 126 81 77 
     
  N (%) N (%) N (%) 
Age categories**    
< 5 years 20 (15.9) 12 (14.8) 12 (15.6) 
5 - 15 years 62 (49.2) 39 (48.2) 37 (48.0) 
> 15 years 44 (34.9) 30 (37.0) 28 (36.4) 
     
Gender    
Male 41 (32.5) 22 (27.2) 21 (27.3) 
Female 85 (67.5) 59 (72.8) 56 (72.7) 
    
Number of bloodfed mosquitoes collected 190 325 620 
    
     
*Demographic information not available for individuals living in 5/40 households (first survey only); **Age at enrolment (first survey) 
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Heterogeneity in actual exposure to malaria vectors 
 
Most (1,066/1,135) collected bloodfed mosquitoes had their blood meal analysed. 100 
mosquitoes had no amplification or only few alleles amplified. More than 60% 
(666/966) of successfully typed blood meals were matched to single study participants 
living in the household where they were collected; this was consistent across surveys 
(65.2, 71.6 and 70.4% at the start, peak and end of transmission season, respectively). 
Mosquito blood meals with more than two alleles in at least three loci (N=153) were 
considered to have multiple human DNA sources and were not included in this 
analysis. In Figure 1, the distributions of the number of mosquito bites each individual 
received during different study surveys are presented. Approximately 20% of 
individuals, including children and adults, provided 85.1, 76.0 and 95.5% of mosquito 
blood meals at the start, peak and end of the transmission season, respectively. 
Throughout the study, a small number of individuals, mostly adults, were matched to 
considerably higher numbers of blood meals compared to the rest of the population. 
Conversely, 32.0 – 76.2% of study participants were not linked to bloodfed 
mosquitoes during the study surveys. In an analysis of data from all surveys, mixed 
effects negative binomial regression better explained the distribution of mosquito bite 
counts than mixed effects Poisson models (P<0.001), after adjustments for age and 
survey and household-level data correlatedness. In sensitivity analyses that assign 
blood meals with multiple human DNA sources to the least exposed individuals in 
each household, the ~20% of the population with most mosquito bites were linked to 
at least 70% of matched blood meals (Supporting Information Figure S2). 
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Figure 1. Inter-individual variation in exposure to Anopheles mosquitoes. In a, the 
distributions of mosquito blood meals matched to each study participant are presented 
for the three different surveys. In b, the cumulative proportion of mosquito blood 
meals (y-axis) matched to study participants (x-axis) sorted by number of mosquito 
bites received is presented for the different surveys. At the peak of the transmission 
season, six individuals were absent or only present during one collection day and were 
not included in this graph. Only singly matched bloodfed mosquitoes linked to 
individuals living in the same household where they were collected are included in 
this figure.  
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For individuals who participated in all surveys, there were positive correlations 
between numbers of matched mosquitoes 1) at the start and peak of transmission 
season (Spearman’s rank correlation coefficient 0.24, P=0.04) and 2) at the start and 
end of transmission season (Spearman’s rank correlation coefficient 0.33, P=0.002), 
suggesting some consistency in preferential biting. However, some individuals with 
highest numbers of matched blood meals at the start of the transmission season 
received few or no mosquito bites in other surveys (Figure 2A and B).  
 
Within-household heterogeneity in mosquito exposure was observed: in many 
households, the most exposed individual was the source of more than 50% of mosquito 
blood meals (Figure 2C). While individuals with high numbers of matched blood 
meals often lived in households with high total numbers of matched mosquitoes 
(Supporting Information Figure S3), in all houses included in this study there were 
individuals with relatively low mosquito exposure. 
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Figure 2. Temporal (a and b) and within-household (c) variation in exposure to 
malaria vectors. In a and b, individuals were ranked according to the number of 
matched mosquito blood meals per collection day at the start of the transmission 
season; each green circle represents a study participant and the distance between 
a green circle and the centre of the panel is proportional to the loge-transformed 
number of mosquito bites received per collection day (see Supporting 
Information for details). Each red circle corresponds to the number of singly 
matched blood meals at the peak (a) or end (b) of the transmission season for 
the individual represented by the radially aligned green circle. The dotted inner 
circle corresponds to no mosquito bites, and the dotted outer circle, to 5 bites per 
day. In c, each of the three columns corresponds to a different survey (S, Start 
of transmission season; P, Peak of transmission season; E, End of transmission 
season) for a select number of households. Individuals in the same household 
are denoted by different colours, which are consistent in the different surveys. 
The proportions of matched blood meals linked to each individual by household 
and survey are on the y-axis; only the 8 households with at least 5 matched 
mosquitoes at the start of the transmission season and three or more study 
participants are shown. The numbers of individuals living in the households 
included in panel c are (from left to right): 5, 5, 4, 4, 6, 5, 3 and 3.
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Anopheles species-specific feeding choices 
 
Mosquitoes collected during the study were genotyped for species identification. At 
the start of the transmission season, Anopheles coluzzii represented 44.7% (142/318) 
of all bloodfed mosquitoes, while at the peak and end of the transmission season most 
bloodfed mosquitoes were Anopheles gambiae sensu strictu (74.0 [450/608] and 
53.7% [102/190], respectively) (Supporting Information Figure S1). Species-specific 
distributions of blood meals matched to study participants are presented in Figure S4 
(Supporting Information) and suggest that heterogeneity in exposure to anopheline 
mosquitoes occurs irrespective of vector species. Of note, mixed effects negative 
binomial models better fit the distribution of Anopheles species-specific mosquito 
bites compared to mixed effects Poisson models (see Supporting Information). 
Additionally, rates at which individuals were bitten by mosquitoes of different species 
were positively associated (Supporting Information Figure S5) (all P < 0.01 in mixed 
effects negative binomial models that included number of species-specific matched 
blood meals and age as covariates).  
 
Transmission of parasites from mosquitoes to humans 
 
The prevalence of malaria parasites in bloodfed mosquitoes identified via PCR of head 
and thorax was higher at the end versus start and peak of the transmission season (22.8, 
4.3 and 8.6%, respectively), and slightly higher in singly-matched mosquitoes 
compared to mosquitoes with multiple meal sources (Supporting Information Table 
S1). A. gambiae s.s. mosquitoes were more frequently infected compared to A. coluzzii 
(P=0.002) (Table 2). Individual- and household-level frequencies of exposure to 
infected mosquitoes are presented in Figure 3A. Only 7.7, 23.6 and 10.3% of study 
subjects were linked to at least one potentially infective blood meal at the start, peak 
and end of transmission season, respectively; the two individuals, equivalent to 1.6 – 
2.8% of the study population at time of survey, with the highest numbers of matched 
meals from infected mosquitoes in each survey experienced 44 – 50% of all exposure 
to infected mosquitoes. As expected, there was a positive association between the 
number of potentially infective mosquito bites an individual received and the total 
number of matched meals regardless of mosquito parasitological status (Figure 3B, P 
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< 0.001 in a mixed effects negative binomial model that included total number of 
matched blood meals as covariate). 
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Table 2. Mixed effects logistic model on mosquito infection status 
     Odds ratio (95% CI) P-value 
       
Mosquito species      
  A. gambiae s.s.  Reference  
  A. coluzzii  0.41 (0.23 – 0.72) 0.002 
  A. arabiensis  0.55 (0.20 – 1.50) 0.24 
     
Timing  
(Transmission 
Season)      
  End  Reference  
 Start  0.18 (0.09 – 0.39) <0.001 
  Peak  0.29 (0.16 – 0.53) <0.001 
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Figure 3. Rates of exposure to potentially infective mosquito bites (i.e. mosquitoes 
with malaria infection detected by PCR) (a) and their association with total mosquito 
exposure (b). In a, blue circles represent study participants; individuals living in the 
same study house are presented together (orange bars). Y-axes show 1) the average 
numbers of falciparum-positive mosquito bites per individual per day (blue circles) or 
2) the total numbers of falciparum-positive fed mosquitoes collected in each house per 
collection day (orange bars); y-axes’ limits vary to improve visualization. Horizontal 
dotted lines represent the average, over all study houses, number of falciparum-
positive bloodfed Anopheles mosquitoes collected per house and day. Only the 20 
houses included in all three surveys are represented in this figure. In the three graphs, 
houses were ordered according to the number of fed mosquitoes collected at the start 
of the transmission season. In b, the top bar of each pair of horizontal bars presents 
the proportions of blood meals from infected mosquitoes linked to different 
individuals, represented by different colours, in each survey. The bottom bar of each 
pair corresponds to the proportions of all singly matched mosquito blood meals linked 
to different study participants; for each survey, each study participant is represented 
by the same colour for both infected and all mosquitoes. Individuals who were not 
matched to infected mosquitoes’ blood meals are represented by white segments.  
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Discussion  
 
In this study, we quantified natural exposure to Anopheles mosquitoes likely to be 
responsible for malaria transmission events having successfully fed on humans. We 
observed significant differences in the numbers of bloodfed mosquitoes matched to 
study participants that are consistent with the Pareto rule, with ~20% of participants 
being the source of more than 80% of all singly-matched blood meals. This 
heterogeneity was also apparent within-household, where individuals who provided 
most blood meals often contributed more than 50% of anopheline meals. Exposure to 
potentially infective mosquito bites also followed an aggregated pattern: 5.1, 13.9 and 
6.3% of the population experienced 80% of parasite inoculations at the start, peak and 
end of the transmission season, respectively. Taken together, our observations indicate 
that relatively few individuals, not necessarily the same during the entire rainy season, 
might be responsible for driving malaria transmission by being repeatedly sampled 
and infected by malaria vectors. These data provide further insights into the 
mechanisms that lead to heterogeneity in human malaria infection risk [15-18]. 
 
A variety of studies have quantified inter-individual differences in attractiveness and 
exposure to mosquitoes. While studies involving experimental huts [1] and 
olfactometers [19] demonstrated the influence of individual-level factors such as 
pregnancy [20] and infection status [21] on attractiveness to mosquitoes, community-
wide assessments of wild-caught mosquitoes [7, 22, 23] are necessary to quantify 
variation in exposure to malaria vectors over larger scales. A study in The Gambia [7] 
used ABO group and haptoglobin typing to identify the sources of mosquito blood 
meals; the small number of variants in these markers [24] limited the selection of 
households. In Tanzania [22], microsatellites were used to link blood meals to humans 
to assess the protection afforded by bed nets against mosquitoes; a high proportion of 
the ~250 analysed bloodfed mosquitoes were matched to individuals sleeping in the 
same room where they were collected, including in the village with bed nets, and 80% 
of matched blood meals came from less than 20% of the population. In our study, we 
matched 666 blood meals to individual study participants and observed that the 
distribution of mosquito bites was overdispersed, with 76.0 – 95.5% of singly matched 
blood meals originating from ~20% of the study population. These results corroborate 
the findings of the study in Tanzania and of a different study in western Kenya [25], 
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where 16% of the study participants were matched to 58% of Anopheles blood meals, 
but show even more unequal exposure patterns across three timepoints in the season. 
The fact that the majority of human-mosquito encounters in our study area involved 
only a few individuals is a consequence of both between- and within-household 
variation in exposure. Indeed, at the peak of the transmission season, the household 
with the highest number of fed mosquitoes had ~150 times more than the household 
with the lowest number. Household characteristics, such as construction material, 
number of windows, eaves as well as geographical proximity to mosquito breeding 
sites have all been associated with increased exposure to mosquitoes indoors and 
explain some of the between-household variation in mosquito abundance. We found 
that household heterogeneity is compounded by inter-individual variation in frequency 
of sampling by mosquitoes for people living in the same house. At the peak of the 
transmission season, the maximum difference in numbers of matched meals for 
participants in the same house ranged from 1 to 53, i.e. a difference of up to ~10 
mosquito bites per day. Age and body size can partially explain differences in 
attractiveness [4] yet we noted age-matched individuals in the same house often with 
dissimilar mosquito exposure (Supporting Information Figure S6). Other individual-
level characteristics such as odours [19, 26], (effective) use of protective measures or 
behaviour will be relevant in natural settings. Of note, the age distribution of our study 
population (Table 1), that included more children than adults, might not reflect the 
true demography of the region. Although our results are in agreement with previous 
studies, we cannot exclude that a difference in age composition, possibly related to the 
fact that only houses with at least one child were included, could have influenced our 
heterogeneity estimates. A technical limitation of this study was that we were not able 
to unequivocally match multiple source blood meals; however, in a conservative 
sensitivity analysis that assigned these meals to the individuals with lowest exposure, 
most mosquito bites were still linked to a small proportion of the population.  
 
Broad differences in anthropophilly between mosquito species are well recognised 
[27] however there are less data [28] on whether different Anopheles species might 
have different feeding preferences with regards to individual humans, or whether some 
individuals might be attractive to a particular mosquito species but not to others. In 
this study, we analysed blood meals in mosquitoes from three species: A. gambiae s.s., 
A. coluzzii and Anopheles arabiensis. Although seasonal differences in species 
  
 108
abundance were evident, we observed aggregation in human biting irrespective of 
vector species and exposure to one species was positively associated with exposure to 
the others. This suggests heterogeneity in exposure to anopheline mosquitoes is a 
common epidemiological phenomenon including in areas with different vector 
populations.  
 
We also determined how the frequency of host-vector contacts might influence the 
variation in the incidence of falciparum infections in human populations. Between 75 
and 90% of the study participants were not matched to feeding by infected mosquitoes 
during the three study periods. Whilst this does not represent all infected mosquito 
bites these individuals received, it does highlight the degree of heterogeneity in biting. 
Some study participants received multiple potentially infective bites over a period of 
a few days; whether these individuals developed liver- and blood-stage infections and 
eventually symptoms and how different inoculations and ongoing blood-stage 
infections interfered with each other [29] is not known. Studies that combine mosquito 
blood meal typing and parasitological and clinical follow-up of human populations 
would be informative to understand heterogeneity in clinical malaria risk [30-32].  
 
In summary, although studies have assessed natural exposure to vectors of other 
infections, such as Aedes [33, 34] and Culex [35], only limited data are available for 
Anopheles mosquitoes [22, 25]. In our field site, characterized by high malaria 
transmission intensity, we show significant heterogeneity both between and within 
households in terms of the number of mosquito blood meals and the distribution of 
potentially infective mosquito feedings; these patterns are consistent with the 20/80 
rule and support the design of interventions that aim to reduce transmission by 
targeting a small proportion of the population. A quantitative understanding of the 
processes leading to this heterogeneity in mosquito exposure would inform at which 
level such interventions should be targeted, household or individual; this would 
require quantification of the relative contributions of household-level factors, 
differential attractiveness to mosquitoes and human behavioural factors.  
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Visualisation of temporal variation in actual exposure to malaria vectors 
 
In Figure 2, individuals were ranked according to the number of matched mosquito 
blood meals per collection day. The distance between each observation and a central 
point is proportional to the log-number of mosquito bites per collection day. Since 
several individuals were not matched to any mosquito blood meal, the mathematical 
constant e was added to each observation to allow inclusion of all data in panels a and 
b. Polar coordinates were used, with the radii equal to loge (number of mosquito bites 
per collection day + e) and the angle varying with the ranking at the start of the wet 
season.  
 
Anopheles species-specific count models 
 
Mixed effects negative binomial models that had as dependent variables the numbers 
of coluzzii and A. gambiae s.s. blood meals were fit. In these models, the conditional 
overdispersion parameter was significantly different from zero: 1.9 (95% CI, 1.2 – 
3.2) and 2.5 (95% CI, 1.8 – 3.6) for models of A. coluzzii and A. gambiae s.s. mosquito 
bites, respectively.  
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Figure S1. Distribution of bloodfed mosquitoes by species and collection day.  
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Figure S2. Sensitivity analyses. In Figure 1, only singly-matched mosquitoes were 
included. A total of 153 mosquito blood meals were likely to have at least two human 
DNA sources. In this graph, two different scenarios were assumed: in Scenario 1, each 
mosquito blood meal with multiple sources was assigned to the two individuals with 
most singly-matched meals in each household; in Scenario 2, each blood meal with 
multiple human DNA sources was assigned to the two individuals with lowest 
numbers of singly-matched mosquito meals in each household. The cumulative 
proportion of blood meals (y-axis) matched to study participants (x-axis) sorted by 
number of mosquito bites received is presented for the three different surveys and two 
different scenarios. Only individuals present on at least 3 mosquito collection days 
were included in this graph.   
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Figure S3. Relationship between household- and individual-level exposures to Anopheles mosquitoes. The y-axis represents the number 
of mosquito blood meals linked to each study participant (left column) and the total number of blood meals matched to individuals living 
in each study household (right column). In each panel, individuals living in the same household are represented by circles of the same 
colour and linked to their household. Only houses with at least 10 (start and peak of transmission season) or 5 (end of transmission season) 
matched mosquitoes are included in this graph; in all other houses, all individuals had 5 mosquito bites or fewer at the start or peak of the 
wet season, and 3 or fewer bites at the end of the transmission season.  
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Figure S4. Cumulative proportion of Anopheles species-specific blood meals (y-axes) 
matched to study participants (x-axes) sorted by number of mosquito bites received. 
Only individuals present in at least 3 mosquito collection days were included in this 
graph. a, A. gambiae s.s.; b, A. coluzzii. Only a few (7 – 16) A. arabiensis mosquitoes 
were matched to study participants. 
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Figure S5. Correlations between vector species-specific numbers of matched blood 
meals. Both y- and x-axes represent the number of mosquito blood meals matched to 
study participants; each circle corresponds to a study participant. Axes limits vary to 
allow better visualisation of patterns in different surveys. 
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Figure S6. Age-independent variability in exposure to Anopheles mosquitoes. 
Individuals whose age difference was 2 years or less and who lived in the same 
household are presented. In the first household, two pairs of age-matched individuals 
were included. For each pair, the youngest individual is presented on the left. Numbers 
of mosquito bites in different surveys are represented by different colours. 
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Table S1. Prevalence of mosquito infection, determined by nested PCR performed 
using mosquitoes’ head-thoraces, by number of mosquito blood meal sources. Only 
mosquitoes with both blood meal typing and infection information were included in 
this table. 
 
 
 
 Prevalence of mosquito infection 
   Singly-matched, % (n/N) Multiple human source, % (n/N) 
Timing  
(Transmission 
Season)  
 
  Start 6.2 (10/160) 3.3 (3/90) 
  Peak 9.9 (37/375) 0 (0/40) 
  End 23.1 (25/108) 21.1 (4/19) 
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Additional Figure 
Additional Figure 1. Distribution of matched mosquito blood meals (x-axes) by 
survey and age. 
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Chapter 5, Primaquine to block malaria transmission 
 
The epidemiological and entomological studies described in Chapters 3 and 4 
provided answers to questions such as “Who are the individuals likely to infect 
mosquitoes in natural settings?”. The work presented in this chapter aimed to assess 
the efficacy of primaquine, a drug that is routinely used in vivax malaria treatment and 
is now recommended to block malaria transmission, in reducing post-treatment 
infectiousness of individuals receiving first-line antimalarial therapy. This study was 
published in BMC Medicine in 2016 (https://doi.org/10.1186/s12916-016-0581-y)  
and the version accepted for publication is included here. An additional figure is 
included at the end of the chapter. 
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Abstract 
 
Background 
A single low dose (0.25 mg/kg) of primaquine is recommended as a gametocytocide 
in combination with artemisinin-based combination therapies for Plasmodium 
falciparum but its effect on post-treatment gametocyte circulation and infectiousness 
to mosquitoes has not been quantified. 
 
Methods 
In this randomised, double-blind, placebo-controlled trial, 360 asymptomatic 
parasitaemic children aged 2-15 years were enrolled and assigned to receive: 
artemether-lumefantrine (AL) and a dose of placebo; AL and a 0.25 mg/kg primaquine 
dose; or AL and a 0.40 mg/kg primaquine dose. On days 0, 2, 3, 7, 10 and 14, 
gametocytes were detected and quantified by microscopy, Pfs25 mRNA quantitative 
nucleic acid sequence based amplification (QT-NASBA), and quantitative reverse-
transcriptase PCR (qRT-PCR). For a subset of participants, pre- and post-treatment 
infectiousness was assessed by mosquito feeding assays on days -1, 3, 7, 10 and 14. 
 
Results  
Both primaquine arms had lower gametocyte prevalences after day 3 compared to the 
placebo arm, regardless of gametocyte detection method. The mean (95% confidence 
interval) number of days to gametocyte clearance in children with patent gametocytes 
on day 0 (N=150) was 19.7 (14.6 – 24.8), 7.7 (6.3 – 9.1) and 8.2 (6.7 – 9.6) for the 
AL-placebo, the 0.25 mg/kg primaquine dose and the 0.40 mg/kg primaquine dose 
arms, respectively. While 38.0% (30/79) of selected gametocytaemic individuals were 
infectious before treatment, only 1/251 participant, from the AL-placebo group, 
infected mosquitoes after treatment.  
 
Conclusions 
We observed similar gametocyte clearance rates after 0.25 and 0.40 mg/kg primaquine 
doses. Infectivity to mosquitoes after AL was very low and absent in primaquine arms. 
 
ClinicalTrials.gov Registration. NCT01935882 
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Background 
 
Infectiousness to malaria vectors depends on the presence of sexual stage parasites, 
gametocytes, in the peripheral blood and is essential to sustain transmission in 
endemic areas [1]. Shortening the duration of gametocyte circulation reduces the 
probability of parasite spread and might, therefore, facilitate control. Artemisinin-
based combination therapy (ACT) is universally adopted as first-line treatment for 
clinical falciparum malaria [2], effectively clears asexual parasites and immature 
gametocytes, and is associated with lower post-treatment infectivity based on 
membrane feeding assays compared to other antimalarials [3]. Mature gametocytes, 
however, persist after ACT in microscopic or submicroscopic concentrations and 
residual transmission has been reported following sulphadoxine-pyrimethamine in 
combination with artesunate [4, 5], dihydroartemisinin-piperaquine [4, 6]  and 
artemether-lumefantrine (AL) [4, 6].  
 
Primaquine, tafenoquine and methylene blue radically clear mature gametocytes; 
primaquine being the only commonly used as antimalarial [7]. The World Health 
Organization recommends a single low dose (0.25 mg/kg) as a gametocytocide in 
combination with ACT for Plasmodium falciparum malaria in elimination and 
artemisinin resistance containment scenarios [8]. However wide-scale adoption of this 
recommendation is limited by safety concerns [9], despite evidence that a higher dose, 
0.40 mg/kg, is associated with only minor haematological changes in G6PD normal 
children [10]. Furthermore, the effect of the 0.25 mg/kg dose in clearing gametocytes 
or preventing transmission after currently used ACT regimens has not been formally 
assessed. A dose-finding study in Uganda suggested a 0.40 mg/kg dose is as 
efficacious in clearing gametocytes as the previously recommended dose of 0.75 
mg/kg [10], which has been associated with haemolysis [11]. At present, only 
mosquito feeding assays can truly determine the lowest efficacious dose of primaquine 
for preventing transmission [12]. 
 
Here, we compare gametocyte dynamics after AL alone or in combination with 0.25 
mg/kg or 0.40 mg/kg primaquine dose in children with asymptomatic falciparum 
infection. We selected asymptomatic parasite carriers since these contribute 
considerably to the infectious reservoir for malaria [13, 14] and malaria elimination 
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and artemisinin containment strategies will need to involve the targeting of 
asymptomatic malaria infections [15]. For a subset of participants, post-treatment 
infectiousness was determined by mosquito membrane feeding experiments. 
 
Methods 
 
Role of the funding source 
 
Authors had full access to the trial data. Funders had no role in study design, data 
collection, analysis, interpretation and decision to publish study findings.  
 
Study design 
 
For this randomised, double-blind, placebo-controlled trial, participants were recruited 
between September 2013 and October 2014 from Balonghin, district of Saponé, an 
area with seasonal malaria in Burkina Faso [16].   
 
Eligible individuals were asymptomatic children aged 2 to 15 years, weighing 10 kilos 
or more, with normal glucose-6-phosphate dehydrogenase (G6PD) activity based on 
BinaxNOW rapid diagnostic test (Alere Inc., Massachusetts, United States) and 
carrying patent P. falciparum asexual parasites or gametocytes. Initially, individuals 
were recruited regardless of microscopy gametocyte status (Study Phase A). Since no 
mosquito infections were detected (0/106 participants), the parasitological criterion 
for inclusion in infectiousness assessments was modified to include only children with 
patent gametocytes at screening, regardless of their asexual parasite count, to 
maximize pre-treatment infectivity (Study Phase B). Exclusion criteria were: 
haemoglobin level at screening lower than 8 g/dL, fever or history of fever in the last 
24 hours, evidence of severe illness, known allergy to study medications, antimalarials 
taken in the last 48 hours, primaquine use in the last 4 weeks, blood transfusion in the 
last 90 days, and non-falciparum malaria infection at screening.  Overall, 360 children 
were enrolled: 210 in Study Phase A (inclusion criterion: asexual parasite density 
1,000 - 200,000 parasites/µL) and 150 participants in Study Phase B (inclusion 
criterion: presence of gametocytes by microscopy) (Figure 1).  
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Ethics, consent and permissions 
 
This clinical trial was conducted in accordance with Good Clinical Practice guidelines, 
and was registered with ClinicalTrials.gov (number NCT01935882). Ethical clearance 
was obtained from the London School of Hygiene and Tropical Medicine ethics 
committee (reference number 6274), and the Comité d'Ethique pour la Recherche en 
Santé (Ministère de la Santé du Burkina Faso; reference number 2012-10-78). Written 
informed consent was obtained from parents or guardians, and assent, from children 
aged 12 years or older. The original protocol for the clinical trial (Additional file 2) 
and the supporting CONSORT checklist (Additional file 3) are provided as 
supporting information. 
  
Randomisation and masking 
 
Children were enrolled by the study clinician and subsequently randomly allocated by 
the study pharmacist, with equal probabilities, to three treatment arms: (1) AL as 
standard 6-dose regimen in combination with a single dose of placebo; (2) AL and a 
single 0.25 mg/kg primaquine dose; and (3) AL and a single 0.40 mg/kg primaquine 
dose.  
 
Treatment assignment was stratified by gender, and sealed envelopes in block sizes of 
six (three study arms and two membrane feeding assays schedules [days 3 and 10 or 7 
and 14 after treatment initiation]) were used. After the first 143 children were 
recruited, mosquito feeding experiments were amended: gametocytaemic children 
were randomised to have feeding assays on days -1 (one day before treatment 
initiation) and 7 or 3 and 7.  
 
Treatment concealment was achieved by the addition of a syrup, which masked colour 
and taste of primaquine and placebo. Participants, investigators, and staff who were 
not involved in study drug administration were blinded to study arm allocation. 
 
Procedures 
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AL (Coartem®; Novartis Pharma, Basel, Switzerland) was administered as half a 
tablet (20 mg of artemether and 120 mg of lumefantrine) per 5 kg of body weight in a 
6-dose regimen over three days. Primaquine doses were prepared as previously 
described [10] and given with the 5th dose (day 2) of AL. All treatment doses were 
administered under supervision and with fatty food (biscuits) to ensure adequate 
absorption [17] and minimise the risk of gastro-intestinal side effects. If a child 
vomited within 30 minutes after a study medication was given, treatment was re-
administered.  
 
Participants were asked to return to the study clinic on days 0, 1, 2, 3, 7, 10 and 14. 
On day 0 (day of enrollment), AL administration was initiated. On each follow-up day, 
study subjects were examined and, except on day 1, had a blood slide prepared to 
detect malaria parasites and their haemoglobin levels quantified by Hemocue 
photometer (HemoCue AB, Angelholm, Sweden). Smears were screened for asexual 
stage parasites and gametocytes, and double-read. Biochemistry and full blood count 
assessments were performed on days 0, 3 and 7 on venous samples.  
 
50 μL-finger-prick-blood samples were collected on all visits, except on day 1, stored 
in 250 µL of RNAprotect® cell reagent (Qiagen), and used for gametocyte detection 
and quantification: quantitative nucleic acid sequence based amplification (QT-
NASBA) [18] was performed for samples collected on days 0 and 7; and quantitative 
reverse-transcriptase PCR (qRT-PCR), which allows better quantification [19], was 
used to estimate gametocyte densities in all available samples for individuals with 
patent gametocytes on day 0. Briefly, total nucleic acids (NA) were extracted using a 
MagNAPure LC automatic extractor (Total Nucleic Acid Isolation Kit – High 
Performance, Roche Applied Science). QT-NASBA was performed directly on total 
NA samples as described [18], with a minor change in the KCl concentration used: 60 
instead of 80 mM. For gametocyte quantification by qRT-PCR, firstly remaining 
genomic human and parasite DNA were removed with the RQ1 DNaseI Digest Kit 
(Promega), then cDNA was synthesized with the High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems); from cDNA samples, Pfs25 sequence was 
amplified using primers described by Wampfler et al [19], GoTaq® qPCR Master Mix 
(Promega), and CFX96™ Real-Time PCR Detection System (BIO-RAD), using the 
standard cycling program as described in the manufacturer’s instructions. 
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Amplification was set to continue for 40 cycles and cut-off for positivity was set at 
assigned gametocyte density of more than 0.02 gametocytes per μL, determined by a 
dilution series of mature stage V in vitro produced gametocytes (NF54 strain). 
 
A subset of recruited children was invited to participate in membrane feeding assays 
[20] at two time-points (Figure 1), with the number of participants being dictated by 
the availability of mosquitoes. For each experiment, venous blood was taken and 
offered to 60 or more locally-reared female Anopheles gambiae mosquitoes. Fully fed 
mosquitoes were selected, kept on glucose at 27–29°C and dissected 7 days later. 
Midguts were examined for the presence of oocysts. 
 
Primary and secondary endpoints 
 
The primary efficacy endpoint was gametocyte clearance time (i.e., number of days to 
undetectable gametocyte levels) in the 0.25 mg/kg primaquine arm compared to the 
0.40 mg/kg primaquine arm. The primary safety endpoint was maximal fall in 
haemoglobin levels during follow-up. Secondary efficacy endpoints were: gametocyte 
prevalences on days 3, 7, 10 and 14, and proportion of mosquitoes developing 
infection and their oocyst counts in feeding assays performed after treatment 
administration. Secondary safety endpoints included: number of participants requiring 
blood transfusion, maximal percentage decrease in haemoglobin concentration, 
proportion of participants with haemoglobin levels below 5 g/dL and number of severe 
adverse events.  
 
Sample size 
 
Sample size calculations were based on non-inferiority of 0.25 mg/kg versus 0.40 
mg/kg primaquine dose. For the gametocyte clearance endpoint, the non-inferiority 
margin was 2.5 days [21]. If mean clearance time was 6.3 days [10] in both arms, with 
a standard deviation of 3, then 40 subjects per arm would give over 90% power at the 
one sided 0.025 level. For QT-NASBA-determined gametocyte prevalence on day 7, 
the non-inferiority margin was 12%. If prevalence in both arms was 10.6% [10], then 
120 subjects per arm would give over 80% power at the one sided 0.025 level. The 
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number of feeding experiments and mosquitoes used in each assay were limited by 
logistical considerations and were not based on sample size calculations. 
 
Statistical analysis  
 
Stata 12.0 (Stata Corporation, Texas, United States) and SAS 9.3 (SAS Institute, North 
Carolina, United States) were used for statistical analysis. The mean time to 
gametocyte clearance was estimated for each treatment arm using a non-linear model 
[21] (Additional file 1); qRT-PCR data from children with patent gametocytes on day 
0 were used (N=150). For the 0.25 mg/kg primaquine dose, a 95% confidence interval 
(CI) for the difference with the 0.40 mg/kg dose was calculated. The non-linear model 
was also used to assess superiority of the primaquine arms over the placebo group. 
Gametocyte prevalences on different visit days were compared between study arms 
by χ2 or Fisher’s exact test. Non-parametric tests (Mann-Whitney and Kruskal-Wallis) 
were used to compare parasite levels among different study groups. To quantify the 
effect of primaquine on transmission, post-treatment mosquito infection rates were 
compared between treatment arms. The maximal fall in haemoglobin levels measured 
by Hemocue photometer was presented as mean (95% CI) per study arm; Student’s t-
test was used for pair-wise comparisons.  
 
Results 
 
We screened 2,176 (877 in Study Phase A and 1,299 in Study Phase B) and enrolled 
360 children (Figure 1). Twenty participants were enrolled despite having < 1,000 
asexual parasites/μL and therefore not fulfilling all enrollment criteria but were 
retained in the analysis (Additional file 1). The median (interquartile range [IQR]) 
age at enrollment was 8 (5-10) years (Table 1). Median (IQR) asexual stage parasites 
concentration at enrollment was 1,824.5 (520–5,041) parasites/μL and similar among 
individuals receiving different treatment regimens.  
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Figure 1. Clinical Trial profile. (A) Study Phase where the presence of asexual parasites (1,000 - 200,000 parasites/µl) at screening was an inclusion 
criterion (initial 143 and final 67 participants). (B) Study Phase where children with patent gametocytes, regardless of their asexual parasite count, 
at screening were eligible (150 participants). Participants were considered to have a complete follow-up, if they had a total of 7 follow-up visits 
(days 0, 1, 2, 3, 7, 10, 14). AL = artemether-lumefantrine; PQ = primaquine. 
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days 3 and 10
(N=17 children)
Feeding assays 
days 7 and 14
(N=17 children)
Pharmacokinetics 
sampling
(N=26 children)
2 lost to  
follow-up
AL + 0.25 mg/Kg PQ
(N=75)
73 completed 
follow-up
Feeding assays 
days 3 and 10
(N=18 children)
Feeding assays 
days 7 and 14
(N=18 children)
Pharmacokinetics 
sampling
(N=37 children)
2 lost to  
follow-up
AL + 0.40 mg/Kg PQ
(N=73)
72 completed
follow-up
Feeding assays 
days 7 and 14
(N=17 children)
Feeding assays 
days 3 and 10
(N=19 children)
Pharmacokinetics 
sampling
(N=36 children)
1 lost to 
follow-up
Non-inclusion (N=667):
26 with G6PD deficiency
498 did not fulfill parasitological criteria
25 with Haemoglobin levels < 8 g/dL
28 with fever or history of fever
54 refused to partipate
36 with other  exclusion criteria
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B 
 
 
 
 
 
 
 
 
 
Screening:
1,299 children
AL only
(N=51)
50 completed  
follow-up
Feeding assays 
days -1 and 7
(N=31 children)
Feeding assays 
days 3 and 7
(N=19 children)
1 lost to 
follow-up
AL + 0.25 mg/Kg PQ
(N=50)
49 completed 
follow-up
Feeding assays 
days -1 and 7
(N=26 children)
Feeding assays 
days 3 and 7
(N=23 children)
1 lost to 
follow-up
AL + 0.40 mg/Kg PQ
(N=49)
47 completed 
follow-up
Feeding assays 
days 3 and 7
(N=28 children)
Feeding assays 
days -1 and 7
(N=19 children)
2 lost to 
follow-up
Non-inclusion (N=1,149):
12 with G6PD deficiency
1,023 did not fulfill parasitological criteria
1 with Haemoglobin levels < 8 g/dL
51 with fever or history of fever
58 refused to partipate
4 with other  exclusion criteria
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Table 1. Study Population. Means and 95% confidence intervals are presented for haemoglobin levels at enrollment; medians and interquartile 
ranges are presented for parasite levels (asexual or sexual stages) and age. Study Phase A = presence of asexual parasites (1,000 - 200,000 
parasites/µl) at screening as an inclusion criterion; Study Phase B = presence of patent gametocytes at screening as an inclusion criterion; AL = 
artemether-lumefantrine; PQ = primaquine. 
 
 
 AL only AL + 0.25 mg/kg PQ AL + 0.40 mg/kg PQ 
 Asymptomatic parasite carriers (Study Phase A)        
Female (%) 51.6 52.0 53.4 
Age (years) 7.5 (4 – 10) 8 (5 – 10) 8 (4 – 10) 
Haemaglobin (g/dL) at enrollment* 10.8 (10.2 – 11.4) 11.3 (10.7 – 11.9) 11.7 (11.2 – 12.2) 
Asexual parasite levels at enrollment (parasites/μL; Microscopy) 2,972.5 (1,147 – 6,865)  2,503 (939 – 5,798) 3,339 (874 – 7,358) 
Gametocyte prevalence (%) at enrollment (Microscopy) 17.7 32.0 20.5 
Gametocyte prevalence (%) at enrollment (QT-NASBA) 96.4 92.9 85.5 
 Asymptomatic gametocyte carriers (Study Phase B)    
Female (%) 43.1 46.0 42.9 
Age (years) 8 (5 – 11) 7 (6 – 11) 8 (6 – 11) 
Haemaglobin (g/dL) at enrollment* 11.4 (11.1 – 11.8) 11.7 (11.4 – 12.1) 11.5 (11.1 – 11.9) 
Asexual parasite levels at enrollment (parasites/μL; Microscopy) 488 (226 – 1,670) 957 (248 – 3,004) 908.5 (198 – 2,297) 
Gametocyte prevalence (%) at screening (Microscopy) 100 100 100 
Gametocyte prevalence (%) at enrollment (Microscopy) 69.4 55.3 83.3 
Gametocyte prevalence  (%) at enrollment  (QT-NASBA) 95.9 93.7 100.0 
Gametocyte levels at enrollment (parasites/μL)** 17.3 (7.2 - 45.1) 18.6 (7.8 - 75.3) 16.6 (7.2 - 40.0) 
* Measured by Hemocue photometer; similar values observed with full blood count assessment using venous samples 
** Quantified by qRT-PCR (only children with patent gametocytes on day 0 [N=150] were included [100/150 were enrolled during Study Phase B]; see Methods) 
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Gametocyte prevalence by microscopy was not significantly different between study 
arms at enrollment, although during Study Phase A it was higher in the 0.25 mg/kg 
primaquine arm (32.0%) compared to the AL-placebo and the 0.40 mg/kg primaquine 
arms (17.7 and 20.5%, respectively). Both primaquine arms had lower 
microscopically-detectable gametocyte prevalences on days 7, 10 and 14, but not on 
days 2 and 3, compared to the AL-placebo group (Table 2). Similar results were 
obtained when only children with gametocytes on day 0 were included in this 
comparison (Additional file 1:  Table S1).  
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Table 2. Gametocyte carriage during follow-up. Gametocyte prevalences, clearance 
times and area under the curve (AUC) of gametocyte distributions over time are 
presented. Gametocyte clearance time: the rate with which malaria sexual stage 
parasites were cleared was estimated for children with patent gametocytes on day 0; 
qRT-PCR data were used (N=150; see Additional file 1). Gametocyte prevalences 
were similar in primaquine study arms throughout the follow-up (all P-values > 0.05), 
except on day 0 (microscopy-based detection; P=0.004) during Study Phase B. AL = 
artemether-lumefantrine; PQ = primaquine. 
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Study Phase A (asymptomatic parasite carriers) AL AL + 0.25 mg/kg PQ AL + 0.40 mg/kg PQ P-values  P-values  
  % (n/N) % (n/N) % (n/N) 
(AL vs.AL+0.25 mg/Kg 
PQ) 
 
(AL vs.AL+0.40 mg/Kg 
PQ) 
 
Gametocyte prevalence by microscopy      
Day 0 17.7 (11/62) 32.0 (24/75) 20.5 (15/73) 0.08 0.83 
Day 2 12.9 (8/62) 16.4 (12/73) 13.7 (10/73) 0.63 1.00 
Day 3 9.8 (6/61) 22.9 (16/70) 14.3 (10/70) 0.06 0.59 
Day 7 6.7 (4/60) 4.2 (3/72) 0.0 (0/71) 0.70 0.04 
Day 10 3.3 (2/60) 1.4 (1/71) 0.0 (0/71) 0.60 0.21 
Day 14 0.0 (0/58) 0.0 (0/73) 0.0 (0/71) - - 
      
Gametocyte prevalence by Pfs25 QT-NASBA        
Day 0 96.4 (54/56) 92.9 (65/70) 85.5 (53/62) 0.46 0.06 
Day 7 46.3 (25/54) 20.3 (14/69) 16.4 (11/67) 0.003 0.001 
          
        
Study Phase B (patent gametocyte carriers at 
screening) 
AL AL + 0.25 mg/kg PQ AL + 0.40 mg/kg PQ P-values  P-values  
  % (n/N) % (n/N) % (n/N) 
(AL vs.AL+0.25 mg/Kg 
PQ) 
 
(AL vs.AL+0.40 mg/Kg 
PQ) 
 
Gametocyte prevalence by microscopy      
Day 0 69.4 (34/49) 55.3 (26/47) 83.3 (40/48) 0.21 0.15 
Day 2 34.7 (17/49) 20.4 (9/44) 28.9 (13/45) 0.17 0.66 
Day 3 28.6 (14/49) 10.9 (5/46) 15.6 (7/45) 0.04 0.15 
Day 7 20.4 (10/49) 6.4 (3/47) 6.7 (3/45) 0.07 0.07 
Day 10 17.4 (8/46) 4.3 (2/47) 0.0 (0/44) 0.05 0.006 
Day 14 13.6 (6/44) 0.0 (0/40) 0.0 (0/38) 0.03 0.03 
      
Gametocyte Prevalence by Pfs25 QT-NASBA       
Day 0 95.9 (47/49) 93.7 (45/48) 100.0 (46/46) 0.68 0.50 
Day 7 55.1 (27/49) 20.4 (10/49) 17.0 (8/47) 0.001 <0.001 
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Table 2 (Continuation) 
      
Only patent gametocyte carriers at enrollment* AL AL + 0.25 mg/kg PQ AL + 0.40 mg/kg PQ P-values  P-values  
 % (n/N) % (n/N) % (n/N) 
(AL vs.AL+0.25 mg/Kg 
PQ) 
 
(AL vs.AL+0.40 mg/Kg 
PQ) 
 
Gametocyte Prevalence by Pfs25 qRT-PCR       
Day 0 95.6 (43/45) 98.0 (48/49) 98.0 (49/50) 0.60 0.60 
Day 2 93.2 (41/44) 87.5 (42/48) 90.4 (47/52) 0.49 0.72 
Day 3 88.4 (38/43) 75.5 (37/49) 92.2 (48/52) 0.18 0.72 
Day 7 66.7 (28/42) 34.0 (17/50) 27.8 (15/54) 0.003 <0.001 
Day 10 65.8 (27/41) 28.6 (14/49) 20.7 (11/53) 0.001 <0.001 
Day 14 42.5 (17/40) 10.2 (5/49) 16.7 (9/54) 0.001 0.01 
      
  Mean (95% CI) Mean (95% CI) Mean (95% CI)   
      
AUC gametocyte densities over time (in gametocytes 
μL-1 days)** 
14.7 (5.5 – 24.0) 5.5 (1.1 – 10.0) 5.6 (2.1 – 9.1)  
- 
- 
Gametocyte clearance time (in days) 19.7 (14.6 – 24.8)  7.7 (6.3 – 9.1) 8.2 (6.7 – 9.6) - - 
        P-values  P-values  
 AL vs. AL + 0.25 mg/kg 
PQ 
AL vs. AL + 0.40 mg/kg 
PQ 
AL + 0.25 mg/kg PQ vs. 
AL + 0.40 mg/kg PQ 
(AL vs.AL+0.25 mg/Kg 
PQ) 
 
(AL vs.AL+0.40 mg/Kg 
PQ) 
 
Difference in gametocyte clearance time (in days) 12.0 (6.7 – 17.3) 11.5 (6.2 – 16.8) -0.5 (- 2.5 – 1.6) <0.001 <0.001 
* 50 children from Study Phase A and 100 from Study phase B 
**Only qRT-PCR measurements on days 3, 7, 10 and 14 for children with qRT-PCR data on all these days are included 
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Molecular detection of gametocytes 
 
Gametocyte prevalences determined by Pfs25 mRNA QT-NASBA were considerably 
higher than by microscopy (Table 2). On day 7, QT-NASBA-determined gametocyte 
prevalence was 50.5% in the AL-placebo arm, 20.3% in the 0.25 mg/kg primaquine 
arm (P<0.001, versus control) and 16.7% in the 0.40 mg/kg primaquine arm (P<0.001, 
versus control; P=0.50, versus 0.25 mg/kg primaquine dose).  
 
Gametocyte prevalences and densities measured by qRT-PCR for children with 
microscopically detectable gametocytes on day 0 are presented in Figure 2. 
Gametocyte levels in gametocyte-positive visits did not differ between treatment arms 
on days 0, 2, 3 and 14; on days 7 and 10, the 0.40 mg/kg primaquine arm had lower 
gametocyte levels compared to the placebo group (Additional file 1: Table S2). 
Gametocyte densities were similar in primaquine arms throughout the follow-up, as 
gametocyte clearance rates. Children receiving either dosages carried sexual stage 
parasites for a shorter time compared to the AL only arm (19.7 [14.6 – 24.8], 7.7 [6.3 
– 9.1] and 8.2 [6.7 – 9.6] days [mean and 95% CI] to gametocyte clearance for the 
AL-placebo, the 0.25 mg/kg primaquine and the 0.40 mg/kg primaquine arms, 
respectively; Table 2).  
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Figure 2. Gametocyte prevalences (A) and densities (B) measured by qRT-PCR in children with patent gametocytes on day 0. 95% confidence 
intervals are presented in (A). Samples were considered to be gametocyte negative if assigned levels were lower than 0.02 gametocytes per μL. 
AL = artemether-lumefantrine; 0.25 mg/kg = 0.25 mg/kg primaquine arm; 0.40 mg/kg = 0.40 mg/kg primaquine arm 
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Infectiousness to mosquitoes 
 
In Study Phase A, when individuals were recruited regardless of gametocytaemia by 
microscopy, 106 children participated in membrane feeding experiments on days 3 
(N= 54), 7 (N= 52), 10 (N=54) and 14 (N=52); during this Study Phase, no mosquitoes 
developed infection (Table 3). In Study Phase B, 149 individuals with patent 
gametocytes at screening participated in feeding experiments prior to treatment 
(N=79) and on days 3 (N=70; 19, 23 and 28 in the AL-placebo, the 0.25 mg/kg 
primaquine and the 0.40 mg/kg primaquine arms, respectively) and 7 (N=144; 49, 49 
and 46 in the AL-placebo, the 0.25 mg/kg primaquine and the 0.40 mg/kg primaquine 
arms, respectively). On average, 45.3 (range 25 - 94) mosquitoes were dissected per 
assay. 38.0% (30/79) of the experiments conducted prior to treatment resulted in ≥ 1 
infected mosquito. In these 30 infectious feeds, the median proportion of infected 
mosquitoes was 20.0% (IQR 8.0 – 39.0) and median oocyst count per infected 
mosquito was 5 (IQR 2 – 15). Only one individual infected mosquitoes following 
treatment, in the AL only arm and infected 4/46 mosquitoes on day 7; this participant, 
who was also infectious before treatment administration (18/48 infected mosquitoes), 
had submicroscopic gametocytemia at the time of feeding on day 7. 
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Table 3. Mosquito feeding assays   
 
  AL only 
AL + 0.25 
mg/kg PQ 
AL + 0.40 
mg/kg PQ 
Study phase A       
Number of mosquitoes 
infected/dissected (proportion)    
     
Follow-up day    
3 0/755 (0) 0/816 (0) 0/862 (0) 
7 0/781 (0) 0/777 (0) 0/767 (0) 
10 0/822 (0) 0/848 (0) 0/890 (0) 
14 0/855 (0) 0/890 (0) 0/841 (0) 
       
     
Study phase B    
Number of mosquitoes 
infected/dissected (proportion)    
     
Follow-up day        
One day before treatment 207/1402 (0.15) 54/1195 (0.05) 80/897 (0.09) 
3 0/863 (0) 0/1053 (0) 0/1281 (0) 
7 4/2104 (0.002) 0/2179 (0) 0/2016 (0) 
 
  
  
144 
 
Adverse events and haematological changes in G6PD normal children 
 
57 mild and moderate adverse events were recorded; 8 (7 mild, 1 moderate), occurring 
in 3, 1 and 4 individuals assigned to the AL-placebo, the 0.25 mg/kg primaquine and 
the 0.40 mg/kg primaquine arms, respectively, were considered to be possibly related 
to study participation (Additional file 1: Table S3). For 5 children who vomited on 
days 0 or 1, study drug was re-administered. No serious adverse events were observed. 
 
At enrollment, haemoglobin levels did not differ between treatment arms (Table 1). 
One child had 6 g/dL on day 0, but this was most likely due to measurement error: on 
day 2, haemoglobin concentration was 10.9 g/dL. Median (IQR) uncorrected 
reticulocyte percentage at enrollment was 2.0% (1.5 – 2.6). The average maximal fall 
in haemoglobin levels for children with measurements on all visits (227/360) was 
larger (P=0.006), in absolute value, in the 0.40 mg/kg primaquine arm, -1.21 (95% CI, 
-1.45 - -0.97, N=76) g/dL, compared to the placebo arm, -0.71 (95 % CI, -0.98 - -0.44, 
N=72). Haemoglobin drop for participants receiving the 0.25 mg/kg primaquine dose 
was -0.96 (95% CI, -1.18 - -0.73, N=79; P=0.16 and 0.12, versus control and 0.40 
mg/kg primaquine arms, respectively). Similar results were obtained when 
considering maximal percentage drop (Additional file 1: Table S4). The lowest 
haemoglobin values relative to baseline were observed on days 3 and 7 (Figure 3). 35 
children (9/113 [8.0%], 12/125 [9.6%] and 14/122 [11.5%] in the AL-placebo, the 
0.25 mg/kg primaquine and the 0.40 mg/kg primaquine arms, respectively) had 
haemoglobin drop of 2 or more g/dL (Additional file 1: Table S5): in 2, one in each 
primaquine arm, haemoglobin fell more than 4 g/dL and levels recovered before 
follow-up was completed. On days 1 and 2, 3 children reported haemoglobinuria. No 
child had haemoglobin levels < 5 g/dL, and no blood transfusions were required. Renal 
and liver laboratory abnormalities were detected in 4 and 7 children, respectively 
(Additional file 1: Table S6). 
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Figure 3. Changes in haemoglobin levels from baseline values. Means and 95% 
confidence intervals are presented. Haemoglobin levels determined by Hemocue 
photometer on day 0 were used as baseline measurement; whenever haemoglobin 
concentrations on day 0 were not available or were only quantified by full blood count 
analysis on venous samples, Hemocue results at screening were used: the median 
(IQR) interval between screening and the day 0 of follow-up was 2 (1 – 2) days. AL 
= artemether-lumefantrine; PQ = primaquine; Hb = haemoglobin. 
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Discussion 
 
Since 2012, the WHO recommends a single 0.25 mg/kg primaquine dose as 
gametocytocide but this dosage had never been formally assessed for gametocyte 
clearance after ACT. In this study, we recruited asymptomatic parasitaemic children, 
a group that is believed to contribute significantly to transmission in endemic areas 
[13] and would potentially be given low dose primaquine if used in future community 
chemotherapy campaigns, and showed that individuals receiving a 0.25 mg/kg 
primaquine dose in combination with AL had similar gametocyte clearance time 
compared to children in the 0.40 mg/kg primaquine arm. Both regimens were 
associated with significantly shorter post-treatment gametocyte circulation compared 
to the ACT partner drug alone. In the subset of participants who had their infectivity 
quantified by feeding experiments, infectiousness was effectively reduced after 
treatment in all arms. Our observations suggest that (i), on the basis of gametocyte 
carriage, the primaquine dose of 0.25 mg/kg is as effective as the previously evaluated 
dose, 0.40 mg/kg, and (ii) gametocytemia is not a good predictor of post-treatment 
infectivity [12]: infectivity is very low after AL and not detected after AL-primaquine. 
 
Previous trials on low dose primaquine’s transmission-reducing properties have 
assessed efficacy based on gametocyte carriage [10]. However, the non-linear 
relationship between gametocyte levels and mosquito infection rates [22] during 
experimental infections suggests that reductions in numbers of circulating 
gametocytes might not be directly translated into changes in transmission potential. 
Additionally, primaquine might have an impact on infectiousness before sexual stage 
parasites clearance is observed [12]. Pfs25 mRNA transcripts are more abundantly 
present in female gametocytes [23, 24] and may also be detected in non-infectious 
gametocytes [25]. It was recently hypothesized that male gametocytes might be more 
sensitive to 8-aminoquinolines in vivo [26] and, since they represent a smaller fraction 
of the total gametocyte population compared to female gametocytes [27], their 
clearance will only minimally influence gametocytaemia by Pfs25 mRNA-based 
quantification methods but significantly affect infectiousness [28]. Thus, estimating 
the effect of primaquine on transmission requires direct assessment of infectivity. In 
this trial, we quantified infectiousness for 255 individuals and 22,894 dissected 
mosquitoes and adapted our study design to maximize discriminative power by 
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enriching our study population for individuals with microscopically-detectable 
gametocytes. 
 
We observed that 38.0% of gametocytaemic individuals infected mosquitoes before 
treatment. This is within the normal range of infectivity in patent gametocyte carriers 
[29], although considerably higher infection rates have been reported [22, 30]. After 
treatment, only one child infected mosquitoes, suggesting that transmissibility was 
substantially reduced by AL [3]. Low infectivity after AL alone made it impossible to 
detect an added value of primaquine in this context. The almost complete absence of 
infected mosquitoes post-treatment contrasts with the limited efficacy of artemisinin 
derivatives against mature gametocytes, and could be related to lumefantrine, that 
inhibits male gametocyte exflagellation and reduces oocyst numbers in vitro [31].  
Factors intrinsic to these infections (e.g., gametocyte sex ratios) or to the host (e.g., 
transmission-reducing immunity) could also have contributed to this low 
infectiousness. Another explanation is that membrane feeding experiments, which in 
general underestimate infectiousness compared to skin feeding assays [29], might not 
have been sensitive enough to detect very low infectivity. The successful detection of 
pre-treatment infectiousness, however, suggests that low sensitivity cannot fully 
explain our findings. Only few studies (summarised in Additional file 1: Table S7) 
assessed the effect of AL on transmission: similar to our observations, in The Gambia, 
post-treatment gametocyte carriage was observed, but mosquito infections were not 
detected [3]. In contrast, in Kenya, transmission was observed after AL [6] and 
clonally complex infections were detected by PCR in infected mosquito guts.  
 
Determining the true impact of primaquine on malaria infectivity should be high on 
the malaria elimination agenda. Larger clinical studies with appropriate sample sizes 
to test efficacy outcomes involving infectiousness reduction are necessary. These 
studies may also determine the optimum timing of primaquine administration. In our 
study, primaquine was administered on the last day of AL use, to follow the same 
treatment procedures as a previous dose-finding trial in Uganda, although there are 
logistical advantages to administering primaquine with the first supervised dose of 
AL. Ideally, these studies will include symptomatic and asymptomatic malaria 
infections to demonstrate the efficacy of primaquine in all infections that contribute to 
the human infectious reservoir for malaria. These studies will be logistically complex 
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and need to consider all factors that influence infectiousness as they might also 
influence efficacy estimates: (1) membrane feeding assays underestimate infectivity 
compared to direct skin feeding assays and consequently low level post-treatment 
infectivity might be misclassified as non-infectiousness when using this artificial 
system; (2) the number of mosquitoes used in each assay might not represent the 
number of mosquito bites an infectious individual would receive in natural settings 
(especially acknowledging as this is a single time point assessment), and binary 
outcomes (e.g., “infectious” versus “not-infectious”) might be less relevant than 
within-individual changes in mosquito infection rates; (3) baseline infectivity will 
depend on the inclusion criteria and although recruiting individuals with high 
gametocyte densities would maximize the power to observe changes in infectiousness 
with treatment, these individuals might not be representative of an “average” infected 
person. As duration and intensity of infectiousness are likely to depend on host age 
and transmission setting, individuals from different ages and study sites, representing 
a wide spectrum of endemicities, would need to be recruited. 
 
Primaquine-induced haemolysis in individuals with G6PD deficiency is a concern for 
control programs and one major reason why this drug is not widely used in Africa. 
Here, a rapid diagnostic test was used to exclude individuals with this condition. No 
cases of severe haemolysis were observed, corroborating previous observations made 
in symptomatic children with normal G6PD activity receiving a single 0.40 mg/kg 
primaquine dose [10]. However, contrary to this previous trial undertaken in Uganda, 
children receiving 0.40 mg/kg primaquine in this study had larger haemoglobin drops 
compared to the placebo group, suggesting that mild haemolysis might have occurred. 
While our study provides detailed haematological assessment after primaquine 
administration in G6PD normal non-anaemic children with asymptomatic falciparum 
infections, G6PD deficiency could lead to greater haemoglobin drops and studies 
recruiting G6PD deficient individuals are necessary. 
 
Conclusion 
 
The ultimate goal of using primaquine in falciparum malaria in conjunction with ACT 
is to minimise post-treatment malaria transmission, reduce the transmission of 
artemisinin-resistant parasites and accelerate attempts to eliminate malaria [32]. 
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Although mathematical models have been developed to estimate the potential impact 
of this drug on population-level transmission [33], its effect on infectiousness needs 
to be quantified. In this study, children receiving 0.40 mg/kg or 0.25 mg/kg primaquine 
doses cleared gametocytes with similar rates; both treatment regimens reduced 
gametocyte carriage compared to ACT alone. Feeding assays, however, indicate that 
infectiousness is considerably reduced by AL alone, suggesting that the benefit of 
adding primaquine to first-line antimalarials is influenced by partner drug. 
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Supplementary Appendix 
 
Single Low Dose Primaquine to Reduce Gametocyte Carriage and Plasmodium 
falciparum Transmission after Artemether-Lumefantrine in Children with 
Asymptomatic Infection: A Randomised, Double-Blind, Placebo-Controlled Trial 
 
Authors: Gonçalves BP, Tiono AB, Ouédraogo A, Guelbéogo WM, Bradley J, Nebie 
I, Siaka D, Lanke K, Eziefula AC, Diarra A, Pett H, Bougouma EC, Sirima SB, 
Drakeley C, Bousema T 
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Non-linear model to estimate gametocyte clearance time 
 
A non-linear model was fit in SAS 9.3 (SAS Institute, North Carolina, United States) 
to estimate the rate of gametocyte clearance in study participants allocated to different 
treatment regimens:  
                                                                                                                                   [1] 
where Gt represents the proportion of individuals with gametocytes at time t. r is the 
rate with which gametocytes are cleared and depends on the treatment received: 
                                                                                                                            [2] 
where r0 corresponds to the clearance rate in the artemether-lumefantrine only group; 
and I1 and I2 are indicator variables representing the 0.25 mg/kg and the 0.40 mg/kg 
primaquine dose arms, respectively. a and b represent the effects of the different 
primaquine doses on the rate of gametocyte clearance and are estimated from the data.   
 
Haematological changes after treatment 
 
Finger-prick measurements 
219 children had haemoglobin levels quantified by Hemocue photometer on day 0. 
For those study subjects without Hemocue-derived haemoglobin levels in the 
beginning of the follow-up, measurements done at screening were used as baseline: 
the median (interquartile range) interval between screening and the day 0 of follow-
up was 2 (1 – 2) days. The majority (227/360) of study participants had haemoglobin 
levels measured on five follow-up visits after day 0; 9 children had 2 or less 
measurements. When all enrolled individuals are considered, regardless of the number 
of Hemocue measurements during follow-up, the average (95% CI) maximal fall in 
haemoglobin concentrations after treatment initiation was -0.60 (-0.81 - -0.39), -0.75 
(-0.95 - -0.56) and -0.84 (-1.08 - -0.61) g/dL in the AL-placebo arm, the 0.25 mg/kg 
primaquine dose arm and the 0.40 primaquine dose arm, respectively (N=355, 
P=0.12). 
 
Venous blood measurements 
During follow-up, haematological parameters were also measured on venous blood 
samples collected on days 0, 3 and 7. When using haemoglobin levels measured on 
these venous samples to assess haemolysis, the average (95% CI) maximal fall in 
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haemoglobin concentrations after treatment initiation was -0.19 (-0.30 - -0.07), -0.30 
(-0.45 - -0.14) and -0.33 (-0.45 - -0.20) g/dL in the AL-placebo arm (N=110), the 0.25 
mg/kg primaquine dose arm (N=122) and the 0.40 primaquine dose arm (N=119), 
respectively (P=0.32).  
 
Reticulocytes 
16 children had reticulocyte levels higher than 5% at enrolment. During follow-up, in 
47 scheduled visits (17 on day 3 and 30 on day 7), reticulocyte levels were above 5%: 
14, 18 and 15 in the AL-placebo, 0.25 mg/kg primaquine and 0.40 mg/kg primaquine 
arms, respectively. Median absolute reticulocyte count at enrolment was 88 (range 66 
– 113) x103 reticulocytes per μL; absolute levels increased on day 7 versus day 0 in 
78/101, 93/116 and 89/110 children in the AL-placebo, 0.25 mg/kg primaquine and 
0.40 mg/kg primaquine arms, respectively. There was a positive correlation between 
increase in reticulocyte levels during the first week of follow-up and haemoglobin 
drop by day 7 in the primaquine arms (Spearman's rank correlation coefficient 0.18 
[P=0.03], N=141). 
 
Parasitological criterion 
 
20 children with less than 1,000 asexual falciparum parasites per μL and no 
gametocytes at screening were mistakenly enrolled. They were equally distributed in 
the different study arms: 6, 7 and 7 were enrolled in the AL-placebo, the 0.25 mg/kg 
primaquine and the 0.40 mg/kg primaquine arms, respectively. 3, one from each study 
arm, of these 20 children had gametocytes on day 0 and were included in the 
gametocyte clearance analysis. Additionally, one child, from the AL-placebo group, 
had P. malariae infection detected by microscopy at enrolment, but not during follow-
up visits. Data from these children were included in analyses presented in this 
manuscript. 
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Tables 
Table S1. Prevalence of microscopically-detectable gametocytes during follow-up in children with patent gametocytes on day 0. AL = 
artemether-lumefantrine; PQ = primaquine. 
 
       
 AL AL + 0.25 mg/kg PQ AL + 0.40 mg/kg PQ 
 % (n/N) % (n/N) % (n/N) 
    
Day 2 38.6 (17/44) 35.4 (17/48) 36.5 (19/52) 
Day 3 34.1 (15/44) 35.4 (17/48) 23.5 (12/51) 
Day 7 20.9 (9/43) 10.4 (5/48) 5.8 (3/52) 
Day 10 19.5 (8/41) 4.1 (2/49) 0.0 (0/51) 
Day 14 15.4 (6/39) 0.0 (0/44) 0.0 (0/45) 
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Table S2. Gametocyte levels (per μL) measured by qRT-PCR during gametocyte-positive visits in children with patent gametocytes on 
day 0. AL = artemether-lumefantrine; PQ = primaquine. 
 
         
 AL AL + 0.25 mg/kg PQ 
AL + 0.40 mg/kg 
PQ 
AL vs. AL + 
0.25mg/kg PQ 
AL vs. AL + 0.40 mg/kg PQ 
 Median (IQR, N) Median (IQR, N) Median (IQR, N) P-value P-value 
      
Day 0 17.26 (7.21 – 45.08, 43) 18.62 (7.76 – 75.27, 48) 
16.63 (7.18 – 39.99, 
49) 
0.58 
0.83 
Day 2 2.33 (0.81 – 10.21, 41) 2.25 (0.75 – 5.83, 42) 
2.52 (0.85 – 9.70, 
47) 
0.57 
0.97 
Day 3 0.64 (0.08 – 2.64, 38)  0.87 (0.30 – 2.28, 37) 
0.70 (0.17 – 2.49, 
48) 
0.35 
0.67 
Day 7 0.48 (0.12 – 1.28, 28) 0.14 (0.08 – 0.45, 17) 
0.15 (0.05 – 0.24, 
15) 
0.12 
0.02 
Day 10 0.49 (0.17 – 1.40, 27) 0.12 (0.08 – 0.54, 14) 
0.13 (0.05 – 0.31, 
11) 
0.07 
0.008 
Day 14 0.30 (0.18 – 0.50, 17) 0.10 (0.10 – 0.66, 5) 0.15 (0.12 – 0.53, 9) 0.56 0.77 
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Table S3. Adverse Events by treatment arm. In (A), adverse events (AEs) are 
presented by severity and causality; in (B), by clinical condition. AL = artemether-
lumefantrine; PQ = primaquine. 
 
(A)  
Adverse Events   
by Severity and causality* 
AL 
only 
AL + 
 0.25 mg/kg PQ 
AL + 
 0.40 mg/kg PQ 
Any AE 15 18 24 
Mild AEs 7 7 9 
Mild AEs possibly related to 
study 2 1 4 
Moderate AES 8 11 15 
Moderate AEs possibly related to 
study 1 0 0 
Severe AEs 0 0 0 
*In total 48 children developed AEs during follow-up; 8 had 2 or more AEs. 
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(B) 
Adverse Event AL only 
AL +  
0.25 mg/kg PQ 
AL +  
0.40 mg/kg PQ 
Bronchitis 2 4 6 
Fever 2 4 5 
Abdominal Pain 1 1 0 
Vomitingα 2 2 2 
Uncomplicated Malaria 2 1 2 
Rhinitis/ Rhino-Bronchitis 1 1 1 
Otitis 0 0 2 
Dysentery 1 2 3 
Epistaxis 0 0 1 
Dental Pain 1 0 0 
High transaminase levels 1 0 0 
Palpebral inflammation 1 0 0 
Muscle pain (Neck) 0 1 0 
Wound 1 1 1 
Trauma on left foot 0 1 0 
Inflammation (left foot) 0 0 1 
α 5/6 vomiting episodes occurred on days 0 or 1; for all these 5 visits, study drug was 
re-administered. 1 child vomited on day 3 after treatment initiation  
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Table S4. Maximal percentage drop in haemoglobin levels, relative to baseline 
(enrolment or screening), by treatment arm. AL = artemether-lumefantrine; PQ = 
primaquine. 
 
 
Maximal % drop in haemoglobin 
Mean % (95% Confidence Interval)   
AL only 5.7 (3.3 - 8.1) 
AL + 0.25 mg/kg PQ 7.8 (5.8 - 9.8) 
AL + 0.40 mg/kg PQ    9.9 (7.9 - 11.9) 
 
 
Table S5. Number of participants with substantial haemoglobin drops (2 or more 
g/dL) during follow-up (N=35). AL = artemether-lumefantrine; PQ = primaquine. 
 
 
Haemoglobin drop (in g/dL) 
 
 
 2 - 3 3 – 4 > 4 
 
AL only 6 3 0 
 
AL + 0.25 mg/kg PQ 11 0 1 
 
AL + 0.40 mg/kg PQ 9 4 1 
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Table S6. Laboratory abnormalities during follow-up (days 3 and 7). In addition to 
the findings presented in this table, 7 children presented white blood cell counts below 
4,000 cells per μL during follow-up: 2, 3 and 2 in the AL-placebo arm, the 0.25 mg/kg 
primaquine dose arm and the 0.40 mg/kg primaquine dose arm, respectively. AL = 
artemether-lumefantrine; PQ = primaquine. 
 
White blood cell counts > 15,000 / μL 
Treatment arm Number of children  
AL only 3  
AL + 0.25 mg/kg 2  
AL + 0.40 mg/Kg 1  
    
Platelet count < 150,000 / μL 
Treatment arm Number of children  
AL only 4  
AL + 0.25 mg/kg 5  
AL + 0.40 mg/Kg 4  
    
Creatinine levels above upper limit of normal range*,φ 
Treatment arm Number of children  
AL only 2  
AL + 0.25 mg/kg 1  
AL + 0.40 mg/Kg 1  
    
Liver transaminases levels above upper limit of normal range¥,¤ 
Treatment arm Number of children  
AL only 4  
AL + 0.25 mg/kg 2  
AL + 0.40 mg/Kg 1  
    
Total bilirubin levels above 20 μmol/L 
Treatment arm Number of childrenα  
AL only 2  
AL + 0.25 mg/kg 5  
AL + 0.40 mg/Kg 7  
* < 6 years: 44.2 μmol/L; 6 - 10 years: 53.0 μmol/L; 10-15 years: 61.9 μmol/L 
φ 2/4 had normal creatinine levels by the end of the follow-up 
¥AST: < 6 years: 79 U/L; 6 - 10 years: 74 U/L; 10-15 years: 69 U/L 
ALT: < 6 years: 80 U/L; 6 - 10 years: 78 U/L; 10-15 years: 76 U/L 
¤ In 6/7 children with liver transaminases above normal range, levels decreased during the follow-up 
α3 children, one in each treatment arm, had bilirubin levels above 20 μmol/L at enrolment 
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Table S7. Summary of previous studies assessing post-artemether lumefantrine 
transmission potential. Mosquito infection rates in the study by Ouédraogo and 
colleagues were based on PCR; the other studies listed in the table used microscopy 
to assess oocyst positivity. 
 
 Study 
type 
Setting 
Inclusion 
trial 
Gametocyte 
positivity 
required for 
feeding 
assay? 
Num
ber 
of 
assa
ys 
Time 
from 
treatmen
t 
initiation 
(feeding 
assay) 
Number of 
infected 
mosquitoes 
in feeding 
assay (AL 
only group) 
Number of 
infectious 
individuals 
in feeding 
assay (AL 
only group) 
Sutherlan
d et al. 
2005 
RCT* Gambia 
Children with 
uncomplicate
d malaria 
Yes 10 Day 7 0/196 (0) 0/10 
Bousema 
et al. 
2006 
RCT Kenya 
Children with 
uncomplicate
d malaria 
No 25 Day 14 
27/750 
(3.6%) 
15/25 
Sawa et 
al. 2013 
RCT Kenya 
Children with 
uncomplicate
d malaria 
No 77 Day 7 
43/2293 
(1.9%) 
24/77 
Ouédrao
go et al. 
2015 
RCT 
Burkina 
Faso 
Asymptomati
c adults 
No** 68 
Days 1 
and 7 
4/560 
(0.7%) 
- 
* randomised controlled trial 
** Although gametocyte positivity was not a criterion for inclusion in feeding assays, only children with positive Pfs25 
mRNA NASBA results had mosquito infection status assessed 
Sutherland CJ et al. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. 
PLoS Med 2005, 2(4):e92 
Bousema JT et al: Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J 
Infect Dis 2006, 193(8):1151-1159 
Sawa P et al.  Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. J 
Infect Dis 2013, 207(11):1637-1645 
Ouédraogo et al. Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a 
double-blind, randomized, clinical trial. Clin Infect Dis. 2015. 
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Additional Figure 
Additional Figure 1. Near absence of infectiousness post-treatment. The y-axis 
corresponds to the proportion of mosquitoes infected in membrane feeding assays. 
Only data from individuals who infected at least one mosquito before treatment 
administration (‘Pre-Rx’) are included. No study participants, except one from the AL 
only arm, were infectious on day 7 after enrolment. 
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Chapter 6, Discussion 
 
In this chapter, I summarise the main findings presented in this document and consider 
aspects of the studies described in Chapters 3 – 5 that were not discussed in detail in 
chapter-specific discussions. 
 
Infectiousness of human populations to mosquitoes in malaria endemic areas 
 
In the epidemiological theory of mosquito-borne infections [1], two human infection-
related parameters are thought to directly influence transmission or more precisely the 
basic reproduction number: the probability that a mosquito bite on an infected 
individual results in mosquito infection and the duration of the infectious period. The 
infectiousness surveys performed in Burkina Faso and Kenya (Chapter 3) generated 
data that allow estimation of the first parameter during dry and rainy seasons. Indeed, 
for those studies, individuals were recruited regardless of parasite status by standard 
or molecular diagnostics and participated in membrane feeding experiments that 
quantify malaria infectiousness to mosquitoes. In Burkina Faso, the prevalences of 
infectiousness (4.9 and 6.4% during dry and wet seasons respectively) were 
considerably lower compared to the prevalences of malaria infection by molecular 
assays (50.5 and 83.8%); and only 0.9 and 1.4% of mosquitoes feeding on parasite-
positive individuals during the dry and wet seasons, respectively, were estimated to 
acquire infection after adjustment for demographics. In the Kenyan study sites, a 
similar pattern was observed: while one third of the study population in Kilifi and 
~25% of study participants in Mbita had falciparum parasites detected by 18S qPCR 
and microscopy, respectively, the prevalences of infectivity in both study sites were 
below 5%.  
 
The reason why infectiousness to mosquitoes is infrequent, even in areas with high 
transmission, is not well understood. The capacity of falciparum parasites to produce 
gametocytes varies in different clinical isolates [2], however, in theory, asexual stage 
parasites of all circulating strains should be able to develop into gametocytes otherwise 
these strains would get extinct. Gametocyte prevalences by Pfs25 mRNA QT-NASBA 
confirm that most infected individuals in these surveys carried sexual stage parasites, 
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although the skewed distribution of gametocyte densities (Chapter 3, Additional 
Figure 1) indicates that in the vast majority of these infections there were too few 
circulating gametocytes to infect mosquitoes at the moment of sampling. An important 
question is whether these ‘snapshots’[3] of gametocyte densities at the time of 
sampling accurately represent the average densities of gametocytes during individual 
infections or during a specified period of time – in other words, how variable are 
gametocyte densities over time in natural infections? Malariotherapy data [4] indicate 
that gametocyte patency often occurs during or immediately after peaks of asexual 
stage parasitemia and is rarely detectable by microscopy between consecutive asexual 
parasitaemia waves. Short-term systematic, rather than random, variation related to 
hypothesised circadian patterns of gametocyte circulation [5] or infectivity [6] could 
also have influenced infectiousness measurements as feeding assays were performed 
only during the day. As mentioned in Chapter 1, there is limited evidence for this 
from studies with intensive sampling over a period of a few days. Possible mechanisms 
for such variation could involve: 1) circadian relocation of gametocytes in different 
vascular beds; 2) circadian variation in release of newly mature gametocytes from 
bone marrow into circulation.  
 
Another possible explanation for the relatively low prevalences of infectiousness 
observed in the xenodiagnostic surveys described in Chapter 3 and in previous 
xenodiagnostic surveys (reviewed in [7]) is that experimental mosquito infections 
might not be sensitive enough to detect very low infection probabilities. Studies that 
concomitantly performed membrane feeding experiments and skin feeding assays, 
where mosquitoes feed on the skin of infected volunteers, indicate that membrane-
based assays are less sensitive than skin feeding experiments [8] and might 
underestimate infectiousness. However, xenodiagnostic studies that used skin feeding 
found prevalences of infectiousness that are similar to those estimated by studies using 
membrane feeding [9-12]. The number of mosquitoes dissected in feeding assays is 
another variable that influences the interpretation of infectiousness assessments, 
particularly when these are expressed as prevalence of infectivity (capacity to infect 
at least one mosquito). The number of mosquitoes dissected in each assay should 
reflect actual exposure over a specified period of time in natural settings. The 
transmission studies in Burkina Faso used relatively high numbers of mosquitoes 
(median [IQR] number of dissected mosquitoes per experiment during dry and wet 
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season surveys, 91 [79 – 97] and 41 [35 – 46], respectively) compared to other 
xenodiagnostic studies [12]. Of note, field estimates from the same area (Chapter 4) 
indicate that these numbers of dissected mosquitoes correspond to the numbers of 
mosquito bites individuals would receive over a period of three months and one month, 
respectively. A more robust metric compared to the categorisation of individuals as 
infectious or non-infectious and that should be reported in xenodiagnostic studies is 
the proportion of mosquitoes infected in individual assays. However even this measure 
is influenced by the number of mosquitoes in each feeding experiment, which 
determines the lower limit of infectivity quantification. All these limitations need to 
be considered when interpreting xenodiagnostic studies of malaria and other vector-
borne pathogens [13]. 
 
In summary, the distribution of gametocyte densities during infections is a likely 
explanation of why, at the time of surveys, only a few individuals infect mosquitoes. 
However, infectivity assessments should be interpreted with caution since gametocyte 
densities change over time and individuals who were not infectious on a particular day 
might become infectious on the following day (and vice-versa), and over one week, 
for example, a much higher proportion of the population might be infectious at least 
one night. Studies quantifying fluctuations in infectivity over different periods of time 
would allow accurate interpretation of cross-sectional infectivity assessments, and 
estimation of a cumulative measure of contribution to transmission. 
 
Infectiousness of specific populations 
 
Pregnancy malaria 
The studies presented in Chapter 3 did not specifically quantify malaria 
infectiousness during pregnancy. Pregnant women, however, are a likely source of 
malaria transmission due to their high parasite densities as well as their attractiveness 
to Anopheles mosquitoes. In an opinion manuscript [14] to which I contributed (the 
manuscript is presented in Appendix), these and other factors influencing malaria 
transmission potential during pregnancy, such as sulfadoxine-pyrimethamine (SP) 
resistance in parasite populations, which reduces parasitological efficacy of 
intermittent presumptive treatment with SP, are described and arguments, put forward 
for the inclusion of pregnant women in future mass treatment campaigns. Indeed, 
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evidence from recent clinical trials [15] that artemisinin-based combination therapies 
(ACTs) can be safely used to treat malaria infections during pregnancy indicates that 
treatment of infected pregnant women identified by community-wide screening of 
placental infections with rapid diagnostic tests, which are sensitive to detect most 
infections during pregnancy, could improve the likelihood of success of mass drug 
administration campaigns aiming to interrupt transmission and also prevent pregnancy 
malaria-associated morbidity [14]. 
 
Clinical malaria  
Whether individuals with malaria symptoms are, as a group, a non-negligible source 
of infection to mosquitoes is an important question for malaria control programmes, 
that need to make decisions on how to best allocate their resources to have a maximum 
impact on transmission levels and morbidity. A limitation of the xenodiagnostic 
surveys described in Chapter 3 is that the overwhelming majority of malaria-infected 
study participants were asymptomatic, which prevented the estimation of the 
infectiousness of individuals with clinical malaria. While in vivax infections 
gametocytes have a short maturation period and a high proportion of individuals with 
clinical disease are infectious when they present to healthcare facilities [16], in 
falciparum malaria the long maturation of gametocytes suggests that symptomatic 
individuals might not necessarily be infectious if they seek treatment early during their 
infection. In fact, the presence of mature gametocytes in the peripheral blood at the 
moment of health seeking behaviour, which depends among other things on the 
duration of the sexual maturation period and how fast the symptoms-causing asexual 
parasite density increases, was highly predictive of infectiousness in a hospital-based 
study undertaken in Cambodia [17]. Interestingly, in Kenya, gametocytaemic children 
with symptoms were less likely to infect mosquitoes compared to asymptomatic 
gametocytaemic children, suggesting that factors linked to the development of 
symptoms, such as parasite virulence factors or host responses associated with 
immunopathology, might affect gametocyte fertility. In addition to differences in the 
duration of the infectious period and in the ‘per gametocyte’ infectivity, in some areas 
symptomatic and asymptomatic malaria cases might also be associated with distinct 
epidemiological processes: in Zambia, where transmission is approaching elimination 
levels, parasites infecting asymptomatic individuals were genetically different from 
those infecting individuals with symptoms [18], which indicates that in some areas 
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there might exist parallel circulation of endemic strains, which would presumably be 
associated with asymptomatic infections, and strains that often cause symptoms (e.g. 
imported parasites against which no strain-specific immunity exists in the 
community). In January 2016, I contributed to a letter to the Journal of Infectious 
Diseases on the importance of malaria transmission from clinical cases [19] (letter 
included in the Appendix).  
 
Heterogeneity in mosquito exposure and spread of parasites at the community level 
 
In Chapter 4, data on exposure to Anopheles mosquitoes were presented. Briefly, 
bloodfed mosquitoes were collected from households in an area with seasonal malaria 
transmission and the sources of mosquito blood meals were identified by DNA 
fingerprinting. In the study area, heterogeneity in exposure was observed at two 
different levels: the number of bloodfed mosquitoes collected in each study house 
varied considerably, and individuals living in the same house were often linked to very 
different numbers of mosquito blood meals. Corroborating findings from previous 
studies that used other methods of mosquito exposure assessment (e.g. direct 
observation or ABO blood group typing), the entomological study in Burkina Faso 
showed that adults are more often exposed to Anopheles mosquitoes than children. 
Age-specific estimates of exposure also allowed for a better quantification of the 
contributions of different age groups to local malaria transmission (Chapter 3).  
Indeed, after accounting for infectiousness, demographics and vector exposure, 
schoolchildren were estimated to contribute 41.1 – 45.8% of transmission in our study 
sites in Burkina Faso, and adults, 51.3 – 55.5%. These results are informative for 
control interventions: for example, by extending the age limit for administration of 
seasonal malaria chemoprevention to include schoolchildren, in addition to reductions 
in morbidity, decreases in community-wide transmission might also occur. 
 
As a consequence of both between- and within-household variation in exposure, a high 
proportion of the study population was not linked to any mosquito blood meals, 
especially at the end of the wet season. Our data suggests that there are two 
mechanisms that could explain this observation: all individuals living in households 
where vector density is low have limited indoor exposure to mosquitoes; and in houses 
with high mosquito counts a subset of residents might remain unexposed. Conversely, 
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some individuals in Balonghin received considerably more mosquito bites than the 
rest of the population. These individuals are likely to be important sources of infection 
to other members of their households and locally: by being frequently sampled by 
different mosquitoes, rather than receiving repeated bites from the same mosquitoes, 
which would only occur where mixing of malaria vectors is limited (for a clear 
explanation of the differences between the concepts of heterogeneity and mixing see 
[20]), these highly-exposed individuals would 1) be more often infected, 2) as a result 
be more often infectious, and 3) due to their level of exposure have more opportunities 
to transmit malaria parasites to previously unencountered (uninfected) mosquitoes .  
 
One aspect of the transmission of parasites in a community that was not captured by 
the mosquito collection studies in Burkina Faso is parasite movement: while spatial 
variation in vector density and host factors influencing exposure to mosquitoes, such 
as bed net use, might result in areas where parasite fitness is high (equivalent to R0 > 
1), migration of parasites from these areas might sustain or boost transmission in other, 
less receptive, areas [21]. Although at a large scale (i.e. countries) human movement 
is more likely to drive parasite introductions, at a village scale, mosquito movement 
is, presumably, highly relevant [22]. If areas with high mosquito density and high 
infectiousness prevalence only rarely export infections to the rest of the community, 
due to distance or factors influencing mosquito movement, households with lower 
exposure to mosquitoes or with fewer infectious individuals but higher connectivity 
might be more important in sustaining transmission locally (Box 1). Quantifying 
mosquito movement at different scales would inform the design of targeted 
interventions to reduce malaria transmission as it would allow the estimation of 
distance ranges within which mosquitoes acquiring infection in particular households 
are likely to cause secondary human infections. These distance ranges might depend 
on mosquito movements, relative locations of oviposition sites and human dwellings, 
and household-level vector densities.  
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Box 1. Malaria transmission in networks of households. Circles represent houses in a 
hypothetical village with endemic malaria transmission, and the lengths of the blue 
lines are proportional to distances between houses. Each circle’s colour represents the 
household-level malaria transmission potential and is dependent on local vector 
density, household characteristics and human behaviour that influence exposure to 
Anopheles mosquitoes and prevalence of infectiousness. The widths of the lines 
connecting different houses depend on the flux of Anopheles mosquitoes from one 
house to another. In this hypothetical setting, the houses with highest transmission 
potential (top left), despite being an important source of infected mosquitoes locally, 
are not major contributors to transmission that occurs in the other cluster of 
households, due to the limited connectivity (in terms of mosquito movement) between 
those houses and the rest of the village. Indeed, a household with lower transmission 
potential but with higher flux of mosquitoes leaving to the rest of the village could be 
more important to the maintenance of transmission in the total area. 
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Possible interactions between mosquito exposure, human immunity and infectivity  
 
Transmission opportunities and capacity to infect mosquitoes do not necessarily 
coincide: while children are on average more infectious than adults, adults are more 
often exposed to mosquitoes. Since the two Burkina Faso studies described in 
Chapters 3 and 4 did not recruit the same individuals, we cannot exclude however 
that within age groups infectious individuals were those who received more mosquito 
bites – to become infectious, an individual would have received at least one infective 
bite few weeks or months earlier. On the other hand, individuals living in areas or 
houses with persistently high vector densities might become infected more often and 
develop immunity that controls parasitemia faster compared to individuals living in 
areas with lower vector densities. An association between long term exposure to 
malaria vectors and immunity development could have two opposite consequences: 
falciparum parasites and gametocytes densities might be lower in infected individuals 
living in high-exposure areas compared to age-matched individuals in areas with less 
frequent Anopheles exposure; and anti-disease immunity [23] (i.e. immunity that 
prevents symptoms after blood stage infection establishment) might also develop 
faster in areas with higher exposure to mosquitoes, which could influence infection, 
and infectiousness, duration by postponing treatment seeking behaviour. Studies that 
longitudinally assess household-level and individual-level mosquito exposure and 
how these relate to gametocyte levels in repeated infections and to the risk of symptom 
development during blood stage infections will help to understand the long-term 
impact of heterogeneity in mosquito exposure on other transmission related 
phenotypes.  
 
Primaquine and residual malaria transmission 
 
Chapter 5 described an efficacy clinical trial that assessed the effect of low dose 
primaquine on both gametocyte clearance, determined by RNA-based molecular 
assays, and infectivity, quantified in membrane feeding assays. Children receiving a 
single primaquine dose (0.25 mg/kg or 0.40 mg/kg) cleared gametocytes faster than 
children who received artemether-lumefantrine alone. Membrane feeding assays 
performed in the same study, however, suggest that artemether-lumefantrine alone can 
block transmission efficiently (Chapter 5 Additional Figure 1), which could be 
  
171 
 
linked to lumefantrine’s effect on exflagellation [24]. The transmission blocking 
activity of artemether-lumefantrine contrasts with the more limited effect of 
dihydroartemisinin-piperaquine on malaria transmission: in Mali, highly 
gametocytaemic individuals who received dihydroartemisinin-piperaquine were often 
infectious after treatment initiation, unless primaquine was co-administered [25]. The 
faster clearance of gametocytes, the added value in blocking transmission when used 
in combination with a drug that has limited activity against transmission stages as well 
as the growing evidence that the WHO-recommended dose is safe, all this indicates 
that primaquine could be used by malaria elimination programmes to accelerate 
reductions in transmission levels.  
 
Community-wide chemotherapy approaches that involve treating individuals based on 
(mass screening and treatment, MSAT) or regardless of (mass drug administration, 
MDA) their parasite statuses are being considered and used by malaria elimination 
programmes. In these mass treatment campaigns, several thousand individuals receive 
treatment simultaneously and some remain or become infectious post-treatment, with 
the frequency of residual infectiousness depending on the drug being used [26]. The 
objective of these campaigns is to eliminate malaria in a particular region by clearing 
all parasites in humans to prevent new mosquito infections; even a small number of 
individuals carrying transmissible gametocytes for a few days after drug 
administration could lead to continuity of transmission. By co-administering 
primaquine, the likelihood of persistence of parasites at a community level would be 
minimised. The data presented in Chapter 4 suggest that some individuals have more 
transmission opportunities, presumably also after antimalarial administration, and 
demographically and spatially targeting primaquine administration could be 
considered where there are safety concerns linked to G6PD deficiency: for example, 
primaquine could be used as part of MDA campaigns where vector density is high but 
not necessarily in areas associated with lower vector exposure.  
 
Conclusion 
 
The studies presented in this document, results of efforts of dozens of scientists, aim 
to provide a comprehensive description of malaria infectiousness at a population level 
and of heterogeneity of exposure to Anopheles mosquitoes. The main findings are: (1) 
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infectivity is not common in randomly selected infected individuals; (2) few 
individuals receive most mosquito bites; (3) primaquine reduces gametocyte carriage 
duration and might thus be a useful tool if the goal is to have complete interruption of 
transmission. These observations also generated questions that need to be addressed 
by future studies: (1) How does human-to-mosquito infectivity relate to heterogeneity 
in Anopheles exposure at different levels (individual and household)? (2) Are 
estimates of malaria transmission parameters based on infectivity assays similar to 
estimates based on detailed genetic analysis of parasites [27]? (3) How often are 
parasites transmitted between households? And is it possible to identify common 
patterns of malaria connectivity in different settings that would allow rational 
development of targeted control interventions?  
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Appendix A, Infectious reservoir of falciparum malaria (past and future)  
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Abstract 
 
Renewed interest in malaria eradication has placed greater emphasis on the 
development of tools to interrupt Plasmodium transmission, such as transmission-
blocking vaccines. However, effective deployment of such tools will likely depend on 
improving our understanding of which individuals transmit infections to mosquitoes. 
To date, only a handful of studies have directly determined the infectiousness of 
individuals in endemic populations. Here we review these studies and their relative 
merits. We also highlight factors influencing transmission potential that are not 
normally considered; the duration of human infectiousness, frequency of sampling by 
mosquitoes, and variation in vector competence among different mosquito 
populations. We argue that more comprehensive xenodiagnostic assessments of 
infectivity are necessary to accurately quantify the infectious reservoir and better 
target interventions.  
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Reducing transmission of malaria: the future of elimination programs 
 
The burden of malaria has declined in many endemic settings in Africa and elsewhere 
[1]. Local malaria elimination is considered achievable with current control 
approaches in some of these areas when transmission intensity is low and re-
introduction unlikely [2, 3]. However, in the majority of endemic areas, operational 
and technical limitations are likely to hinder the complete interruption of transmission 
[4, 5]. New or renewed tools aimed specifically at interrupting the spread of 
Plasmodium species from human to mosquito may therefore be critical for future 
elimination programs [6, 7], especially if transmission efficiency increases as parasite 
prevalence goes down [8]. Unlike traditional control strategies, which aim to reduce 
severe morbidity in vulnerable populations, the effectiveness of transmission reducing 
interventions (TRI) hinges on their coverage of individuals responsible for 
transmission to mosquitoes regardless of their symptomatic status [9]. Despite the 
central importance of human infectivity for TRI [10], there have been few direct 
assessments of human infectivity to mosquitoes. Here we discuss previous studies that 
aimed to directly assess infectivity at the population level, examine factors necessary 
to link these controlled transmission experiments with transmission in nature, and 
advocate the next steps which will provide the key information necessary to better 
target the human infectious reservoir for malaria. 
  
Quantifying the human infectious reservoir of malaria (1957 – 2014) 
 
In infected humans, the life-cycle of a small portion of the total malaria parasite 
population culminates in differentiation and maturation into gametocytes (see 
Glossary). When an anopheline mosquito feeds on blood containing mature 
gametocytes, some may be ingested which then fuse and undergo sporogonic 
development making the insect infectious to humans. The human component of the 
infectious reservoir is the proportion of a population that are capable of infecting 
mosquitoes [11]. 
 
In community surveys, data from microscopy typically show that children and infants 
harbour Plasmodium gametocytes more commonly and in greater number than older 
age groups [12]. Such observations have long galvanised belief among the scientific 
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community that young individuals represent the main source of infection for 
mosquitoes [12]. However, in the late 1940s and early 1950s, xenodiagnostic 
assessments revealed that the presence of gametocytes in blood films was not 
prerequisite to onward transmission [12-15]. The first population-based assessment of 
human infectivity to mosquitoes was conducted in rural Liberia, where individuals 
living in an endemic region were recruited for mosquito feeding experiments 
regardless of their parasite status [16]. Whilst this study found that young children 
were much more infectious to mosquitoes, it also showed that when estimates were 
adjusted for the demographic composition of the population, all age groups were 
relevant contributors to malaria transmission (Box 1). In nearly 60 years since this 
study a handful similar surveys have been reported (Tables 1 and 2). In general, these 
studies show that whilst young children are consistently more likely to be infectious 
per se [17, 18], the contribution of older age groups is by no means negligible; in 
previous xenodiagnostic surveys that were able to sample individuals of all ages, 
individuals >15 years old made up between 21.9 and 40.7% of the total infectious 
reservoir [16-19]. Several studies have assessed human-mosquito transmission using 
entomological parameters [20]. However, these studies provide only broad population 
estimates of infectiousness and they are not able to describe the distribution of the 
reservoir among different members of the population nor allow an examination of the 
role of parasite density and infection dynamics. 
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Box 1. Demography and the malaria infectious reservoir  
In previous surveys, the ‘bottom-heavy’ age structure typical of malaria endemic 
regions has acted to boost the contribution of more infectious children to the total 
malaria infectious reservoir, while less infectious adults, representing approximately 
half of most populations, generally contributed to a lesser extent. Recent demographic 
estimations show that Sub-Saharan African populations are still disproportionately 
young; approximately 17% and 27% of the population are aged between 0-4 and 5-14 
years, respectively (http://esa.un.org/wpp/). The influence of demography on patterns 
of transmission needs to be considered in light of the numerous other factors affecting 
the likelihood of infectious individuals contributing to mosquito infections. Though 
infants and children are over-represented in endemic areas they may be the age group 
least available to and, perhaps, least attractive to mosquitoes (see Determinants of 
human transmission potential: the need for data). Conversely, older children and 
adolescents may represent a privileged group for human-mosquito transmission; 
individuals in this age group possess moderate gametocyte densities, approximately 
double the infectivity of individuals >15 years, lack the severe symptoms that prompt 
treatment, and appear comparatively vulnerable to mosquito biting (Figure 1). 
Women in pregnancy have been observed to attract more than twice as many 
anophelines as non-pregnant women over short distances [21]. However, such 
observations must be weighed against behavioural and demographic parameters 
unique to this group. Census and fertility rate data show that pregnant women 
comprise a small proportion of African populations. In Zambia, 8.7% of women of 
child bearing age were pregnant at any one time in 2013, which equates to 2-2.5% of 
the entire population (http://www.dhsprogram.com/pubs/pdf/FR304/FR304.pdf). 
Pregnant women are also preferentially targeted by net and drug treatment campaigns, 
so the high attractiveness to mosquitoes of this small proportion of the population may 
be balanced by interventions. 
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Table 1. Summary of studies assessing the malaria infectious reservoir where recruitment was conducted without regard for parasite status.a 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referen
ce 
Study location Local 
transmission 
setting 
Feeding 
method 
Assay 
endpointb 
Species Prevalence of 
infectiousness 
(%)c 
Proportional contribution to 
reservoir (%)d 
Mosquito 
infection 
probabilitye 
1 - 4 5 - 9 
10 - 
19 
≥20 
[19] Papua New 
Guinea 
Moderate 
perennial 
Direct & 
Membrane 
Oocysts 
Anopheles farauti  3.8 22.7 32.9 30.3 14.2 0.013 
 
      1 - 4 5 - 14 ≥15    
[16] 
Liberia 
Intense 
perennial 
Direct  
Oocysts Anopheles 
gambiae 
10.6 40.5 28.4 31.1 
  
0.023 
[17] 
Kenya 
Intense 
perennial 
Direct  
Oocysts & CSP 
ELISA 
Anopheles 
gambiae 
10.1 23.2 36.1 40.7  0.010 
[77] 
Burkina Faso 
Intense 
seasonal 
Membrane 
Oocysts Anopheles 
gambiae 
48.0 NDf 39.7 60.3 
 
0.055 
[18] Cameroon 
(Bondi) 
Intense 
seasonal 
Direct  
Oocysts Anopheles 
gambiae 
7.4 28.8 49.2 21.9  0.024 
[18] Cameroon 
(Mengang) 
Intense 
seasonal 
Direct  
Oocysts Anopheles 
gambiae 
8.2 34.7 33.9 31.4  0.011 
[32] 
Senegal Low, unstable Direct  
Oocysts Anopheles 
arabiensis 
8.7 NDf 51.8 48.2 
 
0.002 
a Only studies that have utilised demographic and mosquito feeding data to characterise the human infectious reservoir of Plasmodium in endemic populations were included.  All studies 
were conducted in areas where Plasmodium falciparum and non-falciparum species co-circulate, so the outcome of feeding assays cannot be attributed unambiguously to falciparum malaria. 
One additional study not included in the table utilised population and xenodiagnostic data to quantify the malaria infectious reservoir in Sri Lanka [79]. This study recruited individuals with 
incident malaria over a 17 month period, the majority of which were Plasmodium vivax. The study design and analysis was suitably different as to exclude the possibility of direct comparison 
with the other studies presented in the table. b Assay endpoint was either 1. Oocysts counted on the mosquito midgut by microscopy, or 2. Oocysts counted by microscopy or positivity of 
remaining live mosquitoes at the end of the experiment (day 15) post infection) in the circumsporozoite protein ELISA [17].  d Proportional contribution to the reservoir presents the 
proportional contributions of three or four age groups to population-adjusted reservoir, with age groupings combined where the data in the original publication allowed.  e Mosquito infection 
probability corresponds to the probability that a mosquito biting a random individual in a population will develop infection. This measure was either presented as in the published data, or 
was calculated by combining demographic data, age-specific prevalence of infectiousness and age-specific mosquito infection rates during infective membrane feeding experiments.  f ND: 
Studies failed to perform mosquito feeds on individuals <5 years of age. Data has been adjusted to represent the infectious reservoir of individuals >5 years only. 
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Table 2. Summary of studies assessing the malaria infectious reservoir that recruited only gametocyte positive individuals for feeding assays.a 
 
 
 
 
 
 
                    
 
 
Reference Study location Local 
transmission 
setting 
Feeding method Assay 
endpointb 
Species Prevalence of 
infectiousness 
(%)c 
Proportional contribution to 
reservoir (%)d 
Mosquito 
infection 
probabilitye 1 - 4 5 - 9 10 - 19 ≥20 
[11] The Gambia Intense seasonal Membrane Oocysts Anopheles gambiae 5.6 17.5 21.7 22.2 37.9 0.015 
[11] Tanzania Intense perennial Membrane Oocysts Anopheles gambiae s.l. 3.2 28.4 23.1 14.2 34.0 0.007 
[19] 
Papua New  
Guineaf 
 
Moderate 
perennial 
Direct & 
Membrane 
Oocysts Anopheles farauti  3.6 (1.4) 48.0 12.4 24.0 15.5 0.012 (0.004) 
aOnly studies that have utilised demographic and mosquito feeding data to characterise the human infectious reservoir of Plasmodium in endemic populations were included.  All studies were conducted 
in areas where Plasmodium falciparum and non-falciparum species co-circulate, so the outcome of feeding assays cannot be attributed unambiguously to falciparum malaria.  bAssay endpoint was 
oocysts counted on the mosquito midgut by microscopy.  cPrevalence of infectiousness was calculated as the combined prevalence of individuals infectious to ≥1 mosquito in each age category, adjusted 
for proportion of the population made up by the age groups in the total population.  dProportional contribution to the reservoir presents the proportional contributions of three or four age groups to 
population-adjusted reservoir, with age groupings combined where the data in the original publication allowed.  eMosquito infection probability corresponds to the probability that a mosquito biting a 
random individual in a population will develop infection. This measure was either presented as in the published data, or was calculated by combining demographic data, age-specific prevalence of 
infectiousness and age-specific mosquito infection rates during infective membrane feeding experiments. fFor this study, all species and P. falciparum-specific (within parenthesis) estimates are 
presented. 
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Ultimately, determining the infectiousness of different age groups relative to their 
representation in the population is just one necessary step in characterising the 
infectious reservoir. Contribution to transmission is influenced not only by intrinsic 
parasite and human determinants of infectivity, reflected in the outcome of mosquito 
feeding assays, but by a variety of additional factors that make the capacity to infect 
mosquitoes in controlled experiments distinct from the probability of onward 
transmission in nature (e.g. human exposure to mosquito biting) (Figure 1). These 
factors are not commonly taken into account and are not uniform across time, space, 
or between individuals of different age. To more accurately reflect transmission in its 
epidemiological context, these elements need to be considered and incorporated into 
future assessments.  
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Figure 1. Age contributions to the infectious reservoir.  
A. Individuals in the figure are represented by circles in three age groups; <5, 5-15, 
and >15 years. The abundance of individuals in each group reflects a simplified 
population age-structure in sub-Saharan Africa, as described in Box 1 and in the 
studies detailed in Table 1 and 2 (<5=15%, 5-15=30%, >15=55%) 
(http://esa.un.org/wpp/). B. Speckling within circles represents the presence 
of Plasmodium falciparum gametocytes detectable using quantitative-nucleic acid 
sequence-based amplification (QT-NASBA); age-specific prevalence presented here 
were taken from an area of intense seasonal transmission [87]. C. Solid filled circles 
represent who might infect mosquitoes in a mosquito feeding assay. Some (or most) 
gametocytaemic individuals may not be infectious for a variety of reasons, including 
gametocyte density, maturity, recent treatment, and transmission blocking immunity. 
Infectiousness prevalence for the three age groups (<5=25%, 5-15=13%, >15=7%) is 
based on surveys described in Table 1 [16-18]. Pie chart 1 demonstrates the 
proportional contribution of each age group to the total population infectious reservoir. 
Demographic adjustment is not necessary as this example directly represents the age-
composition of a typical population. Of the theoretical total infectious population 
(9.8% [5/51 individuals]), individuals in the age groups <5, 5-15 and >15 years 
account for 40%, 40% and 20% of the reservoir respectively. D. Equally exposed 
individuals of different ages are differently attractive to mosquito biting, partly due to 
differences in body surface area. To reflect this, individual circles were given a surface 
area proportional to the average body surface area of individuals in the three age 
groups (<5=0.4m2, 5-15=1.2m2, >15=1.6m2; Ratio of surface area 1:3:4), using data 
from Port et al. showing that body surface area correlated positively with mosquito 
biting rate [45]. Pie chart 2 illustrates the potential effect of increased mosquito 
sampling due to body surface area in each age group on the infectious reservoir. 
Finally, to account for some of the age-related differences in exposure intensity, the 
percentage bed net use among individuals in broadly similar age groups from an area 
of seasonal transmission in Western Kenya (Coverage: <5=42%, 6-17=26%, 
>17=57.7%; Ratio of exposure 1:1.2:0.7) was used to adjust the surface area weighted 
contributions to the infectious reservoir (Pie chart 3) [88].  
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Determinants of human transmission potential: the need for data 
 
Duration and dynamics of infectivity 
The likelihood of transmission to Anopheles mosquitoes is determined primarily by 
gametocyte density, fitness and their circulation time. The non-linear relationship 
between gametocyte density and mosquito infection risk has been described several 
times [21-23]. Yet, because of the relatively high proportion of low density 
parasitaemias and gametocytaemias in natural infections, there is increasing focus on 
how important these often sub-patent infections are for the maintenance of 
transmission [24, 25]. While the limited sensitivity of microscopy to detect 
gametocytes is well established [21], many claims of submicroscopic gametocyte 
densities contributing to transmission are based on microscopy-positive asexual 
parasite carriers with accompanying submicroscopic gametocyte densities. This is an 
important difference when considering how current diagnostics may capture the 
human infectious reservoir [26, 27]; infections with submicroscopic gametocytes that 
accompany patent asexual parasites are detectable by conventional diagnostics whilst 
infections with no microscopically detectable parasite stages require more sensitive 
diagnostics [28]. 
 
Because of their cross-sectional nature, previous xenodiagnostic surveys have not 
formally examined the duration of infectiousness, another key factor influencing 
transmission potential. Data from malaria therapy studies suggest infectiousness of an 
individual infection can last for many months [29] however it is difficult to extrapolate 
the observations from a limited age range of malaria naïve to endemic populations. 
Broadly, in endemic settings, children (possessing limited immunity) are likely to have 
more acute, higher density infections that often require treatment [30]. This may result 
in cross sectional surveys missing recently treated infections and identifying only a 
limited number of highly infectious children without recent treatment. Conversely, 
adults and older children (often semi-immune, and presenting few clinical symptoms) 
would have longer, chronic infections, which could result in longer infectious periods, 
balanced by lower infectivity at individual time points [31]. These patterns of infection 
are likely to differ with transmission intensity. In areas of intense malaria transmission 
children may have repeated malaria infections with relatively high gametocyte 
densities and a high likelihood of malaria transmission (Figure 2). In areas with lower 
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transmission, including areas that have reduced transmission in the context of an 
elimination program, infection duration will likely have a more significant influence 
on the infectious reservoir. At present only one study has directly assessed population 
level infectiousness in an area of low malaria transmission [32]. Because of the utility 
of these data to control and elimination programs, further studies assessing the 
infectious reservoir in areas of low transmission would be advantageous. 
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Figure 2. Cross-sectional surveys and infectious reservoir dynamics.  
Data represent hypothetical annual transmission measures in two different endemic 
settings of seasonal and perennial malaria transmission. The dashed line corresponds 
to the timing of cross-sectional xenodiagnostic surveys. The population plots 
underneath the main charts reflect hypothetical population level infectiousness, as 
would be measured in direct assessments of the reservoir. Individuals in the plots are 
represented by circles in three age groups; <5, 5-15, and >15 years. The abundance of 
individuals in each group reflects a simplified population age-structure in sub-Saharan 
Africa, as described in Box 1 and in the studies detailed in Table 1 and 2 (<5=15%, 5-
15=30%, >15=55%) (http://esa.un.org/wpp/). Speckling within circles represents the 
presence of Plasmodium falciparum gametocytes; age-specific prevalence is 
hypothetical. Solid filled circles represent who might infect mosquitoes in a mosquito 
feeding assay; infectiousness prevalence for the three age groups is hypothetical. To 
reflect differences in body size and potentially attractiveness to mosquitoes, individual 
circles were given a surface area proportional to the average body surface area of 
individuals in the three age groups (<5=0.4m2, 5-15=1.2m2, >15=1.6m2; Ratio of 
surface area 1:3:4), using data from Port et al. showing that body surface area 
correlated positively with mosquito biting rate [45]. The combined surface area of 
individuals in the plots can be interpreted broadly as the contribution each group 
makes to the total infectious reservoir. Combined, the figure illustrates that the total 
infectious reservoir and the proportional contribution of differently aged individuals 
are likely to vary, potentially significantly, over time in response to the dynamicity of 
numerous factors. Though variations in transmission potential would probably be 
clearest between surveys where transmission is seasonal, age-specific contributions 
may vary with time in areas where transmission is intense and perennial. 
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In an individual infection, infectiousness per gametocyte may be higher at the 
beginning of an infection than at the end because of changes in parasite competency 
[33], sex ratio [34, 35] and possibly the development of sexual stage immune 
responses [36-38]. Transmission-blocking immunity is boosted by recent exposure to 
gametocytes [37] and may reduce infectiousness during the course of infections that 
last several weeks or months. Superinfecting clones influence parasite growth 
dynamics including total gametocyte biomass [39], and multiplicity of infection could 
in itself be a determinant of transmissibility [40].  This combination of factors might 
also indicate that infectiousness of one infection may not reflect the infectiousness of 
subsequent infections (when multiplicity of infection and transmission blocking 
immunity may differ), suggesting greater complexity than that estimated from a single 
time point during the transmission season.    
 
Mosquito exposure 
 
Artificial feeding experiments in xenodiagnostic surveys have tended to use fixed 
numbers of mosquitoes, improving the precision of estimates of infectiousness by 
maximising mosquito sample sizes. However, in any endemic area mosquito biting 
rates of humans vary considerably. As an example, a recent study in Uganda found 
biting rates varied from 270 to 7399 bites/year between study sites, with each site 
showing distinct seasonal fluctuations [41]. The transmission potential of infectious 
individuals will be determined by the rate at which they are sampled by local 
mosquitoes and the competence of these vectors. Where vector densities and survival 
rates are low the number of mosquitoes that become infected and subsequently 
transmit their infections will be very low even if there are infectious individuals in the 
human population. Although essential to accurately characterize individual-specific 
contributions to transmission, these entomological parameters have never been 
measured in conjunction with xenodiagnostic surveys.  
 
Attractiveness to mosquitoes 
 
In the early 1950s, Muirhead-Thomson observed that Jamaican adults attracted more 
Anopheles mosquitoes than equally exposed children [42]. The conclusions of this 
study are supported by later reports in which wild Anopheles were allowed to feed on 
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unprotected humans under observation [43, 44], or ABO blood typing allowed the 
identification of blood meal origin [45], though some studies show more random 
biting selection [46].  Carnevale et al near Brazzaville, in the Republic of Congo, 
described the biting behaviours of 6500 mosquitoes on 24 individuals of all ages [43]. 
Anopheles biting increased with age, with individuals >20 years old being bitten three 
times more than < 2 year olds. Port et al. were able to ascribe this age-related biting 
pattern to increased body weight and surface area [45]. In addition to increased surface 
area, body temperature and chemical cues change with age and physiological maturity 
and may be associated with attractiveness [47-49]. This might also help explain why 
pregnant women are thought to be more attractive to mosquitoes than non-pregnant 
women [50]. Muirhead-Thomson also observed that infants reacted more actively in 
sleep to the probing of mosquitoes than adults, and that mosquitoes were less likely to 
feed on infants even after alighting on their skin [42]. Data are less robust on the 
influence of Plasmodium infection on mosquito attractiveness. Reports from animal 
models and studies on a small number of humans infected with P. falciparum suggest 
that the presence of gametocytes may increase attractiveness to anopheline mosquitoes 
[51, 52], possibly due to the production of attractive volatiles [53]. It is unclear if the 
small biomass of gametocytes could have specific systemic effects that would increase 
the attractiveness of children (harbouring higher gametocyte densities), and if this 
might counteract the reduced attraction associated with their smaller surface area.  
 
Availability to mosquitoes 
However attractive and infectious the individual, they must be available to mosquitoes 
for feeding and subsequent transmission to occur. This availability is shaped primarily 
by human social and behavioural practices, including use of mosquito nets and 
sleeping patterns. 
Age-specific net use depends on the setting and extent of ownership, but in areas with 
good coverage appears highest among young children (<5 years), and lowest among 
older children and adolescents (5-15 years) [54-57]. In addition to bed-net’s 
community-wide effect on transmission, they may also reduce an individual’s chance 
of infecting mosquitoes and divert vectors to other bloodmeal sources. In the Gambia, 
the introduction of insecticide-treated nets (ITN) protected children against malaria 
and diverted mosquito bites to other hosts (animals or adults) [58]. Net distribution 
has also been linked to changes in vector behaviour and species composition; 
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Anopheles gambiae and Anopheles funestus have showed signs of responsive 
exophagy [59], and there are observations that peak biting in these species may shift 
to the early evening and morning [60, 61]. Net-related reductions in A. gambiae s.s. 
populations have also been linked to increasingly dominant roles for A. funestus [62] 
and Anopheles arabiensis [63]. 
 
These elements together with sleeping times and time spent indoors or outdoors at 
night determine availability to different mosquito populations. Children might be 
expected to sleep earlier than adults, but the protection afforded by long periods of 
time under bed-nets depends on when local vectors are most active. Data on time spent 
indoors, time spent under nets, and on the biting activity of local vectors can be 
combined to determine the true protective efficacy of bed nets by age [64].  This is an 
informative composite measure, which could be used to estimate age-specific patterns 
of mosquito exposure. 
 
Effectively delineating the interaction of mosquito exposure and subsequent malaria 
transmission is difficult.  Individuals identified as infectious in xenodiagnostic surveys 
must have been exposed to malaria vectors at some stage, but heterogeneity in 
attractiveness and the degree of exposure should still significantly influence their 
relative contribution to the infectious reservoir. Surveys quantifying mosquito 
exposure and infectiousness in the same population could provide more realistic 
estimates of age-specific contributions to transmission. 
 
Heterogeneous Mosquito Populations  
 
Although several vector species might contribute to local transmission in endemic 
areas, most xenodiagnostic surveys have been performed using A. gambiae s.s. (Tables 
1 and 2), the majority of which were colony reared. Evidence is limited on whether 
infectiousness to A. gambiae during membrane or skin feeding assays corresponds to 
infectivity to other vector species. Two major malaria vectors, A. funestus and A. 
arabiensis, are distributed throughout Sub-Saharan Africa, often co-existing with A. 
gambiae s.s. [65]. The highly anthropophilic biting preferences of A. funestus [66], its 
high longevity [67] and sporozoite rate [62, 68] (higher than A. gambiae in some 
endemic areas) indicate that a non-negligible part of malaria transmission might be 
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sustained by this vector where it is present. Conversely, A. arabiensis is considered 
more exophilic and exophagic; in Burkina Faso, A. arabiensis was as susceptible to 
infection as A. gambiae s.s. in feeding assays [69], while in Senegal, lower infection 
rates were observed in membrane feeding assays with A. arabiensis compared to A. 
gambiae s.s. [70]. The recent description of cryptic malaria vectors [71, 72] and the 
conflicting results on the differential susceptibility of A. gambiae s.s. and Anopheles 
coluzzi [69, 70] (previously the molecular forms S and M of A. gambiae, respectively 
[73]), further illustrate the need to quantify transmission efficiency against the 
background of diverse vector populations.  
 
Considerations for future studies 
 
To more rigorously assess the human infectious reservoir using direct xenodiagnostic 
surveys, several methodological issues require consideration. In this section, we 
suggest suitable inclusion criteria and methods for measuring or predicting individual 
level mosquito exposure. Other important factors that are discussed include the type 
of feeding assay, measures of infectiousness, and general study design. 
 
Inclusion criteria for direct assessments of the infectious reservoir 
 
There is abundant evidence that microscopy is insufficiently sensitive to detect low 
densities of asexual parasites and gametocytes [15, 19, 74-78]. Studies including only 
individuals with patent gametocytes [11, 19, 79] are likely to have underestimated the 
proportion of populations capable of infecting mosquitoes, and biased measures of 
mosquito infection probability (Table 2). Since low density gametocyte carriage is 
prevalent in many endemic areas [25] and they may represent a major source of 
secondary mosquito infections [22, 80, 81], studies aiming to characterize the human 
infectious reservoir should not have gametocyte positivity by microscopy as an 
inclusion criterion.  
 
Defining infectiousness at the population level 
 
The simplest method for quantifying the infectious reservoir combines the prevalence 
of people in different age groups infecting at least one mosquito, and the proportion 
  
196 
 
of those groups in the total population [16, 77]. Alternatively, population level 
infectiousness may be presented as mosquito infection probability (K); the likelihood 
of a mosquito becoming infected after feeding on any member of the population, 
calculated as the age-adjusted mosquito infection rate. Although the former metric has 
value for efforts that aim to identify or target all individuals who contribute to onward 
malaria transmission, the latter (mosquito infection probability) makes estimates more 
comparable between studies, where the number of mosquitoes used in feeding assays 
may differ widely [18, 19], and captures variations in infectiousness intensity in 
different age groups that may not be apparent when reporting only infectiousness 
prevalence.  
 
Assay methodology 
 
There are two types of mosquito infection assay that have been used in previous 
surveys: direct skin feeding and membrane feeding assays (Table 1 & 2). Direct feeds 
better reflect natural infection and avoid some of the technical challenges that limit 
the wide-scale use of membrane feeding assays (e.g. adapting mosquito colonies to 
membrane feeding, preventing gametocyte activation between bleeding and feeding 
and a potential effect of anticoagulants) [82, 83]. Although their use is currently 
hindered by ethical concerns that have precluded their use in repeated assessments of 
mosquito infection from young children [82], further direct comparisons of 
xenodiagnostic surveys using skin and membrane feeding experiments would be 
highly valuable to parameterise the extent to which the latter reflects the natural 
situation. Unless direct skin feeding is acceptable in all age groups and with sufficient 
mosquito numbers to allow precise estimates of infection, studies aiming to 
characterise the full infectious reservoir in endemic populations should do so using 
direct membrane feeding assays using locally relevant malaria vectors. 
Whether feeding assays measure infection by detection of oocysts in the mosquito gut 
or sporozoites in the salivary glands (Tables 1 and 2) should make little difference to 
the comparability of future studies, as even in low intensity infections (such as those 
occurring commonly in nature) there is a close correlation between oocyst prevalence 
and the prevalence of subsequent salivary gland infection [84]. Salivary gland 
dissections are technically even more demanding than midgut dissections, will result 
in higher mosquito mortality between the day of feeding and the day sporozoites are 
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first detectable and impose additional safety measures for insectaries that need to be 
equipped for holding mosquitoes that form a biohazard to insectary personnel. We 
therefore suggest that detection of Plasmodium oocysts is the most viable measure of 
mosquito infection. 
 
Measuring mosquito exposure 
 
As outlined earlier, the actual number of mosquito bites an individual receives is 
influenced by their physical characteristics and behaviour [42, 45]. There is also 
spatial heterogeneity in exposure, with individuals living in households with higher 
vector densities (e.g. houses nearer to breeding sites) receiving more bites and having 
greater risk of disease than those in households where vector density is lower [85]. 
Infectious reservoir assessments should ideally use a direct approach to quantify 
mosquito biting rates, simultaneously accounting for the availability and attractiveness 
of human hosts to mosquitoes: collection of mosquitoes from households and 
identification of blood meal sources by DNA fingerprinting would provide reliable 
estimates of true exposure to mosquito bites. A recent study in Peru used this approach 
to show that adults were more often bitten by Aedes aegypti mosquitoes compared to 
children living in the same houses [86]. We suggest that in areas where transmission 
is dominated by indoor biting mosquitoes, the rate of secondary mosquito infections 
could be calculated by multiplying individual-specific mosquito biting rates 
(determined experimentally using the above methods) by infectiousness (the 
probability that a mosquito develops infection after feeding, determined with mosquito 
feeding assays). This measure would be informative as it accounts for all major factors 
influencing transmission potential. An obvious problem with this approach is that only 
endophilic mosquitoes are sampled and there are currently no standardized sampling 
strategies for outdoor biting vectors. 
 
Where direct assessments are operationally impossible, or made unreliable by vector 
behaviour, we suggest that daily mosquito biting rates could be estimated for each 
study subject by collating mosquito (e.g. abundance, estimated indoor and outdoor 
biting rate), demographic (e.g. age, body surface area and attractiveness, household 
conditions, distance to breeding sites, number of people living in the same 
house/room) and behavioural (e.g. sleeping times, net use) data, so that a rate of 
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secondary mosquito infections could be broadly estimated by combination with 
experimentally-determined infectiousness. Figure 1 is a simplified and hypothetical 
representation of the potential influence of some of these factors on the contribution 
of different age groups to the infectious reservoir.  
 
Longitudinal studies with mosquito exposure estimation 
 
Longitudinal studies with frequent follow-up would be valuable not only to estimate 
the duration of infectiousness in different age groups but also to assess whether some 
individuals or groups of individuals are infectious throughout a transmission season. 
This approach would help determine if transmissibility is associated with clusters of 
malaria higher infection incidence, i.e. where mosquito-to-human transmission is 
high. The more complete interpretation of such assessments could be made with 
concurrent mosquito biting rates. 
 
Concluding remarks 
 
We acknowledge that there are several malaria endemic settings in which progress 
toward elimination has been made in the absence of detailed local knowledge of the 
infectious reservoir. However, malaria remains a threat in many countries, particularly 
in Africa, and resurgence due to natural receptivity for transmission, drug and 
insecticide resistance means that a better understanding of who within a community 
infects mosquitoes can only benefit malaria control. 
The complexity of factors influencing malaria transmission means that studies aiming 
to fully understand how this occurs is challenging. Previous xenodiagnostic surveys 
provided valuable insights into malaria transmission epidemiology, but these studies 
need to be extended to simultaneously evaluate additional key factors. Moreover, the 
longitudinal nature of infectiousness during natural malaria infections needs to be 
considered in future studies, as this will influence the contribution of different age 
groups to transmission.  
While human and parasite factors, including the intensity and duration of 
gametocytaemia, affect infectiousness at the individual level, entomological factors 
dictate the transmission potential of each individual and the infectious reservoir as 
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whole. Therefore, mosquito exposure assessments need to be an integral part of 
xenodiagnostic surveys if we are to effectively target the reservoir of infection. 
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Box 2. Outstanding questions 
 
If and how does human population infectiousness to mosquitoes differ in areas of low 
malaria transmission? Are traditionally low endemic settings different from those 
under epidemiological transition (i.e. those settings moving from moderate to low 
transmission as a result of heightened control activities)? 
 
What is the duration of infectiousness of individuals to mosquitoes? Are certain people 
infectious for longer periods and, if so, what are their characteristics?  
 
How do fluctuations in mosquito densities and feeding rates affect human 
infectiousness?  
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Appendix B, Pregnancy and malaria elimination 
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Abstract 
 
Community chemotherapy campaigns to reduce malaria transmission often exclude 
pregnant women due to safety concerns related to the drugs. However, pregnant 
women might represent an important source of human-to-mosquito infection due to 
frequent parasite carriage with higher densities of parasites (often detectable by 
microscopy), attractiveness to mosquitoes and modified sleeping behaviour. 
Accumulating evidence of the safety of artemisinin-based combination therapies for 
treatment of malaria during gestation suggests that malaria elimination programmes 
should reconsider this exclusion. Including pregnant women will increase intervention 
coverage and impact, and may thereby accelerate progress towards the desired 
endpoint (e.g. elimination) or increase the chances of success. Studies assessing 
infectiousness of pregnant women and gametocyte dynamics during different 
trimesters of pregnancy will be valuable to support the planning of community 
treatment campaigns. 
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Community chemotherapy campaigns and excluded populations 
 
The World Health Organization (WHO) recently recommended mass drug 
administration (MDA) to accelerate Plasmodium falciparum elimination in areas 
approaching zero endemic transmission and in the Greater Mekong area to prevent 
global spread of artemisinin resistant parasites [1]. Community chemotherapy 
approaches, including MDA, have been deployed in a number of settings [2] with 
varying levels of transmission and, not surprisingly, these studies indicate that high 
population treatment coverage (>80%) that is sustained over repeated rounds is a 
major determinant of success [3]. Indeed, it is the capacity of these community-based 
treatment campaigns to clear a high proportion of asymptomatic malaria infections, 
especially those with higher parasite densities, which are more infectious to 
mosquitoes, and provide a period of effective malaria prophylaxis that will determine 
whether transmission will be eventually interrupted. Individuals who are not 'covered' 
or who are missed by drug administration typically include those absent due to travel 
or work, those with contraindication to the drug, those who are seriously ill and those 
who do not consent to participate. The limited data from previous studies suggest that 
both absenteeism and ineligibility are relevant factors in determining non-participation 
[4, 5]. The malaria infection prevalence of these non-participating individuals at the 
time of the intervention, and therefore their contribution to transmission to mosquitoes 
and the extent to which they adversely affect the outcome of MDA, are likely to be 
context-dependent.  
 
Young children and pregnant women are easily accessible to malaria control 
programmes, but are frequently excluded from MDA target populations (for example, 
[5, 6] and https://clinicaltrials.gov/ct2/show/NCT02914145) due to safety concerns 
related to the drugs being administered. The impact of excluding young children on 
residual malaria transmission will be dependent on the age cut-off used by control 
programmes to define eligibility: for example, the non-inclusion of infants aged 6 
months or younger will generally represent around 1.5 – 2.0% of the population. This 
is expected to have only a minor effect on post-MDA transmission as these children 
are protected against malaria [7] through a variety of mechanisms (e.g. maternal 
antibodies, foetal haemoglobin [8], etc). They are also bitten by mosquitoes less often 
than adults [9, 10] due to their smaller body size [11] and the fact that they are more 
  
212 
 
likely to sleep under bed nets compared to older individuals living in the same 
household [12]. The contribution of pregnant women to malaria transmission, on the 
other hand, has not been evaluated and it is not clear whether additional efforts may 
need to be made to include them in future community-level treatment approaches. 
 
In this opinion article, we consider epidemiological and entomological evidence that 
pregnant women contribute to P. falciparum malaria transmission, use simple 
calculations to argue that they represent a non-negligible part of the infectious 
reservoir, discuss the impact of malaria prevention strategies on their transmission 
potential, and suggest community-based diagnostics of high-density infections in 
pregnant women to improve both MDA effectiveness and maternal health. 
 
Malaria transmission during pregnancy  
 
During pregnancy, women immune to high-density falciparum infections through 
previous exposure become susceptible again due to the abundance of the parasite 
adhesion receptor chondroitin sulfate A (CSA) in the placenta [13], which allows 
asexual stage parasites to sequester and develop in the intervillous space. This can 
cause high parasite densities resulting in morbidity for mother, foetus and infant [14]. 
While in areas with low malaria transmission women of all parities are at risk of 
developing these high-density placental infections, where exposure to malaria 
parasites is more frequent, women acquire immunity that prevents adhesion of CSA-
binding parasites with successive pregnancies [15, 16], the average density of 
placental infections decreases with gravidity, and primigravidae are at highest risk.  
In addition to the deleterious effects to the mother and her offspring, the relatively 
high P. falciparum parasite prevalence and densities, both in the placenta and in the 
peripheral circulation [17], compared to non-pregnant adults implies that pregnant 
women might be an important source of malaria infection to mosquitoes. These high 
asexual stage parasite densities could generate high numbers of circulating 
gametocytes (the stage of the parasite life cycle that infects Anopheline mosquitoes) 
in pregnant women. As previously hypothesised [18], pregnancy-associated changes 
in the bone marrow [19], an organ where immature gametocytes develop [20, 21], 
could also potentially influence gametocyte levels. However, few epidemiological 
studies have assessed the presence of gametocytes during pregnancy [18, 22, 23]. In a 
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study in a peri-urban area in Malawi [18], the prevalence of sexual stage parasites in 
pregnant women at their first antenatal care visit was 4.9% whilst 20% of pregnant 
women with asexual stage parasites detected by microscopy had patent gametocytes. 
In the same study, gametocytaemia at enrolment was frequently associated (80%) with 
placental haemozoin deposition at delivery. Although these observations suggest that 
in the absence of treatment placental infections might result in chronic high density 
(patent) gametocyte carriage, a comparison with non-pregnant adults living in the 
same community and consequently exposed to the same infection risk would be 
necessary to assess whether pregnant women are more frequently gametocytaemic and 
have a higher gametocyte commitment during infections. A more comprehensive 
quantification of the importance of pregnancy-associated malaria to transmission 
could be achieved by the measurement of gametocytes by both microscopy and 
molecular diagnostic methods [24, 25] during antenatal care visits. Ideally this would 
be supported by mosquito feeding assays [26], a method that allows assessment of 
malaria infectivity, in a selection of individuals to estimate the association between 
gametocytaemia and mosquito infection rates in this specific subpopulation.  
 
Previous studies [27-30] estimating the contribution of different age groups to the 
infectious reservoir of P. falciparum malaria using experimental mosquito infection 
assays (reviewed in [31]) did not specifically report on the infectiousness of pregnant 
women. We can, however, indirectly estimate the proportion of potentially infectious 
individuals that pregnant women represent by examining the percentage of women 
that are pregnant, and their likely infectiousness prevalence. Data on the proportion of 
the female population that is pregnant are available for many malaria endemic 
countries, and in Ghana, for example, 7.1% of women aged between 15 and 49 years 
were pregnant at the time of a recent demographic survey 
(dhsprogram.com/pubs/pdf/FR307/FR307.pdf), which corresponds to 1.7% of the 
total population. Although malaria infectivity has not been assessed during pregnancy, 
transmission studies have determined infectiousness prevalence (i.e., the percentage 
of individuals able to infect at least one mosquito in membrane feeding experiments) 
in different age groups. Based on differences in parasite density between pregnant 
women and non-pregnant adults, which is higher in the former, it is expected that the 
proportion of pregnant women that are infectious will be more similar to the proportion 
of children who are infectious than to the proportion of non-pregnant adults that can 
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infect mosquitoes. Figure 1 illustrates this difference in parasite burden during 
established infections: pregnant women, especially primigravidae, with falciparum 
infection detected by molecular methods often had parasites detected by standard 
malaria rapid diagnostic tests (RDTs), which have a relatively high limit of detection 
of 100 to 200 parasites per µL [32]. Assuming two different scenarios of infectiousness 
during pregnancy (in one scenario, infectiousness prevalence in pregnant women is 
similar to that in schoolchildren; in the other, pregnant women and non-pregnant adults 
have similar infectiousness prevalence), pregnant women could represent 0.8 – 2.9% 
of the infectious population (Box 1), and up to 23.9% of all infectious individuals 
immediately after an MDA round with 90% coverage of the non-pregnant population, 
when transmission might resurge due to infected untargeted individuals. These are 
only rough estimates as detailed data on gametocyte carriage and infectiousness in 
pregnant women would be required to develop mathematical models of malaria 
transmission potential during pregnancy and to estimate the impact of repeated MDA 
rounds on the contribution of pregnant women to residual transmission. To a great 
degree, these estimates are also likely to vary according to transmission intensity, 
which determines susceptibility to infection (and subsequent infectiousness) in both 
pregnant women and non-pregnant individuals.  
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Figure 1. Relative parasite burden in pregnant women, non-pregnant adults and 
children and effect of preventive measures on high-density parasitaemia during 
pregnancy. In this figure, high-density infections are those detectable by malaria rapid 
diagnostic tests (RDT+). In A, the proportion of infections detected by PCR (PCR+) 
that are also RDT+ (y-axis) is presented: baseline data at enrolment from a multicentre 
randomised trial were used to estimate this proportion for pregnant women (re-
analysis of data from [55]); for comparison, age-specific estimates by Wu and 
colleagues for areas with parasite prevalence higher than 20% are also presented [32]. 
In B, the prevalence of high-density infections (y-axis) throughout pregnancy (x-axis) 
is illustrated for pregnant women receiving (blue line) or not receiving (red line) 
preventive measures. As the pregnancy progresses from the first to the second 
trimester, infections that were initially submicroscopic reach levels that can be 
detected by RDTs in the absence of interventions. In the presence of interventions the 
prevalence of RDT+ infections remains lower and the detectability fluctuates around 
the baseline prevalence of parasites by RDT in the adult population. IPTp, intermittent 
preventive treatment; ITN, insecticide treated nets. 
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Box 1. Pregnancy and the malaria transmission reservoir.  
We estimated the contribution of pregnant women to the pool of infectious individuals 
and of mosquito infections. Demographic data from Ghana (The DHS Program, 
dhsprogram.com/pubs/pdf/FR307/FR307.pdf) were used (Figure I, panel A). 
Contributions to the population of infective individuals (Figure I, panel B; the radius 
of this graph is proportional to the age-adjusted infectiousness prevalence in the 
population) were calculated using the following equation, which is similar to formulas 
used by previous xenodiagnostic studies [27, 30]:  
[1]   
Ci is the proportion of all infectious individuals that each group i represents; and di 
relates to the demographic structure (percentage of individuals in each age group). 
Since individuals with subpatent parasite levels can infect mosquitoes and most 
xenodiagnostic studies performed thus far did not present infectivity data by 
microscopy status, we used group-specific transmissibility prevalence (ti,) in our 
calculations. For panels B and C, age-specific infectivity data from Bonnet and 
colleagues (2003) were used [30], and we assumed that pregnant women are as 
infectious as schoolchildren (infectiousness prevalence of 11.4%). Under these 
assumptions, estimated Ci values for children younger than 5 years, children aged 
between 5 – 15 years, non-pregnant adults and pregnant women were 0.26, 0.46, 0.25 
and 0.03. 
To estimate the contribution of different groups to the reservoir of infected mosquitoes 
(Figure I, panel C; a hypothetical population of 100 infected mosquitoes is 
represented), we defined:  
[2]   
 
[3]   
 
We assumed that the proportion of infected mosquitoes in a given area acquiring their 
infection from group i (Mi) depends on the proportion of the total number of mosquito 
bites on individuals from each group (bi; ai representing relative attractiveness to 
mosquitoes) and the probability (pi) of mosquito infection after feeding on an 
individual from group i, itself dependent on the infectiousness prevalence and 
mosquito infection rates in positive experimental transmission assays. In these 
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calculations, we assumed that ai increases with age, with children younger than 5 
years, schoolchildren, non-pregnant adults and pregnant women being exposed to 
mosquito bites on a 1:3:4:8 ratio. 
 
Figure I. Contribution of infections in pregnant women to local malaria epidemiology 
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There are other factors that might exacerbate the hypothesised increased 
infectiousness of pregnant women compared to non-pregnant women and men of 
similar age. Pregnant women have been reported to be more attractive to mosquitoes 
over both short [33] and long distances [34]. Additionally, behavioural changes might 
also increase availability to mosquitoes: pregnant women leave their bed at night more 
often than non-pregnant women [34] and may thus be unprotected by their net for 
longer periods of time. In our calculations in Box 1, we assumed that attractiveness to 
mosquitoes increases monotonically with age, with children younger than 5 years, 
schoolchildren and adults (aged 15 years or more) being exposed to mosquito bites on 
a 1:3:4 ratio [10], and that pregnant women are twice as attractive to Anopheles 
mosquitoes compared to non-pregnant adults. Under these assumptions, and after 
incorporating data on the average proportion of infected mosquitoes in positive 
feeding experiments, the figure in Box 1 shows estimates of the contribution of 
pregnant women to mosquito infections in endemic areas, adjusted for this potential 
increase in mosquito exposure during pregnancy. Up to 10% of mosquito infections 
might originate from pregnancy-associated malaria parasites.  
 
In areas of lower transmission intensity, particularly those approaching elimination of 
falciparum malaria, women will be unlikely to be infected in each pregnancy, and the 
first malaria infection while pregnant will occur more frequently in multigravidae. 
Interestingly, recent data from southern Mozambique suggest that, when malaria 
transmission transitions to lower levels, the total number of infected pregnant women 
decreases while their parasite densities during infections increase [35]: the prevalence 
of PCR-confirmed maternal P. falciparum infections dropped from 33% in 2003-2004 
to 6% in 2012, while peripheral and placental parasite densities in pregnant women 
were approximately ten times higher in the latter period. Whether this increase in 
asexual stage parasitaemia was accompanied by a similar increase in peripheral 
gametocytaemia is not known. However, these observations suggest that onward 
transmission from pregnant women remains relevant in low endemic settings. 
 
Reducing transmission from pregnant women 
 
Malaria transmission from pregnant women could be reduced by 1) ensuring that 
infections in pregnant women are promptly and effectively treated and 2) reducing the 
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probability that mosquitoes feed on infectious pregnant women. In many malaria 
endemic countries, both intermittent preventive treatment (IPTp) and insecticide 
treated nets (ITN) are targeted to pregnant women to reduce the burden of disease in 
this group and in their offspring [36]. IPTp with sulfadoxine-pyrimethamine (SP) is 
currently recommended as a single dose at each scheduled antenatal care visit after the 
first trimester, provided that these visits occur at least one month apart 
(www.who.int/malaria/iptp_sp_updated_policy_recommendation_en_102012.pdf). 
IPTp-SP clears existing infections and provides prophylaxis [37], reducing prevalence 
of infection [38, 39] both in the placenta and in the peripheral blood, and as a 
consequence is expected to limit infectiousness by reducing the duration of parasite, 
including gametocyte, circulation. The direct effects of SP on parasite transmission 
due to post-treatment gametocytaemia, on the other hand, are less clear. Whilst SP has 
been shown in in vitro studies and in field studies recruiting non-pregnant adults and 
children to increase gametocytaemia post-treatment [40-42], mosquito feeding assays 
performed on individuals treated with SP suggest that the infectiousness of these 
gametocytes is comparatively lower [43] but persists for at least two weeks after 
treatment [44]. The continuing spread of SP resistance [45] could also influence post-
IPTp infectivity. Pooled analysis of clinical data generated in different sites in Sub-
Saharan Africa with a wide range of SP resistance prevalence showed that where 
malaria parasites routinely carried mutations linked to SP resistance up to 40% of 
pregnant women receiving SP carried falciparum parasites on day 42 after treatment 
administration [46]. Whether SP resistant parasites persist, or reinfect, through 
multiple IPTp doses will determine the total duration of the infectious period for 
pregnant women living in these areas. Encouragingly, in the same multisite study, 
ITPp-SP was associated with beneficial effects on birth weight and risk of maternal 
anaemia, including in areas with high SP resistance. Taken together, these studies 
suggest that where SP resistance prevails, although IPTp with SP is still an efficacious 
strategy to prevent falciparum-related morbidity, it might not prevent malaria 
transmission from pregnant women.  
 
An alternative to SP, dihydroartemisinin-piperaquine (DHA-PPQ) is effective and safe 
for treating malaria in pregnancy [47, 48] and will now be evaluated to assess its safety 
and effectiveness within IPTp regimens. Although residual falciparum transmission to 
mosquitoes has been observed after the administration of DHA-PPQ [49, 50], this 
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regimen shortens the overall infectious period through effective clearance of malaria 
parasites, including of immature gametocytes, and could reduce transmission from 
pregnant women. This effect would be maximal in the second and third trimesters of 
pregnancy when IPTp is recommended and infectiousness and mosquito attractiveness 
would be greatest. Of note, twenty-year prospective observational data collected in 
antenatal clinics in the Thai-Myanmar border [51] suggest that treatment of falciparum 
malaria in the first trimester of pregnancy with artemisinin derivatives is not associated 
with an increased risk of miscarriage or major malformation diagnosed by clinical 
examination compared to treatment with quinine. These findings and new evidence 
reported in a recent WHO recommendation 
(www.who.int/malaria/publications/atoz/istp-and-act-in-pregnancy.pdf) indicate that 
artemisinin-based combination therapies (ACTs) might be a safe alternative for 
malaria treatment also during the first trimester of pregnancy.  
 
 In addition to IPTp, ITNs, the other key strategy for the prevention of malaria in 
pregnancy [52], also have the benefit of decreasing the probability of women with 
malaria in pregnancy transmitting their infections to mosquitoes. In Figure 1B, we 
illustrate how these preventive measures can influence malaria transmission potential 
of pregnant women. Despite the benefits associated with them, the proportion of 
pregnant women in Sub-Saharan Africa at risk of malaria infection who receive IPTp 
or sleep under ITN remains highly variable and is particularly low in primigravidae: 
recent model-based estimates suggest that in 2015 only 35% of women whose 
pregnancy could result in malaria-attributable low birth weight used bed nets and 
21.6% of all pregnant women at risk of malaria infection received at least two doses 
of IPTp-SP (Walker et al, in press). IPTp and ITN are therefore unlikely to prevent 
pregnancy-associated malaria parasites from sustaining transmission during mass 
chemotherapy campaigns. Although IPTp is a form of demographically-targeted 
MDA, it is likely to be less effective at reducing transmission compared to community-
wide MDA because IPTp is asynchronous (it does not clear all infections over a short 
time-window), because SP does not clear gametocytes, and because the parasitological 
efficacy (ability to clear blood-stage infection) of SP is low in areas of SP resistance 
whilst it may still be clinically effective (i.e. effectively reduce clinical consequences 
for mother and offspring).  
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Community-based diagnosis of infection in potentially pregnant women during 
MDA could boost effectiveness and improve maternal health 
 
Given the factors outlined above, elimination programmes should reconsider the 
exclusion of pregnant and potentially (based on the timing or lack of knowledge of 
their last menstrual period) pregnant women, especially in areas where IPTp is not 
being implemented or not being effective due to poor implementation or parasite 
resistance. Indeed, the high sensitivity of RDTs for placental infection in women with 
few previous infections in pregnancy (Figure 1A) suggests that providing RDT-based 
diagnosis and treatment with effective antimalarials as part of the MDA campaign 
could substantially reduce the number of high density placental infections present 
within the population. As transmission approaches elimination levels, parasite burden 
during pregnancy-associated malaria infections increases and the proportion of these 
infections with parasitaemia above the threshold for RDT positivity might also 
increase, suggesting that this approach could be used throughout elimination 
campaigns. Where preventive treatment is absent or infrequent, the community-based 
diagnosis of malaria infections in pregnancy would result in both improvements in the 
effectiveness of the MDA in reducing transmission and preventing the likely adverse 
pregnancy outcomes associated with malaria infection. In areas where IPTp has been 
successfully implemented, if ACTs are found to be an acceptable alternative to SP as 
preventive therapy during pregnancy, MDA campaigns could work with antenatal care 
clinics to identify women who have not been regularly treated and need to receive the 
MDA treatment. For women of reproductive age who do not have pregnancy diagnosis 
at the time of an MDA round, a pregnancy test would need to be performed: those 
women with negative pregnancy test result would immediately receive MDA 
treatment; those with positive pregnancy test result would be tested for malaria 
infection. Only pregnant women with negative malaria RDT result would not receive 
MDA treatment. In this approach, pregnancy-testing during MDA campaigns might 
also promote early identification of pregnant women, who need or will eventually need 
to receive IPTp doses. Pregnancy testing during mass treatment campaigns that use 
primaquine as part of the chemotherapy would be particularly important as this drug 
is contraindicated in pregnant women [53]. On the other hand, screening for pregnancy 
will increase direct costs of MDA campaigns and might discourage participation by 
women who do not want to be tested. National guidelines for mass chemotherapy 
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should be followed and, in areas where pregnant women are included in MDA 
campaigns, enhanced pharmacovigilance will increase the probability of detecting rare 
teratogenic effects.  
 
Concluding Remarks 
 
Annually, more than 85 million pregnancies occur in areas with falciparum 
transmission, 30 million only in Africa [54]. Previous efforts to reduce malaria 
transmission levels using community-based chemotherapy approaches often excluded 
pregnant women, despite the lack of data on their transmission potential. The high 
parasite levels observed during pregnancy suggest that these ‘non-targeted’ 
individuals might harbour infections with higher densities of transmissible 
gametocytes compared to infections in non-pregnant adults, and this could result in 
high infectivity. Their attractiveness to mosquitoes also means that pregnant women 
are frequently sampled by malaria vectors and their gametocytes have more 
opportunities to be ingested by mosquitoes. Together, these observations suggest that 
pregnant women might become an important source of mosquito infections after MDA 
rounds with high coverage. Accumulating evidence from clinical and epidemiological 
studies indicate that the highly effective ACTs could be used to clear infections of 
pregnant women, who would be screened for malaria with RDTs during MDA 
campaigns. Studies assessing the intensity and duration of falciparum infectiousness 
during different trimesters of pregnancy (see Outstanding Questions box) are 
necessary to develop accurate mathematical models of the contribution of pregnant 
women to local transmission and will be important to support the planning of these 
interventions. 
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Appendix C, Molecular quantification of gametocytes  
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Abstract 
 
Background 
Quantifying gametocyte densities in natural malaria infections is important to estimate 
malaria transmission potential. Two molecular methods (Pfs25 mRNA quantitative 
reverse transcriptase PCR (qRT-PCR) and Pfs25 mRNA quantitative nucleic acid 
sequence based amplification (QT-NASBA)) are commonly used to determine 
gametocyte densities in clinical and epidemiological studies and allow gametocyte 
detection at densities below the microscopic threshold for detection. Here, 
reproducibility of these measurements and the association between estimated 
gametocyte densities and mosquito infection rates were compared. 
 
Methods 
To quantify intra- and inter-assay variation of QT-NASBA and qRT-PCR, a series of 
experiments was performed using culture-derived mature Plasmodium falciparum 
gametocytes from three different parasite isolates (NF54, NF135, NF166). Pfs25 
mRNA levels were also determined in samples from clinical trials in Mali and Burkina 
Faso using both methods. Agreement between the two methods and association with 
mosquito infection rates in membrane feeding assays were assessed.  
 
Results  
Intra- and inter-assay variability was larger in QT-NASBA compared to qRT-PCR, 
particularly at low gametocyte densities (<1 gametocyte per μL). Logistic models, 
including log-transformed gametocytaemia estimated by QT-NASBA, explained 
variability in mosquito feeding experiment results as well as log-transformed 
gametocytaemia by qRT-PCR (marginal R2 0.28 and 0.22, respectively); densities 
determined by both methods strongly correlated with mosquito infection rates 
(Spearman’s rank correlation coefficient, 0.59 for qRT-PCR and 0.64 for QT-NASBA 
(P<0.001 for both)). Gametocyte densities estimated by qRT-PCR were higher than 
levels estimated by QT-NASBA or light microscopy at high densities (>100 
gametocyte per μL). Samples collected in one of the two transmission studies had 
extremely low gametocyte densities by both molecular methods, which is suggestive 
of RNA degradation due to an unknown number of freeze-thaw cycles and illustrates 
the reliance of molecular gametocyte diagnostics on a reliable cold-chain.  
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Conclusions 
The experiments indicate that both qRT-PCR and QT-NASBA are of value for 
quantifying mature gametocytes in samples collected in field studies. For both assays, 
estimated gametocyte densities correlated well with mosquito infection rates. QT-
NASBA is less reproducible than qRT-PCR, particularly for low gametocyte densities. 
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Background 
 
The transmission of malaria from humans to mosquitoes requires the presence of 
mature sexual stage parasites (gametocytes) in the peripheral blood. Upon ingestion 
by Anopheles mosquitoes and following sporogonic development, these gametocytes 
can render mosquitoes infectious to humans. Quantifying the density of these 
gametocytes in the peripheral blood is a fundamental part of estimating the 
infectiousness of individuals with malaria infections. For over a century, light 
microscopy was the only method available to quantify malaria parasites, including 
gametocytes. The development of sensitive molecular methods has uncovered some 
of the limitations of microscopy. In endemic areas, a substantial proportion of infected 
individuals carry parasites at levels below the microscopic threshold of detection [1-
4], and many of these individuals also have low, sub-microscopic, densities of 
gametocytes [5, 6]. Together with early observations that individuals with no 
gametocytes detected by microscopy could be infectious to Anopheles mosquitoes [7], 
these studies suggest that the use of more sensitive methods is necessary to 
characterize the infectious reservoir of malaria [8, 9].  
 
The most widely used target for molecular gametocyte detection and quantification is 
Pfs25 mRNA [9], which is gametocyte-specific and highly conserved among different 
parasite isolates [6]. Although expression of Pfs25 mRNA is upregulated in female 
gametocytes [10], the female-biased gametocyte sex ratio and the high abundance of 
Pfs25 mRNA relative to the male specific marker Pfs230p make it an attractive target 
for sensitive gametocyte detection and quantification [11].  
 
Various molecular techniques have been used for gametocyte detection and 
quantification. For Pfs25 mRNA there are two commonly used protocols, one based 
on quantitative reverse transcriptase PCR (qRT-PCR) and another based on 
quantitative nucleic acid sequence based amplification (QT-NASBA) [6, 12]. 
Although previous studies on other malaria-specific targets suggest that the accuracy, 
precision and operational attractiveness may differ between assays [13], QT-NASBA 
and qRT-PCR, as currently routinely used, have never been directly compared for 
Plasmodium falciparum gametocyte quantification. Additionally, differences in Pfs25 
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transcript levels between malaria parasite strains have been hypothesized but never 
directly examined [14].  
 
Here, Pfs25 mRNA QT-NASBA and qRT- PCR were compared for intra- and inter-
assay variation using gametocytes from three different isolates [6, 12]. The association 
between gametocyte densities estimated by these two molecular methods in natural 
malaria infections and infectiousness quantified by membrane feeding assays was also 
determined.  
 
Methods 
 
Study design 
In this study, both parasite culture-derived samples and samples from naturally 
infected individuals were used. For the estimation of intra-assay variation for both QT-
NASBA and qRT-PCR, culture-derived mature P. falciparum gametocytes at known 
densities were assayed in triplicates on the same 96-well plate with the same reaction 
mixtures; for the inter-assay variation analysis, gametocyte dilution series were tested 
on separate plates and with separately prepared reaction mixtures. Samples collected 
from naturally infected individuals living in malaria-endemic regions were used to 
assess the correlation between gametocyte levels measured by microscopy, qRT-PCR 
and QT-NASBA and human infectiousness to mosquitoes, determined by mosquito 
feeding experiments. 
 
Gametocyte culture 
Plasmodium falciparum gametocytes from three laboratory parasite strains (NF54, 
NF135, NF166) were cultured in shaker flasks, as previously described [15-17]. 
Briefly, asexual blood stage parasites were reseeded at 5% haematocrit (erythrocytes 
provided by healthy Dutch donors with blood type A) and 0.5% parasitaemia in culture 
medium containing RPMI 1640 with HEPES (5.94 g/L), hypoxanthine (0.05 g/L), 
10% (v/v) pooled human sera (also blood type A) obtained from malaria-naive 
individuals, and 0.2% (w/v) sodium bicarbonate. Culture medium was automatically 
changed twice a day, and on day 4 50 mM of N-acetylglucosamine (NAG) was added 
in order to prevent the next generation of merozoites from infecting new erythrocytes. 
Gametocytes were allowed to mature until day 14.  
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Gametocyte dilution series 
On day 14, mature gametocytes were harvested and Percoll purified according to the 
protocol described in Kariuki et al. [18]; 63%, instead of 65%, Percoll gradient was 
used. Cultures and material used for purification were continuously kept at 37°C to 
avoid gametocyte activation. Following Percoll purification, gametocytes were 
counted by a single reader using a haemocytometer and diluted in whole blood at 
densities of 103, 102, 101, 100, 10-1, and 10-2 or 5x103, 5x102, 5x101, 5x100, 5x10-1, and 
5x10-2 gametocytes per µL. Fifty µL aliquots of each dilution were further diluted in 
250 µL of RNAprotect Cell Reagent (Qiagen) when analysing standard curve 
triplicates and samples collected in Burkina Faso (see below) or in 450 µL of L6 buffer 
when analysing samples collected in Mali, and stored at -80°C until further use [19].  
 
Samples from naturally infected individuals in clinical trials 
Blood samples from patent gametocyte carriers were collected during clinical trials in 
Mali and Burkina Faso [20, 21]. In the study undertaken in Mali, male participants 
with at least 32 gametocytes per μL of blood based on gametocyte enumeration against 
500 white blood cells (WBC), assuming 8000 WBCs/µL, were recruited. The trial in 
Burkina Faso had as an inclusion criterion the presence of at least one microscopically 
detectable gametocyte at screening slides, where 100 microscopic fields were 
examined. In both studies, blood samples were taken at multiple time-points, before 
and after treatment initiation, to assess gametocyte clearance. Samples (venous blood 
in EDTA (Mali) or heparin (Burkina Faso) vacutainer) taken before initiation of anti-
malarials were used in the current study. In Burkina Faso, 50 µL aliquots of blood 
were transferred into 250 µL of RNAprotect Cell Reagent. In Mali, 100 µL of blood 
were transferred into 900 µL of L6 buffer. Both sets of samples were kept at -80°C 
until shipment, although the samples collected in Burkina Faso may have been 
exposed to freeze-thaw due to power-cut of unknown duration during political unrest 
in November 2014. For both studies, samples were shipped in dry ice at controlled 
temperature (-70 to -80ºC) to Radboud University Medical Centre (Nijmegen, The 
Netherlands), where the laboratory work was performed. 
 
For all samples, total nucleic acids (NA) were extracted using a MagNAPure LC 
automatic extractor (Total Nucleic Acid Isolation Kit – High Performance, Roche 
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Applied Science) and eluted into 50 µL of elution buffer; while all of the 300 µL of 
samples collected in Burkina Faso were extracted, only half of the volume (500 µL of 
the 1 mL) of samples collected in Mali were used for total NA extraction. 
 
Mosquito membrane feeding experiments 
All individuals, whose samples were included in this analysis, participated in mosquito 
feeding experiments: a small quantity of heparinized venous blood (400-500 μL) was 
offered to female Anopheles gambiae mosquitoes (180 mosquitoes in the Mali study 
and 60 in the Burkina Faso study) through a membrane [20-22]. Fully fed mosquitoes 
at the end of each experiment were selected, kept for one week on glucose at 27-29°C 
to allow for parasite development, and dissected. In both studies, light microscopy was 
used to detect oocysts on the midgut wall, and their presence was confirmed by a 
second microscopist. The proportion of mosquitoes with at least one oocyst was used 
as outcome measure. 
 
Pfs25 mRNA qRT-PCR 
The use of reverse transcriptase PCR (RT-PCR) for the detection of Pfs25 mRNA was 
first described by Babiker et al. [23]; recently it was further developed into a qRT-
PCR [6]. Here, a protocol described by Schneider et al. was used [11] with primers 
designed by Wampfler et al. [6]. Briefly, total NA extraction was followed by RQ1 
DNaseI digest (Promega) and cDNA synthesis (High Capacity cDNA Reverse 
Transcription Kit, Applied Biosystems). The DNase treatment and the RT-step were 
done once for each sample; the qPCR step was done in triplicate for samples included 
in the intra-assay variation analysis. Success of the DNase treatment was tested by 
performing qPCR, with the same primers, on two to five randomly selected samples 
of each plate (in total 35 samples) before proceeding to the RT-step. No residual 
genomic DNA was detected in these assays, which indicates successful DNase 
treatment. PCR conditions were according to manufacturer’s instructions, described 
as standard cycling programme of GoTaq® qPCR Master Mix (Promega). qRT-PCR 
cycle of threshold (Ct) values (the cycle at which the fluorescence signal crosses a pre-
determined threshold during the exponential phase of the amplification) were obtained 
using CFX96™ Real-Time PCR Detection System (BIO-RAD). For samples from 
naturally infected individuals, Ct values were converted into gametocyte density using 
plate-specific standard curve. Samples with estimated densities below 0.02 
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gametocytes per µL or 1 gametocyte per 50 µL of sample were considered negative. 
At the highest density of the gametocyte dilution series, cDNA corresponding to 363.6 
gametocytes was estimated to have been included in qRT-PCR reactions (Additional 
file 1).  
 
Pfs25 mRNA QT-NASBA 
QT-NASBA was performed as in Schneider et al. [12]. KCl concentrations in 
experiments performed for this study varied from 50 to 60 mM, and differed from the 
concentration used in the original protocol (80 mM) [12]. For samples from the 
Burkina Faso study, the extracted total NA used for qRT-PCR was also used for QT-
NASBA (before DNase treatment and cDNA production). For samples collected in 
the Mali trial, different aliquots of the same sample were extracted (total NA) and used 
for the different molecular assays; the QT-NASBA aliquot did not undergo DNAse 
treatment and cDNA production. QT-NASBA results are expressed as time to 
positivity (TTP), as in this method amplification happens at a constant temperature, 
not in cycles. Standardized manual thresholds to remove background noise are set at 
the begin value of 3 min and the end value of 15 min. As with qRT-PCR, gametocyte 
densities were assigned based on plate-specific gametocyte dilution series, which was 
diluted in whole blood before extraction of total NA. For samples from infected 
individuals, estimated gametocyte densities below 0.02 gametocytes per µL were 
considered to be negative. At the highest density of the gametocyte dilution curve, 
total NA corresponding to 2,500 gametocytes was estimated to have been included in 
QT-NASBA reactions (Additional file 1).  
 
Statistical analysis 
Analyses were conducted using STATA version 12 (Stata Corporation, College 
Station, TX, USA) and R (R Foundation for Statistical Computing, Vienna, Austria). 
 
Intra-assay variation was assessed by estimating coefficients of variation (CV, 
expressed in %) (i.e., standard deviation divided by mean, and multiplied by 100) for 
each level of gametocytaemia tested in triplicate, in culture-specific gametocyte 
dilution series. Gametocyte dilution series were also used to quantify inter-assay 
variation: CV was estimated for each gametocyte density for all series tested in 
different reaction plates. To analyse the agreement between qRT-PCR- and QT-
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NASBA-defined gametocyte levels in samples from infected individuals in the Mali 
study, a Bland-Altman plot was constructed, whereby differences between densities 
assigned by these two methods are presented by the average assigned level. 
Generalized linear mixed models, with study participant as random effect, were fit to 
assess the association between mosquito infection status in feeding assays and 
gametocyte densities (fixed effect) assigned by these two molecular methods; for each 
quantification method, Akaike information criterion was used to select gametocyte 
density scale (linear or logarithmic) in the models. Marginal R2, variance explained 
by fixed effects, was estimated using the ‘r.squaredGLMM’ function in MuMIn 
package in R [24]  
 
Results 
 
Intra-assay variation 
Plasmodium falciparum gametocytes of the NF54, NF135 and NF166 strains were 
used to prepare dilution series with 103, 102, 101,100, 10-1, and 10-2 gametocytes per 
μL. Additionally, for the NF54 strain, samples originating from three different culture 
flasks were tested. For each gametocyte density of individual dilution series, Pfs25 
mRNA expression was analysed in triplicate, using both qRT-PCR and QT-NASBA.  
 
In Fig. 1 (panels A and B), TTP and Ct values for QT-NASBA and qRT-PCR, 
respectively, are presented. For both assays, Pfs25 mRNA was not detected at the 
lowest gametocyte densities (0.01 gametocytes per µL) of the NF135 and NF166 
dilution series. Although results from dilution series appeared comparable between all 
three P. falciparum strains, the failure to detect the lowest gametocyte concentration 
for NF135 and NF166 might indicate lower Pfs25 transcript levels compared to the 
NF54 strain that only affects detection and quantification at extremely low densities. 
Additionally, in 5/15 0.10-gametocytes-per-µL samples, Pfs25 mRNA was not 
detected by qRT-PCR. In samples where amplified Pfs25 transcript was detected CV 
were inversely related to gametocyte levels and much lower for qRT-PCR compared 
to QT-NASBA at all gametocyte densities. 
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Figure 1.  Intra (A-D) and inter (E-H) assay variation of QT-NASBA and qRT-
PCR. In A-D, different colours represent different strains and cultures used for intra-
assay variation assessment. In E-H, different experiments used in the inter-assay 
variation assessment are represented by different colours. Time to positivity (TTP) 
values for samples tested by QT-NASBA are presented in A and E and coefficients of 
variation (CVs), in C and G. Cycle of threshold (Ct) values for samples tested by qRT-
PCR are presented in B and F; CVs are presented in D and H. In A, B, E and F, circles 
outside the y-axis range correspond to samples where Pfs25 mRNA was not detected. 
Of note, for experiments included in inter-assay variation analysis, different densities 
were used in gametocyte dilution series for QT-NASBA and qRT-PCR. 
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Inter-assay variation 
Seven (including the following densities 5x103, 5x102, 5x101, 5x100, 5x10-1, and 5x10-
2 gametocytes per μL) and ten (including the densities 103, 102, 101,100, 10-1, and 10-2 
gametocytes per μL) gametocyte dilution series, each tested on a different plate, were 
used to assess QT-NASBA and qRT-PCR inter-assay variation, respectively. Only 
NF54 strain parasite cultures were used in these experiments. Samples with the lowest 
density in each series were often negative for Pfs25 mRNA. Despite the higher 
densities used for the QT-NASBA versus qRT-PCR dilution series, a similar pattern 
to the intra-assay variation experiments was observed (Fig. 1, panels G and H): CVs 
were considerably higher for QT-NASBA compared to qRT-PCR and decreased with 
increasing gametocyte densities.   
 
Gametocyte densities in naturally infected individuals 
Blood samples collected prior to treatment from gametocytaemic individuals 
participating in mosquito feeding experiments in Mali were analysed by microscopy, 
qRT-PCR and QT-NASBA. For the two molecular assays, gametocyte densities were 
estimated based on dilution series of culture-derived P. falciparum gametocytes of the 
NF54 strain tested in the same plate, as routinely done [5, 12]. As a consequence of 
enrolment criteria, all individuals (N=73) had microscopically detectable gametocytes 
at the time of the feeding assay (median (IQR) 80 (64-112) gametocytes per μL), and 
all their samples were assigned gametocyte levels above the threshold of positivity for 
both molecular assays (minima gametocyte levels were 0.04 and 6.1 gametocytes/µL 
for qRT-PCR and QT-NASBA, respectively). Median (IQR) gametocytaemias 
estimated by QT-NASBA and qRT-PCR were similar: 94.8 (41.6-180.7) and 69.8 
(29.8-263.0) gametocytes per μL, respectively. The agreement between microscopy 
and QT-NASBA, between microscopy and qRT-PCR and between the two molecular 
methods was assessed by Bland-Altman plots (Fig. 2). At high gametocyte 
concentrations (>100 gametocytes per μL), gametocyte densities estimated by qRT-
PCR were higher than densities estimated by microscopy or QT-NASBA.  
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Figure 2.  Bland-Altman plots to assess agreement between light microscopy, QT-
NASBA and qRT-PCR levels in samples from naturally infected individuals. In 
the y-axes, differences between gametocyte levels estimated by two different methods 
are presented: (A) QT-NASBA levels minus microscopy-defined densities, (B) qRT-
PCR minus microscopy levels, (C) qRT-PCR levels minus levels estimated by QT-
NASBA. The x-axes present the average of the densities estimated by the two methods 
included in the calculation of the respective y-axes. In panel A, the differences (y-axis) 
are limited to a narrower range of values compared to panels B and C, and the inset 
plot presents the same data using different y-axis limits. 
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In the same study in Mali, 73 membrane-feeding assays were performed. The median 
(IQR) number of mosquitoes fed and dissected was 176 (174-177) and 142 (130-152), 
respectively. Some 58/73 (79.4%) individuals infected at least one mosquito, and the 
median (IQR) mosquito infection rate (proportion of infected mosquitoes, i.e., 
proportion of mosquitoes with ≥one oocyst) was 12.4% (3.4-32.6). Gametocyte levels 
were lower in non-infectious versus infectious individuals (Additional file 2), and 
correlated with mosquito infection rates (Spearman’s rank correlation coefficient 0.59, 
0.62 and 0.64 (P<0.001 for all assays) for qRT-PCR, microscopy and QT-NASBA, 
respectively). Statistical models including log-transformed gametocyte levels 
estimated by QT-NASBA or microscopy explained a slightly higher proportion 
(marginal R2=0.28 and 0.26, respectively) of infectiousness variability compared to 
models including log-transformed densities by qRT-PCR (marginal R2=0.22) (Fig. 3). 
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Figure 3. Mosquito infection rates (y-axes), presented as proportions, by 
gametocyte counts (x-axes) in samples collected in a clinical study in Mali. 
Gametocyte densities were estimated by QT-NASBA (A), qRT-PCR (B) and light 
microscopy (C). Fitted curves and 95% confidence intervals were estimated using 
glmmadmb package in R. 
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Lower-than-expected gametocyte densities in molecular assays  
 
Venous samples collected from 77/79 children participating in mosquito-feeding 
experiments in Burkina Faso were also analysed. Of these 77 children, 27 did not carry 
microscopically detectable gametocyte densities on the day of their membrane feeding 
assay, despite having gametocytes detected by microscopy during the screening phase 
of the study (one to three days earlier). Median (IQR) gametocyte density determined 
by microscopy was 12 (0-24) gametocytes per μL. Twenty of 77 did not have Pfs25 
mRNA detected by qRT-PCR, and four had assigned gametocyte levels between 0 and 
0.02 gametocytes per μL, and were considered gametocyte negative. However, ten of 
these 24 children with no gametocytes detected by qRT-PCR had gametocytes 
detected by microscopy. Gametocyte densities estimated by QT-NASBA were also 
very low for most samples: 55 children, including 31 with microscopically detectable 
gametocytes, had assigned levels below 0.02 gametocytes per μL (and were thus 
classified as gametocyte negative) and for one child of 76 Pfs25 mRNA was not 
detected. All 23 samples with no Pfs25 mRNA amplification or with densities below 
0.02 gametocytes per μL by qRT-PCR and that were also tested by QT-NASBA had 
assigned densities below 0.02 gametocytes per μL by this method. Considering that 
all these children had microscopically detectable gametocytes one to three days before 
sample collection, it is likely that RNA material was of insufficient quality. It is highly 
plausible that freeze-thaws with unknown duration or frequency have affected RNA 
integrity of this set of samples, all kept in the same box throughout the storage period 
and shipment. The infectivity of study participants in the clinical trial in Burkina Faso 
was lower than the infectivity of individuals enrolled in the Malian study: 29/77 
(37.6%) children infected at least one mosquito in feeding experiments. Although 
differences in the prevalence of host factors that influence infectivity, such as 
transmission-blocking immunity [25]or haemoglobinopathies [26], could have 
contributed to this observation, this disparity in infectiousness prevalence is probably 
due to real differences in gametocyte levels as suggested by microscopy-based 
quantification and differences in the number of dissected mosquitoes (median number 
of mosquitoes dissected per assay, 142 and 45 in Mali and Burkina Faso, respectively). 
The facts that five of 29 and 17 of 29 individuals who infected mosquitoes did not 
have Pfs25 mRNA detected by qRT-PCR or had very low assigned levels (<0.02 
gametocytes per μL) by QT-NASBA, respectively, and that the gametocyte density-
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mosquito infection rate plot is shifted to the left compared to the corresponding graph 
for the Malian study (Additional file 3) support the freeze-thaw explanation. 
 
Discussion 
 
In this study, Pfs25 mRNA QT-NASBA and qRT-PCR were evaluated using culture-
derived gametocyte samples and samples from naturally infected individuals. In in 
vitro experiments, both intra- and inter-assay variations were lower for qRT-PCR 
compared to QT-NASBA. When analysing samples from naturally infected 
individuals, gametocyte densities estimated by qRT-PCR were higher than densities 
estimated by QT-NASBA and microscopy in individuals with high gametocyte levels. 
Gametocyte densities estimated by the two molecular assays, as well as by 
microscopy, correlated well with mosquito infection rates. Overall, the findings 
indicate that both assays are useful for quantifying sexual stage parasite densities in 
samples from naturally infected individuals, but qRT-PCR showed better 
reproducibility.  
 
Determining the variability of quantitative assays is important for the interpretation of 
results. The experiments here suggest that qRT-PCR has lower intra- and inter-assay 
variation compared to QT-NASBA. The higher precision of qRT-PCR is evident for 
the entire range of gametocyte densities used in the dilution series, despite involving 
extra reaction steps, such as DNase treatment and cDNA production, which are known 
to be a source of variation [27]. These two steps were performed once for each dilution 
series density, for the three different NF54 cultures and the NF135 and the NF166 
cultures. There was considerably less between-strain and -culture variation for similar 
densities in qRT-PCR versus QT-NASBA. In QT-NASBA reactions, from the time of 
primer depletion, amplification will mostly depend on the initial number of transcripts, 
resulting in a linear increase of amplicons. This exact moment when amplification 
starts may differ between samples depending on when and how the enzyme is added 
into the reaction wells, which adds a level of uncertainty to this methodology [28]. 
The range of TTP values in dilution series is also sensitive to the KCl concentration 
in the mix, which requires regular optimization with new targets, batches of primers 
or molecular beacons [29]. 
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Despite qRT-PCR being a more precise method for gametocyte quantification, QT-
NASBA might detect a larger number of very low gametocyte densities (<0.1 
gametocytes per μL). QT-NASBA was originally developed for highly sensitive 
qualitative detection. The apparent higher sensitivity of QT-NASBA compared to 
qRT-PCR may be explained by methodological differences: for QT-NASBA it is not 
necessary to dilute samples, in order to complete DNase treatment and cDNA 
production (Additional file 1) and the equivalent of a larger volume of the original 
sample is therefore added into the final reaction in QT-NASBA compared to qRT-
PCR. This additional dilution in the qRT-PCR protocol could be avoided by using 
column-based RNA extraction with on-column DNase digestion [6]. Also, while qRT-
PCR, in the protocol used here, carries on for a set amount of 40 cycles, the QT-
NASBA reaction is continuous at a stable temperature for the duration of 90 minutes. 
This might allow for more sensitive amplification of low numbers of transcripts, but 
could also lead to the detection of single stranded DNA, in cases in which genomic 
DNA has been degraded and exists in the sample in a single stranded form. A stringent 
cut-off density below which samples are considered negative must therefore be 
applied in QT-NASBA, as with all other molecular assays. 
 
Whether qRT-PCR overestimates true gametocyte levels or QT-NASBA and 
microscopy underestimate densities is not clear. When qRT-PCR is compared with the 
other methods, high mean densities correspond to the qRT-PCR measurement being 
larger than the other measurements. There are two possible reasons for observing this 
pattern: 1) qRT-PCR overestimates high gametocyte concentrations; or, 2) qRT-PCR 
measurements have greater variability [30]. Since the in vitro experiments suggest that 
qRT-PCR has lower variability than QT-NASBA, it is likely that qRT-PCR has an 
upward bias at high gametocyte concentrations (>100 gametocytes per μL). The 
overestimation is unlikely to be caused by residual DNA in the RNA samples used in 
the qRT-PCR analysis, as the success of the DNase treatment was tested for two to 
five samples per plate, with no amplification detected. 
 
The value of molecular methods in detecting epidemiologically relevant malaria 
infections is becoming increasingly well established. A recent meta-analysis 
comparing PCR, microscopy and rapid diagnostic test (RDT) sensitivities showed that 
on average RDTs detect less than half of PCR-positive P. falciparum infections, and 
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microscopy detects slightly less infections than RDTs [8]. The density of these sub-
microscopic infections and their concurrent gametocyte levels are of relevance in 
estimating the contribution to malaria transmission. For P. falciparum parasite density 
(including asexual parasites and gametocytes), RNA-based QT-NASBA was 
previously compared to DNA-based qPCR for the quantification of P. falciparum 18S 
RNA and DNA, respectively [13]. Another recent study, this time on Leishmania 
parasites, compared 18S rRNA-based quantification by qRT-PCR and QT-NASBA to 
18S rRNA gene DNA-based detection with qPCR [31]. In the first study, QT-NASBA 
was found to be more convenient and equally applicable for quantification purposes 
as real-time PCR, with strong correlation with quantification by microscopy and 
similar inter-assay variation to both methods [13]. In the second study, intra- and inter-
assay CVs were deemed equal for all three molecular methods and qRT-PCR was 
preferred over the other two methods for convenience reasons [31]. One explanation 
for these conflicting conclusions is the method used for detection of the amplified 
target in QT-NASBA: in the study comparing Leishmania quantification, the 
electrochemiluminescence (ECL) read-out added to the general workload of the assay. 
Additionally, co-amplification with a known amount of quantitative (Q)-RNA, as was 
originally done for the quantification of the different gametocyte stages as well as the 
Leishmania parasites, added an extra factor to the analysis of results [12, 31]. The 
direct comparison to a standard curve with microscopically determined density of 
parasites, in addition to the use of molecular beacons, simplified the quantification 
process of QT-NASBA results [13]. As mentioned earlier in the context of assay 
sensitivity, also convenience-wise, an important advantage of QT-NASBA is that it 
can be performed directly on extracted NA. 
 
Several factors, such as the type of anticoagulant used in sample collection and the 
storage conditions, might influence the outcome of molecular assays on samples [9, 
32]. The analysis of samples from Burkina Faso provides indirect evidence for this: 
the extremely low assigned gametocyte levels, including in samples collected from 
children with microscopically detectable gametocytes, suggest that these samples 
might have gone through more than one freeze-thaw cycle. In these situations, sample 
quality may be compromised: mRNA may be degraded and, although abundant 
transcripts, such as Pfs25 mRNA, might still be detectable, quantification becomes 
less reliable [33]. Quantification of constitutively expressed human RNA targets and 
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comparison of transcript levels among samples is one method that could have 
confirmed whether RNA degradation occurred and is recommended for future studies 
where there is uncertainty about sample integrity.   
 
Ultimately, the goal in quantifying gametocytes is to indirectly estimate human 
infectivity, as mosquito-feeding assays are logistically complex and only a handful of 
research institutes currently have the infrastructure to perform these experiments in 
sub-Saharan Africa. In this study, it was observed that QT-NASBA- and microscopy-
defined densities explain a slightly higher proportion of the variation in infectivity 
compared to gametocyte levels assigned by qRT-PCR but this difference should be 
interpreted with caution. The statistical method used here to evaluate this relationship 
was recently employed to assess the association between viraemia and mosquito 
infection risk in feeding assays involving dengue-infected individuals [34]. While the 
sigmoidal curves estimated by these models seem to fit mosquito infection data well 
for QT-NASBA and microscopy, it is possible that qRT-PCR-defined high densities 
were overestimated (Fig. 2B) and that could possibly explain the poorer fit of the 
model for that assay. These comparisons are based on a statistical model. More 
complex models [35], allowing for more flexible sigmoidal curves, would be required 
to formally assess the shape of the association between gametocyte density and 
mosquito infection rates. The quantification of other parasite (e.g., sex ratio) or host 
factors (e.g., transmission-blocking immune responses and haematological factors) 
that might influence infectivity is likely to improve the predictive value of these 
models [36]. Of note, the enrolment criterion of multiple gametocytes being observed 
by microscopy (two or more gametocytes per 500 WBC) makes it difficult to directly 
extrapolate these results to sub-microscopic infections. By definition, microscopy has 
no quantitative value in sub-patent infections and molecular methods will need to be 
used to characterize the gametocytaemia-infectivity curve at low gametocyte densities. 
 
Despite being the most commonly used amplification target for estimating mature P. 
falciparum gametocytes counts, the use of Pfs25 transcripts for quantifying 
gametocyte densities has drawbacks. Pfs25 mRNA levels are much lower in male 
compared to female gametocytes [11]. Although it is generally assumed, due to the 
female bias in sex ratios (4-5:1) in natural infections, that female gametocyte levels 
are a good surrogate for all-sex gametocytes counts, quantification of the less abundant 
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male gametocyte-specific Pfs230p mRNA or other male targets would provide more 
accurate estimates of the total number of mature gametocytes as well as sex ratios [11], 
a factor known to influence infectiousness [37]. In addition to these targets, transcribed 
only in mature gametocytes, transcripts of other genes have been used for the study of 
sexual stage malaria: an alternative marker of female gametocytes is pfg377, the 
expression of which begins in the sequestered stage III [38]; a traditional marker for 
commitment to gametocytogenesis is Pfs16 [12, 39], which is present in all 
gametocyte stages. Another early marker of commitment is PfGEXP5, the expression 
of which starts in ring-stage parasites committed to gametocytogenesis, is a potentially 
useful tool to be used in studies aiming to identify factors influencing commitment to 
sexual stage [40]. For all of these targets, transcript detection is possible both by the 
more convenient QT-NASBA and by the more laborious but more reproducible qRT-
PCR. Design of intron-spanning primers may close the gap between the attractiveness 
of both methods and retain the advantage of the more reproducible qRT-PCR [41]. 
 
Conclusion 
 
Estimating the contribution of sub-microscopic infections to malaria transmission is a 
priority in the malaria elimination era. Molecular methods that can quantify 
gametocytes levels in microscopically undetectable infections come with a promise to 
improve understanding of malaria epidemiology [42]. qRT-PCR of Pfs25 mRNA is 
more reproducible compared to QT-NASBA. Gametocyte densities estimated by both 
methods, and by microscopy, correlate well with infectiousness in untreated 
individuals. Although this analysis of field samples suggest that these assays are 
suitable to quantify patent gametocyte levels, their use to understand the detectability 
and infectivity of sub-microscopic gametocyte densities is even more important. 
Future studies thus need to be designed to include individuals with sub-patent 
gametocyte levels to confirm the sensitivity, precision and relative merits of these 
assays. Precise quantification of gametocytes at very low levels is of relevance to 
determine if a threshold density is associated with infectivity provided molecular 
targets are informative of gametocyte viability and not merely of density [43]. 
Importantly, neither of the two molecular methods is routinely used in areas where 
field studies are undertaken and both assays are highly dependent on sample RNA 
quality.  
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Abstract 
Low dose primaquine is recommended to prevent Plasmodium falciparum malaria 
transmission in areas threatened by artemisinin resistance and areas aiming for malaria 
elimination. Community treatment campaigns with artemisinin-based combination 
therapy in combination with the gametocytocidal primaquine dose target all age 
groups but no studies thus far have assessed the pharmacokinetics of this 
gametocytocidal drug in African children. We recruited forty children participating in 
a primaquine efficacy trial in Burkina Faso to study primaquine pharmacokinetics. 
These children received artemether-lumefantrine and either a 0.25 or a 0.40 mg/kg 
primaquine dose. Seven blood samples were collected from each participant for 
primaquine and carboxy-primaquine plasma levels determinations: one sample was 
collected before primaquine administration and six, after, according to partially 
overlapping sampling schedules. Physiological population pharmacokinetic modelling 
was used to assess the impact of weight, age and CYP2D6 genotype on primaquine 
and carboxy-primaquine pharmacokinetics. Despite linear weight normalized dosing, 
the areas under the plasma concentration – time curves and the peak concentrations 
for both primaquine and carboxy-primaquine increased with age and body weight. 
Children who were CYP2D6 poor metabolizers had higher levels of the parent 
compound, indicating lower PQ CYP2D6-mediated metabolism. Our data indicate 
that primaquine and carboxy-primaquine pharmacokinetics are influenced by age, 
weight and CYP2D6 genotype and suggest that dosing strategies may have to be re-
considered to maximize the transmission-blocking properties of primaquine. 
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Introduction 
 
Since 2012, the World Health Organisation (WHO) recommends the use of a single 
0.25 mg/kg dose of primaquine (PQ) in combination with standard artemisinin-based 
combination therapy (ACT) for the treatment of Plasmodium falciparum malaria in 
elimination and resistance containment settings [1]. The rationale for using PQ is to 
prevent transmission of malaria to mosquitoes as it is the only currently available 
antimalarial that accelerates the clearance of mature gametocytes post-ACT [2]. 
Several recent trials assessed the efficacy of the WHO-recommended dose and 
concluded that it reduces gametocyte carriage compared to ACT alone and effectively 
prevents transmission in mosquito infection experiments [3-6]. In addition to its use 
to prevent P. falciparum transmission as single dose treatment, PQ has been used for 
decades in multiple-dose regimens for clearance of Plasmodium vivax hypnozoites [7, 
8].  
 
The parent compound is not responsible for PQ effects on P. vivax hypnozoites [9] 
and P. falciparum gametocytes [10], and the drug metabolising cytochrome P450 2D6 
(CYP2D6) enzyme has been implicated in the formation of unknown active 
metabolites that are responsible for the pharmacological effect of PQ [9, 11-13]. In 
mice, knocking out the CYP2D locus can reduce the metabolism of PQ into its active 
metabolite against P. berghei [11], and increase the area under the plasma 
concentration – time curve for PQ [14]. The gene coding for this enzyme (CYP2D6) 
is hypervariable in humans and there is limited knowledge on the effects of the 
variation at this locus on the pharmacokinetics of PQ in humans [9]. Early 
pharmacokinetic studies of PQ in adults [15-19]  identified the main PQ metabolite, 
carboxy-PQ (C-PQ), which is slowly eliminated and is present at plasma 
concentrations up to 10 times higher than those of its parent compound [16]. C-PQ is 
produced by monoamine oxidase (MAO)-A [12], an enzyme involved in drug 
metabolism in the liver [20], and indirect evidence [9, 21] suggests that it is not the 
active metabolite against malaria parasites or one of its precursors. 
 
To date, there are only limited PQ pharmacokinetic data [16-18, 22]. This is 
particularly evident for single low dose PQ and for pharmacokinetic data in children: 
only one study, undertaken in Papua New Guinea and using single PQ doses of 0.5 or 
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1.0 mg/kg, recruited children [22]. The difficulty to accurately dose children by 
extrapolating dosing schemes from adults [23-26] was previously illustrated for the 
antimalarials sulphadoxine-pyrimethamine and dihydroartemisinin-piperaquine [27]. 
Since children are frequently infectious to mosquitoes [28] and comprise an important 
part of the human infectious reservoir for malaria [29], data on single low dose PQ 
pharmacokinetics in children are highly needed for the planning of community 
treatment campaigns with PQ to reduce P. falciparum transmission.  
 
To identify factors that impact PQ pharmacokinetics in children, we have performed 
a pharmacokinetic study of PQ in the largest paediatric population thus far.   
 
Materials and Methods  
 
Study site, approvals and patients 
A randomised placebo-controlled trial to assess the effect of low dose PQ on malaria 
transmission was undertaken in Balonghin, a village with endemic malaria 
transmission in Burkina Faso. Study procedures and results were described in detail 
elsewhere [4]. Briefly, parasitaemic children aged between 2 and 15 years without 
malaria symptoms (no measured fever, reported fever or anaemia) and with normal 
glucose-6-phosphate dehydrogenase (G6PD) enzyme activity were recruited and 
treated with artemether-lumefantrine (AL) alone, AL and a 0.25 mg/kg PQ dose or AL 
and a 0.40 mg/kg PQ dose. PQ dosing was achieved by crushing a 15 mg PQ tablet 
and preparing 1 mg/mL solution by dissolving the crushed tablet in 15 mL of water. 
This allowed precise dosing: the mean difference between the actual dose given and 
the assigned dose was -0.004 (95% confidence interval -0.006 – -0.001) mg of PQ/kg 
of body weight for participants included in this pharmacokinetic study. AL was given 
twice daily over three days, and PQ or placebo was administered with the fifth AL 
dose. A subset of study subjects not included in mosquito membrane feeding 
experiments was invited to participate in the pharmacokinetic study. To minimise the 
number of blood samples taken per participant whilst maximizing the number of time-
points with information on PQ and C-PQ levels, partially overlapping sampling 
schedules were designed and sampling times were sequentially allocated to 
participants. The exact time when each blood sample was collected was recorded and 
used in pharmacokinetic analyses. A total of seven 1.5 – 2 mL venous blood samples 
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were collected for each study subject: one sample before PQ or placebo administration, 
four in the first 12 hours following this dose, and two between 24 and 72 hours. All 
samples were centrifuged within two hours of collection and plasma was subsequently 
stored at -80°C. Forty participants, 20 from each PQ study arm, had PQ and C-PQ 
plasma levels quantified and were included in this analysis.  
 
The study was registered at ClinicalTrials.gov (reference number NCT01935882). 
Written informed consent was obtained for participation in the pharmacokinetics 
sampling. The clinical trial received ethics approval from the London School of 
Hygiene and Tropical Medicine ethics committee (reference number 6274), and the 
Comité d'Ethique pour la Recherche en Santé (Ministère de la Santé du Burkina Faso; 
reference number 2012-10-78).  
 
Quantification of PQ and C-PQ plasma levels 
PQ and C-PQ levels were determined by liquid chromatography/mass spectrometry 
(LC-MS) as previously described [30]. The system consisted of a Shimadzu LCMS-
2010A mass spectrometer operated using electrospray ionization (ESI) in positive ion 
detection mode.  Data were collected in the selected ion monitoring mode at 325.35 
m/z for quinine (internal standard, retention time 3.7 minutes), 260.30 m/z for PQ 
(retention time 5 minutes) and 275.25 m/z for C-PQ (retention time 8 minutes).  The 
analytical column was a Phenomenex Synergi  Polar RP (150 x 2 mm, 4u), preceded 
by a Phenomenex Polar RP security guard column (2 x 4mm, Torrance, CA). The 
standard curve ranged from 4 to 1,000 ng/mL, with a lower limit of quantitation of 4 
ng/mL and a lower level of detection of 1 ng/mL. All control values were within 15% 
of their nominal value. 
 
CYP2D6 genotyping 
EDTA-anticoagulated venous blood and/or saliva samples collected with Oragene kit 
(OG-500 or OG-575) were used as sources of human genomic DNA for CYP2D6 
genotyping. DNA was extracted using a MagNAPure LC automated extractor and 
extraction kits for large volume samples according to manufacturer’s instructions. 
DNA concentration was measured fluorometrically using a Qubit fluorometer and 
accompanying high sensitivity (HS) kit. Samples were diluted according to 
manufacturer’s instructions for assays determining copy number variation (CNV) and 
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for preamplification as well as sequence variant determination with QuantStudio 12K 
Flex OpenArrays with TaqMan assays. OpenArray analysis was repeated for five 
samples without preamplification, due to undetermined genotype. In total, two CNV 
assays (hs00010001_cn targeting exon 9 and hs04083572_cn targeting intron 2 of 
CYP2D6) and 19 sequence variants in CYP2D6 were analysed (see Supplemental 
Material Table S1 for assay details) and genotype was determined according to the 
cytochrome P450 allele nomenclature website [31]. Inferred phenotype was 
determined using the Activity Score (AS) [32].  
  
Pharmacokinetic modelling  
A physiological population pharmacokinetic model was developed to allow better 
extrapolation and enable identification of pharmacokinetic parameters that cannot be 
identified in classical empirical models [33]. Pharmacokinetic analysis was performed 
by means of non-linear mixed effects modelling with the software NONMEM V.7.3.0, 
and Piraña as an interface for NONMEM, R-statistics and Perl Speaks Nonmem 
V4.6.0 [34]. The covariance step in NONMEM was used to calculate parameter 
precision. To account a priori for changes in pharmacokinetics related to growth, liver 
volume (VL) was calculated from total body weight and height [35]. All other volumes 
and flow parameters were allometrically scaled to a total body weight of 70 kg, as 
previously proposed. The exponents of the allometric models were fixed at 0.75 and 1 
for flow and volume parameters, respectively [36]. Due to the high co-linearity of age 
and weight, this enabled to separately assess the impact of age and weight on PQ 
pharmacokinetics. The PQ dose and measured plasma concentrations of PQ and C-PQ 
were converted to their molar equivalents for this analysis. Parameter shrinkage, with 
a shrinkage of >25% indicating uninformative data to estimate the parameter [37], was 
derived from the NONMEM results file. 
 
As PQ is thought to be mainly metabolised by MAO and cytochrome P450s in the 
liver [12], a well-stirred liver model, a well-established model to describe hepatic 
metabolism of drugs, was implemented to describe the physiologically plausible 
relationship between first-pass and central metabolism [38, 39]. Apparent intrinsic 
hepatic clearances for MAO- and CYP2D6-mediated metabolism (CLint,MAO and 
CLint,CYP2D6, respectively ) were estimated. C-PQ was assumed to originate from the 
MAO-mediated metabolism of PQ. The individual CYP2D6 intrinsic clearance 
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(CLint,CYP2D6,i) was calculated from the population intrinsic clearance (CLint,CYP2D6,pop) 
and CYP2D6 AS with the formula 
 
We assumed a liver plasma flow (QH) of 49.5 L/h, derived from an adult total blood 
flow of 90 L/h and a plasma fraction of 55% in whole blood (haematocrit level of 
45%). The hepatic extraction (EH) was defined as  
 
and the apparent MAO- and CYP2D6-mediated hepatic clearances (CLH,MAO and 
CLH,CYP2D6) were calculated using the formula  
 
Gradual onset of oral drug absorption was described with a chain of transition 
compartments, as described earlier [40]. In short, the mean absorption time (MAT) 
was estimated and the rate constant (ktr) for these transition compartments was 
calculated using  
 
where n equals the number of transition compartments. The inter-individual variability 
was modelled by means of an exponential variance model. Throughout model 
building, basic goodness-of-fit plots and prediction-corrected visual predictive checks 
[41] were explored.  Concentrations that were below the limit of quantification were 
retained in the analysis employing the M6 method, as proposed by Beal [42] and, 
therefore, the first concentrations below the limit of quantification (BLOQ) were fixed 
to ½ LOQ and a fixed residual additive error of ½ LOQ was introduced in the model. 
Individuals with missing or inconclusive CYP2D6 genotype data (N=4) were retained 
in the model by imputing the individual activity scores using mixture modelling, based 
on the frequencies observed in the study population, as proposed earlier [43]. The 
Bayesian imputed activity score was estimated to be 1.5 for all four children. As fixing 
the individual activity scores manually resulted in better model stability and no 
significant change of model goodness-of-fit, in the final model these missing activity 
scores were manually set to 1.5. The final model was used to obtain the empirical 
Bayes estimates for the area under the concentration – time curve (AUC) to infinity, 
the maximum concentration (Cmax), and the time of Cmax (Tmax) for both PQ and C-PQ. 
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Results 
 
Study population 
40 afebrile children aged 2 to 14 years who received a single low dose (0.25 or 0.40 
mg/kg) of PQ on the final day of the 6-dose AL regimen were included in this study. 
37/40 had patent asexual stage P. falciparum parasites at enrolment (median and 
interquartile range [IQR] 1,252 [578-2,503] parasites per μL). Median (IQR) 
haemoglobin level at enrolment was 11.6 (10.8 – 12.5) g/dL and similar in the two 
study arms. Table 1 summarises demographics and baseline laboratory results for 
these 40 children.  
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Table 1. Baseline Characteristics 
  Study arm 
  0.25 mg/kg PQ 0.40 mg/kg PQ 
Number of participants 20 20 
Gender (%, female) 55 60 
  Median (IQR
¥
) Median (IQR) 
Age (years) 8 (6 - 10) 10 (6.5 - 12) 
Body weight (kg) 19.8 (16.2 - 26.3) 24.9 (15.9 - 31.6) 
   
Height (cm) 118 (104 - 133.5) 129 (104 - 144.5) 
Temperature (ºC) 36.6 (36.4 – 37.0) 36.7 (36.1 – 36.9) 
Asexual parasites (per μL) 991 (635.5 - 2066.5) 1188 (284.5 - 3340) 
Haemoglobin (g/dL)
¤
 11.4 (10.6 - 12.5) 11.9 (11.1 - 12.7) 
Alanine transaminase (U/L) 22.5 (17.5 - 34.5) 22 (17 - 29) 
Aspartate transaminate (U/L) 38 (32 - 46) 36 (27 - 41) 
Total bilirubin (μmol/L) 7.4 (5.4 - 9.9) 10.8 (8 - 13.8) 
Creatinine (μmol/L) 37.8 (35.5 - 40.8) 38.4 (32.7 - 45.2) 
¥
Interquartile range 
¤ 
Haemoglobin levels measure by Hemocue 
 
  
266 
 
CYP2D6 genotyping  
CYP2D6 genotyping was successful for 36/40 children. For 3/40 participants, no 
samples were available for genotyping, and for one, genotyping was inconclusive. 
Allele frequencies are presented in the Supplemental Material (Table S2). 1/36 (2.8 
%), 10/36 (27.8 %), 22/36 (61.1 %) and 3/36 (8.3 %) study subjects were classified as 
poor metabolizer (PM, AS of 0), intermediate metabolizer (IM, AS of 0.5 or 1.0), 
extensive or normal metabolizer (EM, AS of 1.5 or 2.0) and ultrarapid metabolizer 
(UM, AS of 3.0), respectively [44, 45].  
 
Pharmacokinetics 
A total of 274 plasma samples were collected. Two of the 40 children were excluded 
from the pharmacokinetic analysis because it was not possible to determine PQ and 
C-PQ levels in their samples due to inadequate sample volume. 
 
The raw pharmacokinetic data of PQ and C-PQ per dose group are depicted in Figure 
1. As observed, PQ was rapidly absorbed and plasma C-PQ concentrations were 
generally higher than plasma PQ concentrations. Overall, the pharmacokinetics of the 
parent compound and of its main plasma metabolite presented substantial inter-
individual variation.  
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Figure 1. PQ and C-PQ plasma levels (y-axes) after PQ administration (x-axes). In A 
and C, PQ levels are presented for participants who received the 0.25 and 0.40 mg/kg 
PQ dose, respectively. In B and D, C-PQ levels are presented for the 0.25 and 0.40 
mg/kg PQ study arms, respectively. Assay results of all samples collected after PQ 
administration, including those with PQ or C-PQ levels below the limit of detection 
(i.e. with assigned level of 0 ng/mL), are presented. 
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A physiological pharmacokinetic model was developed to estimate pharmacokinetic 
parameters for both PQ and C-PQ (Figure 2). First order kinetics with two absorption 
transit compartments and one compartment disposition for PQ and C-PQ fit the 
observed plasma levels well. PQ was rapidly absorbed with a mean absorption time of 
0.706 h (relative standard error [coefficient of variation] 12%). Although allometric 
clearance appeared to explain most weight-related variability in pharmacokinetics, 
over-prediction of plasma PQ and C-PQ concentrations was observed in the youngest 
children of our study population. This resulted in higher than expected estimates for 
apparent volume of distribution and apparent clearance in these children. This 
phenomenon may be explained by a reduced relative bioavailability at younger age. 
Therefore, maturation of relative bioavailability (F) with age (i.e., the increase in 
bioavailability with age) was described by an Emax model with the formula 
 
 
 
where F50 is the age in years at which the relative bioavailability is 50% that of the 
mature value. F50 was estimated to be 4.27 years (relative standard error 44%), 
explained all observed inter-individual variability in relative bioavailability, 
significantly (P<0.001) improved model fit and was, therefore, retained in the model. 
In addition to apparent age-dependent bioavailability, the inclusion of CYP2D6-
mediated clearance of PQ, assumed to be linearly related to the CYP2D6 activity 
score, significantly improved model fit (p<0.001) and was also retained in the final 
model. Diagnostic prediction-corrected visual checks of the model are shown in 
Figure 3 and additional goodness-of-fit assessments are presented in the Supplemental 
Material (Figures S1 and S2). Estimated model parameters and their variability are 
presented in Table 2.  
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Figure 2. Schematic representation of the model. The mass transport of this model 
can be described with the following rate constants:  
k12 = 3/MAT 
k23 = 3/MAT 
k34=3/MAT 
k40 = CLH, CYP2D6/VL 
k45 = CLH, MAO/ VL 
k50 = CLCPQ/VCPQ 
k46 = (QH (1-EH))/VL 
k64=QH/VPQ.  
 
  
Depot
k40
PQ
Absorption transit compartments
Liver
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Figure 3. Prediction-corrected visual predictive check of observed data. Left and right panels depict the prediction-corrected visual predictive 
checks for PQ and C-PQ, respectively, based on 1000 simulations. Prediction-corrected simulated (shaded areas) and observed (circles and lines) 
PQ and C-PQ concentrations are presented over time (h; y-axes). The thick red line connects the observed median values per bin. The dotted red 
lines connect the 5th and 95th percentiles of the observations. The light blue areas are the 95 % confidence interval of the 5th and 95th percentiles, 
and the light red area indicates the confidence interval of the median.  
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Table 2. Pharmacokinetic model parameters. All flow and volume parameters were 
allometrically scaled to a body weight of 70 kg with an allometric exponent of 0.75 
for flow parameters and an exponent of 1 for volume parameters. CV = coefficient of 
variation. 
 
Parameter Estimate Relative standard 
error of estimate (% 
CV) 
Shrinkage 
(%) 
Mean absorption time (MAT) 0.706 h 12% - 
PQ volume of distribution (VPQ)  
(70kg) 
127 L 20% - 
Inter-individual variability 
VPQ(%) 
82.9% 38% 12.2% 
C-PQ volume of distribution 
(VCPQ) (70 kg) 
21.7 L 39% - 
CLint,MAO (70 kg) 7.35 L/h 41% - 
Inter-individual variability 
CLint,MAO(%) 
65.3% 33% 13.1% 
CLint,CYP2D6,pop (70 kg) 6.70 L/h 69% - 
CLCPQ (70 kg) 1.50 L/h 35% - 
F50 4.27 y 44% - 
    
Residual error PQ  
Proportional 
Additive 
 
32.7% 
2 ng/mL 
(FIX) 
 
42% 
 
19.5% 
Residual error CPQ 
Proportional 
Additive 
 
45.2% 
2 ng/ml 
(FIX) 
 
20% 
 
21.6% 
FIX: values were fixed during modelling 
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Model-derived median (range) AUC, Cmax and Tmax for PQ were 600.26 (259.87 – 
3,315.40) h x ng/mL, 68.42 (20.21 – 391.16) ng/mL and 1.59 (0.96 – 2.12) h, 
respectively, and are in agreement with previous studies [18]; for C-PQ these values 
were 3,468.35 (962.05 – 10,506) h x ng/mL, 147.23 (25.61 – 403.95) ng/mL and 6.80 
(2.73 – 16.03) h, respectively. The 0.40 mg/kg PQ dose was associated with higher 
AUC and Cmax compared to the 0.25 mg/kg dose (Table 3), although there was 
substantial variation within each study arm: Cmax estimates included values that were 
6 – 10 times higher than the lowest model-derived Cmax in each study arm; a similar 
pattern was observed for AUC.  
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Table 3. Model-derived pharmacokinetic parameters for PQ and C-PQ in African 
children receiving a single PQ dose of 0.25 (n=18) or 0.40 mg/kg (n=20). Values are 
reported as medians (minimum – maximum). 
 
 
Parameters 
0.25 mg/kg PQ 0.40 mg/kg PQ 
PQ C-PQ PQ C-PQ 
Tmax (h) 1.6 (1.2 – 1.9) 7.1 (4.3 – 10.1) 1.6 (1.0 – 2.1) 6.6 (2.7 – 16.0) 
Cmax (ng/ml) 
50.2 (20.2 – 
138.7) 
108.3 (25.6 – 
240.2) 
88.9 (24.4 – 
391.2) 
196.8 (29.3 – 
404.0) 
AUC0-∞ (h x 
ng/mL) 
450.4 (259.9 – 
875.9) 
2912.3 (962.1 – 
5076.3) 
730.7 (334.2 – 
3315.4) 
5091.7 (1075.0 – 
10506) 
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Host characteristics influencing PQ pharmacokinetics 
PQ doses are linearly scaled with body weight. To assess whether this approach is 
appropriate, we analysed plasma PQ and C-PQ concentrations by weight. In Figure 
4, the distribution of model-derived AUC values by weight and PQ dose is presented. 
For each dose, despite linear dose extrapolation based on weight, AUC estimates of 
PQ and C-PQ were positively correlated with body weight. A similar pattern was 
observed when analysing the relationship between AUC values and age (Supplemental 
Material, Figure S3).  
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Figure 4.  Area under the plasma concentration – time curve for both PQ (left panel) 
and C-PQ (right panel) by weight (x-axes).  
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CYP2D6 AS was an important determinant of PQ and C-PQ concentrations. In Figure 
5, typical plasma PQ and C-PQ concentration – time curves for children aged 2 (body 
weight 12 kg) and 14 (body weight 40 kg) years old and with different CYP2D6 
metabolizer status are presented. Toddlers who are IM have particularly low plasma 
levels of PQ compared to schoolchildren with PM status.  
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Figure 5. Effect of age and CYP2D6 Activity Score (AS) on PQ and C-PQ plasma 
concentrations over time after 0.25 mg/kg single dose of PQ. Panels A and B 
respectively show the effect of age on PQ and C-PQ concentrations over time, in two 
hypothetical children of different ages (2-year-old 12kg and 14-year-old 40 kg body 
weight), with CYP2D6 AS=1.0. Panels C and D respectively show the effect of 
genetically determined CYP2D6 AS, in four hypothetical 14-year-old children, on PQ 
and C-PQ concentration over time. The values use to construct curves are model 
derived. 
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Discussion  
 
The use of PQ to prevent P. falciparum transmission may support malaria elimination 
activities and efforts to contain artemisinin resistance. Understanding PQ 
pharmacokinetics is important to optimise dosing regimen aimed at clearing 
gametocytes and reducing infectivity to mosquitoes. We performed the first PQ 
pharmacokinetic study in African children and observed that age, body weight and 
CYP2D6 genotype influenced PQ and C-PQ plasma levels: younger children and 
children with lower body weight have lower levels of PQ and C-PQ, while poor 
CYP2D6 metabolizers have higher levels of PQ. These findings indicate that linear 
weight-based dosing may be sub-optimal to achieve efficacious PQ concentrations.  
 
Since the 1980s several PQ pharmacokinetic studies have been performed; however 
only one of these studies enrolled children [22]. This is the first PQ pharmacokinetic 
study recruiting African children, a group that may represent 28.4 – 51.8% of all 
individuals capable of infecting mosquitoes in some endemic areas [28] and thus are 
an important target population for PQ treatment. Our analysis generated several 
insights into PQ pharmacokinetics in this age group. First, both age and weight explain 
variability in PQ pharmacokinetics in children and show a non-linear relationship with 
PQ exposure. This is illustrated by the clear relationship between age and PQ exposure 
despite linear dose normalization based on weight. Therefore, linear dosing based on 
total body weight is inappropriate to obtain similar drug exposure in children as in 
adults, confirming earlier findings that (non-linear) allometric scaling of 
pharmacokinetics of PQ accounted for the observed variability in Papua New Guinean 
children [22]. However, this study did not report an age effect on bioavailability as 
observed by us. This might be explained by the fact that in our study PQ was 
administered using 1 mg/mL solutions, which allows for more accurate dosing than 
tablet-based regimens, and that our study population covered a wider age range (2 – 
14 years) compared to the previous study in Papua New Guinea (6 – 10 years). The 
physiological cause of the observed maturation of bioavailability remains unclear. 
This phenomenon is not uncommon in paediatric pharmacokinetics: for example, the 
bioavailability of the liquid formulation of the antiretroviral drug efavirenz also 
matured with age in young children [46].  Potential causes could be age-related 
changes in gastrointestinal motility, pH or pre-hepatic expression of metabolic 
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enzymes or transporters, possibly resulting in increased absorptive capacity with age 
[47, 48]. These findings should be confirmed prospectively with additional PQ 
pharmacokinetic and pharmacodynamic studies in paediatric as well as adult 
populations to assess the effect of weight and age on PQ-related pharmacokinetics as 
well as gametocyte clearance, transmission reduction and toxicity. 
 
Another important finding of our study is that CYP2D6 genotype influences PQ 
pharmacokinetics [14]. Initial PQ concentrations are affected by CYP2D6 genotype 
since CYP2D6-mediated metabolism occurs both systemically and pre-systemically. 
The influence of CYP2D6 metabolizer status on PQ efficacy was previously shown 
by an increased P. vivax relapse rate in individuals with CYP2D6 PM and IM 
genotypes [9]. Individuals with higher relapse rates, presumably because of an 
inability to clear P. vivax hypnozoites, had a significantly higher PQ AUC than 
extensive metabolizers but no differences in C-PQ pharmacokinetics parameters, 
which suggests that CYP2D6 activity is a rate-limiting step in the formation of active 
metabolite(s) against P. vivax hypnozoites [9, 11]. It has been hypothesized that 
unknown metabolites formed through CYP2D6 are also responsible for the effect of 
PQ on P. falciparum transmission, however direct evidence for this is lacking and 
available field studies with comprehensive CYP2D6 data are too small to assess the 
effect of CYP2D6 metabolizer status on gametocytaemia and transmission potential 
after single low dose PQ. CYP2D6-related differences in PQ transmission-blocking 
efficacy would be particularly relevant in malaria elimination settings, where mass 
drug administration are used to accelerate transmission interruption: CYP2D6 poor 
metabolizers might remain infectious for longer periods of time after PQ 
administration compared to individuals with other CYP2D6 genotypes and could 
represent a source of residual malaria transmission in these areas, depending on the 
frequency of alleles linked to this phenotype in the population. 
 
Since PQ metabolism is considered essential to its effect on falciparum transmission 
[10], one may argue that exposure to the parent drug (PQ) is not important. However, 
as formation of active metabolites depends on the presence of parent drug, one should 
aim for adequate initial exposure of PQ. Our findings suggest that age, body weight 
and CYP2D6 genotype can all influence PQ levels and consequently may determine 
the levels of active metabolites generated. These observations and the fact that 
  
280 
 
currently available PQ tablet sizes are not optimal for paediatric dosing, posing further 
challenges in achieving the target PQ dose in children, indicate that PQ dosing 
strategies may have to be re-considered. The therapeutic range over which PQ prevents 
malaria transmission is currently not well established but may include doses lower 
than the WHO-recommended PQ dose of 0.25 mg/kg [5]. PQ efficacy and added value 
over ACT alone may also depend on the ACT used [4, 5, 49]. The gametocytocidal 
and transmission blocking effects of AL are superior to that of dihydroartemisinin-
piperaquine but there are concerns for drug-drug interactions between AL and PQ. 
Indeed, although artemether does not influence PQ metabolism [50], lumefantrine 
inhibits CYP2D6 in vitro [51, 52]. In our study, although participants were treated 
with lumefantrine, we found that CYP2D6 Activity Score explained variability in PQ 
pharmacokinetics, indicating that if CYP2D6 was indeed inhibited by lumefantrine, 
this inhibition was incomplete at the time of PQ administration. Since AL alone is by 
far the most widely used ACT, our CYP2D6-related findings are of immediate 
relevance for ACT-PQ policies and our findings of age-dependent exposure to PQ and 
C-PQ are likely to be independent of the type of ACT-PQ combination.  
 
PQ is considered a valuable tool to support malaria elimination efforts. Whether it is 
deployed during mass drug administration campaigns, when all individuals in a 
community receive treatment, or during treatment of symptomatic falciparum malaria 
episodes, a substantial proportion of PQ doses are likely to be given to young children. 
Age-related changes in PQ pharmacokinetics, like maturation of bioavailability or 
non-linear change in clearance with weight, indicate that dose extrapolation from adult 
regimens based solely and linearly on weight may not be an optimal approach. A 
limitation of our study is that the studied population was relatively small and did not 
include subjects outside the 2 – 14 years range. Extrapolation of our findings outside 
this range should, therefore, be performed with caution. Future studies relating plasma 
concentrations of PQ and its (active) metabolites are needed to quantify the 
implications of our findings for the ability to prevent P. falciparum transmission by 
PQ treatment and to inform better dosing strategies.  
 
 
Acknowledgements 
  
281 
 
We thank the children who participated in this trial and members of the field team, 
clinical team, and entomology team at the Centre National de Recherche et de 
Formation sur le Paludisme, Ouagadougou, Burkina Faso. We acknowledge the expert 
technical assistance of Larissa V. Stebounova and Joshua R Lemm for the completion 
of the primaquine plasma assays. Lastly we would like to thank Alwin Huitema at the 
Netherlands Cancer Institute for useful discussions on pharmacokinetic modelling. 
We have no conflicts of interest to declare. 
 
Funding 
This work was supported by the Bill and Melinda Gates Foundation (AFIRM 
OPP1034789); T. B. is supported by a fellowship from the European Research Council 
(ERC-2014-StG 639776). 
  
  
282 
 
References 
1. WHO, Single dose Primaquine as a gametocytocide in Plasmodium 
falciparum malaria. 2012. 
2. Vale, N., R. Moreira, and P. Gomes, Primaquine revisited six decades after its 
discovery. Eur J Med Chem, 2009. 44(3): p. 937-53. 
3. Eziefula, A.C., et al., Single dose primaquine for clearance of Plasmodium 
falciparum gametocytes in children with uncomplicated malaria in Uganda: a 
randomised, controlled, double-blind, dose-ranging trial. Lancet Infect Dis, 
2014. 14(2): p. 130-9. 
4. Goncalves, B.P., et al., Single low dose primaquine to reduce gametocyte 
carriage and Plasmodium falciparum transmission after artemether-
lumefantrine in children with asymptomatic infection: a randomised, double-
blind, placebo-controlled trial. BMC Med, 2016. 14(1): p. 40. 
5. Dicko, A., et al., Primaquine to reduce transmission of Plasmodium 
falciparum malaria in Mali: a single-blind, dose-ranging, adaptive 
randomised phase 2 trial. Lancet Infect Dis, 2016. 
6. Okebe, J., et al., The gametocytocidal efficacy of primaquine in malaria 
asymptomatic carriers treated with dihydroartemisinin-piperaquine in The 
Gambia (PRINOGAM): study protocol for a randomised controlled trial. 
Trials, 2015. 16: p. 70. 
7. Baird, J.K. and S.L. Hoffman, Primaquine therapy for malaria. Clin Infect 
Dis, 2004. 39(9): p. 1336-45. 
8. John, G.K., et al., Primaquine radical cure of Plasmodium vivax: a critical 
review of the literature. Malar J, 2012. 11: p. 280. 
9. Bennett, J.W., et al., Primaquine failure and cytochrome P-450 2D6 in 
Plasmodium vivax malaria. N Engl J Med, 2013. 369(14): p. 1381-2. 
10. Adjalley, S.H., et al., Quantitative assessment of Plasmodium falciparum 
sexual development reveals potent transmission-blocking activity by methylene 
blue. Proc Natl Acad Sci U S A, 2011. 108(47): p. E1214-23. 
11. Pybus, B.S., et al., The metabolism of primaquine to its active metabolite is 
dependent on CYP 2D6. Malar J, 2013. 12: p. 212. 
12. Pybus, B.S., et al., CYP450 phenotyping and accurate mass identification of 
metabolites of the 8-aminoquinoline, anti-malarial drug primaquine. Malar J, 
2012. 11: p. 259. 
13. Bowman, Z.S., D.J. Jollow, and D.C. McMillan, Primaquine-induced 
hemolytic anemia: role of splenic macrophages in the fate of 5-
hydroxyprimaquine-treated rat erythrocytes. J Pharmacol Exp Ther, 2005. 
315(3): p. 980-6. 
14. Potter, B.M., et al., Differential CYP 2D6 metabolism alters primaquine 
pharmacokinetics. Antimicrob Agents Chemother, 2015. 59(4): p. 2380-7. 
15. Fletcher, K.A., et al., Studies on the pharmacokinetics of primaquine. Bull 
World Health Organ, 1981. 59(3): p. 407-12. 
16. Mihaly, G.W., et al., Pharmacokinetics of primaquine in man: identification 
of the carboxylic acid derivative as a major plasma metabolite. Br J Clin 
Pharmacol, 1984. 17(4): p. 441-6. 
17. Mihaly, G.W., et al., Pharmacokinetics of primaquine in man. I. Studies of the 
absolute bioavailability and effects of dose size. Br J Clin Pharmacol, 1985. 
19(6): p. 745-50. 
  
283 
 
18. Ward, S.A., et al., Pharmacokinetics of primaquine in man. II. Comparison of 
acute vs chronic dosage in Thai subjects. Br J Clin Pharmacol, 1985. 19(6): p. 
751-5. 
19. Greaves, J., et al., Plasma kinetics and urinary excretion of primaquine in man. 
Br J Clin Pharmacol, 1980. 10(4): p. 399-404. 
20. Saura, J., et al., Localization of monoamine oxidases in human peripheral 
tissues. Life Sci, 1996. 59(16): p. 1341-9. 
21. Bates, M.D., et al., In vitro effects of primaquine and primaquine metabolites 
on exoerythrocytic stages of Plasmodium berghei. Am J Trop Med Hyg, 1990. 
42(6): p. 532-7. 
22. Moore, B.R., et al., Pharmacokinetic properties of single-dose primaquine in 
Papua New Guinean children: feasibility of abbreviated high-dose regimens 
for radical cure of vivax malaria. Antimicrob Agents Chemother, 2014. 58(1): 
p. 432-9. 
23. Barnes, K.I., et al., Sulfadoxine-pyrimethamine pharmacokinetics in malaria: 
pediatric dosing implications. Clin Pharmacol Ther, 2006. 80(6): p. 582-96. 
24. Mwesigwa, J., et al., Pharmacokinetics of artemether-lumefantrine and 
artesunate-amodiaquine in children in Kampala, Uganda. Antimicrob Agents 
Chemother, 2010. 54(1): p. 52-9. 
25. Salman, S., et al., Pharmacokinetic comparison of two piperaquine-containing 
artemisinin combination therapies in Papua New Guinean children with 
uncomplicated malaria. Antimicrob Agents Chemother, 2012. 56(6): p. 3288-
97. 
26. Ursing, J., et al., Chloroquine is grossly under dosed in young children with 
malaria: implications for drug resistance. PLoS One, 2014. 9(1): p. e86801. 
27. WorldWide Antimalarial Resistance Network, D.P.S.G., The effect of dosing 
regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a 
pooled analysis of individual patient data. PLoS Med, 2013. 10(12): p. 
e1001564; discussion e1001564. 
28. Stone, W., et al., Assessing the infectious reservoir of falciparum malaria: past 
and future. Trends Parasitol, 2015. 31(7): p. 287-96. 
29. Muirhead-Thomson, R.C., The malarial infectivity of an African village 
population to mosquitoes (Anopheles gambiae); a random xenodiagnostic 
survey. Am J Trop Med Hyg, 1957. 6(6): p. 971-9. 
30. Page-Sharp, M., et al., Simultaneous determination of primaquine and 
carboxyprimaquine in plasma using solid phase extraction and LC-MS assay. 
J Chromatogr B Analyt Technol Biomed Life Sci, 2012. 902: p. 142-6. 
31. Gouagna, L.C., et al., Genetic variation in human HBB is associated with 
Plasmodium falciparum transmission. Nat Genet, 2010. 42(4): p. 328-31. 
32. Gaedigk, A., et al., The CYP2D6 activity score: translating genotype 
information into a qualitative measure of phenotype. Clin Pharmacol Ther, 
2008. 83(2): p. 234-42. 
33. Tsamandouras, N., A. Rostami-Hodjegan, and L. Aarons, Combining the 
'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting 
PBPK models to observed clinical data. Br J Clin Pharmacol, 2015. 79(1): p. 
48-55. 
34. Keizer, R.J., M.O. Karlsson, and A. Hooker, Modeling and Simulation 
Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose. CPT 
Pharmacometrics Syst Pharmacol, 2013. 2: p. e50. 
  
284 
 
35. Johnson, T.N., et al., Changes in liver volume from birth to adulthood: a meta-
analysis. Liver Transpl, 2005. 11(12): p. 1481-93. 
36. Anderson, B.J. and N.H. Holford, Tips and traps analyzing pediatric PK data. 
Paediatr Anaesth, 2011. 21(3): p. 222-37. 
37. Savic, R.M. and M.O. Karlsson, Importance of shrinkage in empirical bayes 
estimates for diagnostics: problems and solutions. AAPS J, 2009. 11(3): p. 
558-69. 
38. Gordi, T., et al., A semiphysiological pharmacokinetic model for artemisinin 
in healthy subjects incorporating autoinduction of metabolism and saturable 
first-pass hepatic extraction. Br J Clin Pharmacol, 2005. 59(2): p. 189-98. 
39. van Erp, N.P., et al., A Semi-Physiological Population Model to Quantify the 
Effect of Hematocrit on Everolimus Pharmacokinetics and 
Pharmacodynamics in Cancer Patients. Clin Pharmacokinet, 2016. 
40. Shen, J., A. Boeckmann, and A. Vick, Implementation of dose superimposition 
to introduce multiple doses for a mathematical absorption model (transit 
compartment model). J Pharmacokinet Pharmacodyn, 2012. 39(3): p. 251-62. 
41. Bergstrand, M., et al., Prediction-corrected visual predictive checks for 
diagnosing nonlinear mixed-effects models. AAPS J, 2011. 13(2): p. 143-51. 
42. Beal, S.L., Ways to fit a PK model with some data below the quantification 
limit. J Pharmacokinet Pharmacodyn, 2001. 28(5): p. 481-504. 
43. Keizer, R.J., et al., Performance of methods for handling missing categorical 
covariate data in population pharmacokinetic analyses. AAPS J, 2012. 14(3): 
p. 601-11. 
44. St Jean, P.L., et al., Tafenoquine treatment of Plasmodium vivax malaria: 
suggestive evidence that CYP2D6 reduced metabolism is not associated with 
relapse in the Phase 2b DETECTIVE trial. Malar J, 2016. 15(1): p. 97. 
45. Gaedigk, A., et al., Prediction of CYP2D6 phenotype from genotype across 
world populations. Genet Med, 2016. 
46. Salem, A.H., C.V. Fletcher, and R.C. Brundage, Pharmacometric 
characterization of efavirenz developmental pharmacokinetics and 
pharmacogenetics in HIV-infected children. Antimicrob Agents Chemother, 
2014. 58(1): p. 136-43. 
47. Tetelbaum, M., et al., Back to basics: understanding drugs in children: 
pharmacokinetic maturation. Pediatr Rev, 2005. 26(9): p. 321-8. 
48. Fernandez, E., et al., Factors and Mechanisms for Pharmacokinetic 
Differences between Pediatric Population and Adults. Pharmaceutics, 2011. 
3(1): p. 53-72. 
49. Sawa, P., et al., Malaria transmission after artemether-lumefantrine and 
dihydroartemisinin-piperaquine: a randomized trial. J Infect Dis, 2013. 
207(11): p. 1637-45. 
50. Bangchang, K.N., J. Karbwang, and D.J. Back, Primaquine metabolism by 
human liver microsomes: effect of other antimalarial drugs. Biochem 
Pharmacol, 1992. 44(3): p. 587-90. 
51. White, N.J., M. van Vugt, and F. Ezzet, Clinical pharmacokinetics and 
pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clin 
Pharmacokinet, 1999. 37(2): p. 105-25. 
52. Mackinnon, M.J., et al., Quantifying genetic and nongenetic contributions to 
malarial infection in a Sri Lankan population. Proc Natl Acad Sci U S A, 2000. 
97(23): p. 12661-6. 
 
  
285 
 
Appendix E, Malaria reservoir in low endemic areas 
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Letter 
 
The contribution of low density, subpatent Plasmodium falciparum to mosquito 
infection and onward transmission of the disease has received much recent attention 
as a determinant of the success of malaria elimination strategies. The study by Lin and 
colleagues [1] addresses this issue in the context of low malaria transmission intensity 
in Cambodia. The authors observed that 5.9% of adults with symptomatic malaria 
were infectious in mosquito feeding experiments and that the vast majority of these 
infections (96%) arose from patients whose blood had microscopically detectable 
gametocytes. The study provides valuable information on infectivity in this particular 
group, i.e. adults with clinical malaria attending hospital. It also suggests that areas 
where individuals seek medical care early in their infection, with fewer mature 
gametocytes, would have lower infectivity than areas where clinic attendance is 
delayed, perhaps because symptoms take longer to develop and/or individuals 
postpone seeking treatment, and gametocyte levels have more time to increase.  
 
Whilst these observations made in the Cambodian study are valuable, there are several 
important considerations when using these clinic-based observations to draw broader 
conclusions on the human infectious reservoir for malaria. In many settings, the 
majority of malaria infections do not elicit effective care seeking behaviour but persist 
as asymptomatic infections. A recent large epidemiological study in Cambodia, 
Vietnam and Thailand-Myanmar border showed that 20% of the population in these 
settings harboured infections, most of which were afebrile [2]. Imwong and colleagues 
[3] recently demonstrated that the mean density of these asymptomatic infections is 
approximately 5 parasites per microliter; the majority of infections are thereby present 
at densities that are unlikely to be detected by microscopy or rapid diagnostic tests [4, 
5]. It is the contribution of these asymptomatic and often submicroscopic infections to 
the infectious reservoir that is poorly characterised.  
 
The conclusion of Lin and colleagues that ultrasensitive diagnostics are not required 
to identify those who are most infectious to mosquitoes is most probably correct. It is 
however, still very much an open question what proportion of all mosquito infections 
is caused by individuals with clinical malaria seeking treatment and what proportion 
by asymptomatic, chronic infections which may be submicroscopic. Indeed, in an 
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earlier study in Thailand, Pethleart and colleagues [6] concluded that the infectious 
reservoir was largely driven by the latter group, that is, infected individuals who did 
not attend clinics. That study also concluded that submicroscopic gametocytes were 
an important source of mosquito infections in this population. Moreover, the true 
relevance of the results from any of the artificial mosquito infections needs to be 
balanced by natural mosquito dynamics such as local abundance, biting rates and the 
species-specific susceptibility to infection [7]. 
 
Ultimately, where the health system is able to (or can be improved to be able to) 
rapidly identify and treat infections it seems reasonable to assume that the duration of 
symptomatic infections will be shortened resulting in fewer infectious individuals. 
This could have an important impact on overall malaria transmission as suggested in 
the optimistic conclusions of Lin et al. However in many settings in Africa and Asia, 
asymptomatically infected individuals vastly outnumber those with symptoms and the 
lack of interaction with the health systems means that many infections remain 
untreated. It is imperative that health facility identification and treatment of malaria 
remain the cornerstone of malaria control programmes but specific targeting of 
asymptomatic infections is likely to accelerate the progress toward elimination. 
Further studies on the importance of asymptomatic and submicroscopic malaria 
infections for onward transmission will facilitate this progress. 
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Appendix F, Heterogeneity in exposure to Anopheles mosquitoes 
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Abstract 
Variation in biting frequency by Anopheles mosquitoes can explain some of the 
heterogeneity in malaria transmission in endemic areas. In this study in Burkina Faso, 
we assessed natural exposure to mosquitoes by matching the genotype of blood meals 
from 1,066 mosquitoes with blood from residents of local households. We observed 
that the distribution of mosquito bites exceeded the Pareto rule (20/80) in two of the 
three surveys performed (20/85, 76, and 96) and, at its most pronounced, is estimated 
to have profound epidemiological consequences, inflating the basic reproduction 
number of malaria by 8-fold. The distribution of bites from sporozoite-positive 
mosquitoes followed a similar pattern, with a small number of individuals within 
households receiving multiple potentially infectious bites over the period of a few 
days. Together, our findings indicate that heterogeneity in mosquito exposure 
contributes considerably to heterogeneity in infection risk and suggest significant 
variation in malaria transmission potential.   
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Introduction 
Malaria epidemiology is doubly dependent on the frequency and efficiency of contacts 
between human hosts and Anopheles mosquitoes, which link the number of mosquito 
infections caused by an infectious human host and the rate at which uninfected humans 
acquire infections. Describing the variability in the frequency of human sampling by 
malaria vectors is therefore essential to understand parasite transmission from and to 
humans. While at a local level vector density determines average mosquito exposure, 
even within the same locality individuals may not be equally likely to be bitten by 
Anopheles mosquitoes (1-4). Exposure to malaria vectors is influenced by host 
availability (i.e., amount of time an individual remains unprotected against mosquito 
bites in an environment where anopheline mosquitoes are present) and attractiveness 
to mosquitoes (5, 6). Availability determines when and where individuals might be 
sampled by mosquitoes: a multicentre study in Africa that collected entomological and 
human behavioural data estimated that more than three quarters of human exposure to 
anopheline mosquito bites occur when individuals are indoors (7). For individuals who 
are accessible to malaria vectors, age and body surface area (3, 8) are two major 
determinants of attractiveness to mosquitoes, although other factors also play a role 
(2).  
 
The multifactorial nature of mosquito exposure in malaria endemic areas indicates 
that, while experimental and quasi-experimental, e.g. involving modified tents and 
huts, entomological studies are valuable, they will not accurately capture inter-
individual variation in actual exposure. Identifying transmission heterogeneities, 
especially extreme heterogeneities, is however critical to better inform infectious 
disease epidemiology and well-established theory has elucidated their implications for 
pathogen spread and control measures (9, 10). Here, we describe the variability in 
natural exposure to malaria vectors by linking, through DNA fingerprinting, blood 
meals of wild-caught mosquitoes to humans living in the households where they were 
collected. Previously we have shown that these mosquitoes fed more often on adults 
(11). We now extend this analysis to assess the degree of heterogeneity in the 
distribution of mosquito bites in the population at different times during the 
transmission season. We also present the frequency of Anopheles species-specific 
mosquito bites, and potential parasite inoculations (i.e., sporozoite-positive mosquito 
bites) per individual.  
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Results 
Study households 
We performed indoor resting collections of anopheline mosquitoes in an area with 
seasonal malaria transmission in Burkina Faso. Thirty-five households were included 
in this analysis. The median number of individuals living in each study household was 
3 (range, 2 – 5). Reported bed net use among the study participants was high (111/126, 
88.1%). At enrolment (October – December 2013), most (79.2%) individuals were 
parasite-positive by 18S qPCR; in 21/35 houses, all individuals were infected. We 
collected 325, 620 and 190 bloodfed Anopheles mosquitoes at the start (2014), peak 
(2014) and end (2013) of the transmission season, respectively (Table 1). During the 
2013 survey, 21/35 houses had at least one bloodfed mosquito collected; in 2014, 
19/20 and 20/20 households had fed mosquitoes collected at the start and peak of the 
transmission season, respectively. The average number of bloodfed mosquitoes 
collected per day in each household was higher at the start (median 2.3, interquartile 
range [IQR] 0.7 – 5.5) and peak (median 3.9, IQR 2.1 – 8.5) compared to the end 
(median 0.1, IQR 0 – 0.6 mosquitoes per day) of the transmission season (P = 0.001 
and < 0.001, respectively). There was no correlation between the average number of 
bloodfed mosquitoes collected per day and the number of individuals living in each 
household (Spearman’s rank correlation coefficients, 0.14, 0.09 and 0.05 for the first, 
second and third surveys respectively; all P > 0.05). Of note, at the end of the 2013 
transmission season, most mosquito collections performed after mid-November were 
unsuccessful, suggesting a village-wide reduction in mosquito abundance during this 
period. 
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Table 1. Study surveys 
 
  First Survey Second Survey 
Third 
Survey 
  
   
Start Date October, 2013 June, 2014 
September, 
2014 
Number of sampling days 54 20 20 
  
   
Timing 
End of transmission 
season 
Start of transmission 
season 
Peak of 
transmission 
season 
  
   
Number of households 35* 20 20 
  
   
Number of participants 127 81 77 
  
   
  N (%) N (%) N (%) 
Age categories** 
   
< 5 years 20 (15.9) 12 (14.8) 12 (15.6) 
5 - 15 years 62 (49.2) 39 (48.2) 37 (48.0) 
> 15 years 44 (34.9) 30 (37.0) 28 (36.4) 
  
   
Gender 
   
Male 41 (32.5) 22 (27.2) 21 (27.3) 
Female 85 (67.5) 59 (72.8) 56 (72.7) 
    
Prevalence of falciparum 
parasites 99 (79.2) - - 
Prevalence of falciparum 
gametocytes 79 (64.2) - - 
    
Number of bloodfed mosquitoes 
collected 190 325 620 
    
  
   
*Demographic information not available for individuals living in 5/40 households (first survey only); 
**Age at enrolment (first survey) 
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Heterogeneity in exposure to malaria vectors 
DNA extracted from mosquito blood meals and blood samples from individuals living 
in study households were genotyped using a microsatellite-based assay (see Materials 
and Methods). Most (1,066/1,135, 93.9%) collected bloodfed mosquitoes had their 
blood meal analysed. One hundred mosquitoes did not produce discernible 
amplification products. Mosquito blood meals with multiple human DNA sources (N 
= 153), and typed blood meals that were not matched to residents of study houses (N= 
139) were not included in this analysis. Estimates of mosquito exposure were based 
on 68.9% (666/966) of the successfully typed blood meals; this percentage was 
consistent across surveys (64.9, 71.7 and 69.8% at the start, peak and end of 
transmission season). In Figure 1, the distributions of the number of mosquito bites 
each individual received during different study surveys are presented. Approximately 
20% of individuals, of all ages, provided 85.1, 76.0 and 95.5% of single mosquito 
blood meals at the start, peak and end of the transmission season, respectively. 
Throughout the study, a small number of individuals, mostly adults, were matched to 
considerably higher numbers of blood meals compared to the rest of the population. 
Conversely, 32.0 – 76.2% of study participants were not linked to bloodfed 
mosquitoes during the surveys, including 15/77 individuals present in all surveys who 
were never matched to collected fed mosquitoes. Reported bed net use and parasite 
and gametocyte carriage at enrolment were not significantly associated with mosquito 
exposure during our study (incidence rate ratio of 0.70 [95% confidence interval, CI, 
0.22 – 2.20, P = 0.55] for reported bed net use versus no net use in a model adjusted 
for survey and of 3.42 and 0.99 [95% CI 0.50 – 23.45 and 0.32 – 3.10, P = 0.21 and 
0.99] for parasite and gametocyte carriage at enrolment, respectively, in models that 
only included data from the first survey). In an analysis of data from all surveys, 
negative binomial regression with mixed effects better explained the distribution of 
mosquito bite counts than mixed effects Poisson models (P < 0.001), after adjustments 
for age, which influences Anopheles exposure in this population (11),survey and intra-
household data correlation. In sensitivity analyses that assigned blood meals with 
multiple human DNA sources to the least exposed individuals in each household, the 
~20% of the population with most mosquito bites were linked to at least 70% of 
matched blood meals (Supporting Information Figure S1). We also performed an 
analysis that assigned multiple source blood meals to study participants based on 
minimal genetic distances to those meals (11). This approach results in a similar 
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pattern: ~20% of the population received 78.6, 76.3 and 94.2% of all mosquito bites 
at the start, peak and end of the transmission season, respectively.  
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Figure 1. Inter-individual variation in exposure to Anopheles mosquitoes. In a, the 
frequency distributions of mosquito blood meals matched to each study participant are 
presented for the three different surveys. Data from the peak transmission season are 
presented as bars; data from the other surveys (non-zero proportions) are presented as 
coloured circles. In b, the cumulative proportion of mosquito blood meals (y-axis) 
matched to study participants (x-axis) sorted by number of mosquito bites received is 
presented for the different surveys. The points where the dotted vertical line intersects 
the three curves correspond to the highest proportions of mosquito blood meals linked 
to 20% of the study population. At the peak of the transmission season, six individuals 
were absent or only present during one collection day and were not included in this 
graph. Only singly matched bloodfed mosquitoes linked to individuals living in the 
same household where they were collected are included in this figure.  
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For individuals who participated in all surveys, there were positive correlations 
between numbers of matched mosquitoes 1) at the start and peak of transmission 
season (Spearman’s rank correlation coefficient 0.24, P=0.04) and 2) at the start and 
end of transmission season (Spearman’s rank correlation coefficient 0.34, P=0.002), 
suggesting some consistency in preferential biting. However, some individuals with 
highest numbers of matched blood meals at the peak of the transmission season 
received few or no mosquito bites in other surveys (Figure 2a).  
 
  
302 
 
Figure 2. Temporal (a) and within-household (b) variation in exposure to malaria vectors. In a, individuals were ranked (y-axis) according to the 
number of matched mosquito blood meals at the peak of the transmission season. The left and right, symmetrical, x-axes represent the number of 
mosquito bites each individual received at the peak (orange bars), and at the start (blue bars) and end (red circles) of the transmission season 
respectively. Only individuals present during at least 3 collection days per survey in all surveys and matched to at least one blood meal (N=62) are 
included in this panel. In b, each group of three columns corresponds to a different survey (S, Start of transmission season; P, Peak of transmission 
season; E, End of transmission season) for a select number of households. Individuals in the same household are denoted by different colours, 
which are consistent in the different surveys. The proportions of matched blood meals linked to each individual by household and survey are on 
the y-axis; only the 8 households with at least 5 matched mosquitoes at the start of the transmission season and three or more study participants 
are shown. The numbers of individuals living in the households included in panel b are shown above the columns. 
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Within-household heterogeneity in mosquito exposure was observed (Figure 2b): 
considering data from houses with at least three study participants and five matched 
mosquitoes in single surveys, in 4/8, 14/15 and 7/7 households at the start, peak and 
end of the transmission season respectively, the most exposed individual was the 
source of at least 50% of matched mosquito blood meals. While individuals with high 
numbers of matched blood meals often lived in households with high total numbers of 
matched mosquitoes (Supporting Information Figure S2), in all houses included in 
this study there were individuals with relatively low mosquito exposure. 
 
Anopheles species-specific feeding choices 
Mosquitoes collected during the study were genotyped for species identification. At 
the start of the transmission season, Anopheles coluzzii represented 44.7% (142/318) 
of all bloodfed mosquitoes, while at the peak and end of the transmission season most 
bloodfed mosquitoes were Anopheles gambiae sensu stricto (74.0 [450/608] and 
53.7% [102/190], respectively). In all surveys, A. coluzzii mosquitoes had higher 
percentages of blood meals from multiple human sources (20.6, 22.0 and 18.9% at the 
start, peak and end of the transmission season, respectively) compared to A. gambiae 
s. s. mosquitoes (11.9, 16.1 and 10.3%). Species-specific distributions of blood meals 
singly matched to study participants are presented in Figure S3 (Supporting 
Information) and suggest that heterogeneity in exposure to anopheline mosquitoes 
occurs irrespective of vector species. Of note, negative binomial models better 
explained the distribution of Anopheles species-specific mosquito bites compared to 
Poisson models, providing evidence of overdispersion that is not explained by 
covariates. In these models, the conditional overdispersion parameter was 
significantly different from zero: 1.9 (95% CI, 1.2 – 3.2) and 2.5 (95% CI, 1.8 – 3.6) 
for models of A. coluzzii and A. gambiae s. s. mosquito bites, respectively. 
Additionally, rates at which individuals were bitten by mosquitoes of different species 
were positively associated (Supporting Information Figure S4) (all P < 0.001 in mixed 
effects negative binomial models that included number of A. coluzzii or A. gambiae s. 
s. matched blood meals, age and survey as covariates).  
 
Exposure to infected mosquito bites 
The prevalence of malaria parasites in bloodfed mosquitoes identified via PCR of head 
and thorax was higher at the end versus start and peak of the transmission season (23.4, 
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4.9 and 8.0%, respectively), and slightly higher in singly-matched mosquitoes 
compared to mosquitoes with multiple meal sources (Table 2). A. coluzzii mosquitoes 
were less often infected compared to A. gambiae s. s. (odds ratio 0.41 95% CI, 0.22 – 
0.76 in a model that adjusted for timing of survey). Individual- and household-level 
frequencies of exposure to infected mosquitoes are presented in Figure 3a. Only 7.7, 
23.6 and 10.5% of study subjects were linked to one or more potentially infectious 
mosquito meals at the start, peak and end of transmission season, respectively. In each 
survey, the two individuals with the highest numbers of matched meals from infected 
mosquitoes experienced 44 – 50% of all exposure to infected mosquitoes. As expected, 
there was a positive association between the number of potentially infective mosquito 
bites an individual received and the total number of matched meals regardless of 
mosquito parasitological status (Figure 3b, P < 0.001 in a mixed effects negative 
binomial model that had the total number of matched blood meals as a covariate and 
only included individuals with at least one matched meal). Conditional on the total 
number of bites, there was evidence of household-level clustering of infectious bites 
(intra-class [household] correlation 0.19, 95% CI 0.08 – 0.38, P < 0.001 in a mixed 
effects logistic model that included singly matched mosquitoes); however, there was 
no evidence of individual-level clustering after adjustment for household-related 
variability (P = 0.50). 
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Table 2. Prevalence of mosquito infection, determined by PCR performed using 
mosquitoes’ head-thoraces, by blood meal source (A) and mosquito species (B), and 
results of mixed effects logistic model on mosquito infection status (C). 
          
A 
   
Prevalence of mosquito infection by blood meal source 
  
   
Singly-matched, % 
(n/N) 
Non-matched % 
(n/N) 
Multiple human sources, % 
(n/N)  
Timing (Transmission 
Season) 
   
  
  Start 
  
6.2 (10/160) 4.5 (2/44) 3.3 (3/91) 
  Peak 
  
9.9 (37/375) 3.3 (2/61) 0 (0/41) 
  End     23.1 (25/108) 25.0 (7/28)  21.1 (4/19) 
  
     
  
B 
   
Prevalence of mosquito infection by mosquito species* 
  
   
A. gambiae s. s., % 
(n/N) A. coluzzii, % (n/N) A. arabiensis, % (n/N) 
Timing (Transmission 
Season) 
   
  
  
     
  
  Start 
  
4.9 (5/101) 2.5 (3/118) 9.7 (3/31) 
  Peak 
  
9.3 (36/386) 3.8 (4/106) 12.5 (1/8) 
  End     31.4 (27/86) 15.4 (8/52) 0 (0/11) 
  
     
  
C 
   
Mixed effects logistic model on infection status* 
  
   
Odds ratio (95% CI) P-value   
  
     
  
Mosquito species 
    
  
  A. gambiae s. s. 
 
Reference 
 
  
  A. coluzzii 
  
0.41 (0.22 – 0.76) 0.005   
  A. arabiensis 
 
0.60 (0.19 – 1.84) 0.37   
  
     
  
Timing  
    
  
(Transmission Season) 
   
  
  End 
  
Reference 
 
  
  Start 
  
0.20 (0.09 – 0.45) <0.001   
  Peak     0.22 (0.11 – 0.44) <0.001   
*Only mosquitoes with amplified human DNA were included in these calculations 
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Figure 3. Rates of exposure to potentially infective mosquito bites (i.e., bites from 
mosquitoes with malaria parasites detected in their head-thoraces) (a) and their 
association with total mosquito exposure (b). In a, blue circles represent study 
participants; individuals living in the same study house are presented together (orange 
bars). Y-axes show i) the numbers of falciparum-positive mosquito bites per individual 
per day (blue circles), ii) the total number of falciparum-positive fed mosquitoes 
collected in each house per collection day (orange bars), and iii) the number of 
falciparum-positive fed mosquitoes collected in each house per individual resident in 
the house per collection day (black horizontal lines in orange bars); y-axes’ limits vary 
to improve visualization. Horizontal dotted lines represent the average of iii over all 
houses. Only the 20 houses included in all three surveys are represented in this figure. 
In the three graphs, houses were ordered according to the number of infected fed 
mosquitoes collected at the start of the transmission season. In b, in each pair of bars, 
each colour represents an individual: the top bar represents individuals matched to 
infected mosquitoes; the bottom bar, individuals matched to mosquitoes regardless of 
sporozoite status. Individuals who were only matched to uninfected mosquitoes are 
represented by white segments. The horizontal axes represent proportions of blood 
meals. Multiple source meals are not included in panel b.   
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Effect of exposure heterogeneity on malaria R0 
The impact of biting heterogeneity on the resilience of vector-borne disease 
transmission to control interventions can be estimated using the methods described in 
(12, 13): compared to uniform biting, the basic reproduction number (R0) of a vector-
borne disease, which corresponds to the number of secondary infections generated by 
an infectious individual in the absence of any control and any population immunity, is 
inflated by the factor (1 + α), where α is the squared coefficient of variation of the 
human biting rate. Figure 4 illustrates the impact that more extreme heterogeneity can 
have on the calculated R0 of malaria: R0 is increased by a factor of 4.8, 4.2 and 8.4 in 
settings where mosquito exposure and its variability are similar to those observed at 
the start, peak and end of the transmission season in our study area. R0 is high even 
when the skew is reduced by the conservative sensitivity analysis that allocates 
multiply fed mosquitoes’ meals to the least exposed individuals, yielding R0 increases 
by a factor of 3.3, 3.2 and 5.7 at the start, peak and end of the transmission season, 
respectively.  
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Figure 4. The relationship between the fold increase in R0 and the level of aggregation in mosquito bites. This relation depends on the mean 
mosquito biting rate (see below), and the different curves represent the shape of this effect for different mosquito exposure levels: blue, orange 
and green lines correspond to settings where host-vector contact rates (mean numbers of matched mosquito bites) are similar to those observed ata 
the start, peak and end of the transmission season, respectively. Aggregation level increases along with the inverse of the aggregation parameter k 
from the negative binomial distribution, where k can be calculated as the squared mean number of mosquito bites (μ2) divided by the variance in 
bite number (σ2) minus the mean, i.e.    = 

  	 . R0 is inflated by factor (1 + α) whereby α = 




 ; in other words, α is the squared coefficient 
of variation (14). In the special case whereby bites are perfectly homogenous, the coefficient of variation is zero, and the standard formulation for 
R0 is regained (15, 16). The fold increases in R0 for the levels of aggregation observed in our surveys are represented by the coloured crossed-lines. 
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Discussion  
In this study, we quantified natural exposure to Anopheles mosquitoes using blood 
meals linked to household occupants. We observed significant differences in the 
numbers of bloodfed mosquitoes matched to study participants that are consistent with 
or even exceeding the Pareto rule, with ~20% of individuals being the source of more 
than 80% of all singly-matched blood meals. This heterogeneity was also apparent 
within-household, where the individual who received the most bites often contributed 
more than 50% of anopheline meals. Exposure to potentially infective mosquito bites 
also followed an aggregated pattern: 5.1, 13.9 and 6.5% of the population experienced 
80% of parasite inoculations at the start, peak and end of the transmission season, 
respectively. Taken together, our observations indicate that relatively few individuals 
at different timepoints disproportionally contribute to malaria transmission by being 
repeatedly sampled and infected by malaria vectors. These data provide further 
insights into the mechanisms that lead to heterogeneity in human malaria infection risk 
(17-20). 
 
Several previous studies have quantified inter-individual differences in attractiveness 
and exposure to mosquitoes using a range of methodologies. While studies involving 
experimental huts (1) and olfactometers (21) demonstrated the influence of individual-
level factors such as pregnancy (22) and infection status (23) on attractiveness to 
mosquitoes, community-wide assessments of wild-caught mosquitoes (8, 24, 25) are 
necessary to quantify variation in exposure to malaria vectors over larger scales. A 
study in The Gambia (8) in the 1980s used ABO group and haptoglobin typing to 
identify the sources of mosquito blood meals; the small number of variants in these 
markers (26) limited the selection of households. In Tanzania (24), microsatellites 
were used to link blood meals to humans to assess the protection afforded by bed nets 
against mosquitoes; a high proportion of the ~250 analysed bloodfed mosquitoes were 
matched to individuals sleeping in the same room where they were collected, including 
in the village with bed nets, and 80% of matched blood meals came from less than 
20% of the population. In our study, we matched 666 blood meals to individual study 
participants and observed that the distribution of mosquito bites was highly 
overdispersed in relation to a Poisson assumption, with 76.0 – 95.5% of singly 
matched blood meals originating from ~20% of the study population. These results 
corroborate the findings of the study in Tanzania and of a different study in western 
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Kenya (27), where 16% of the study participants were matched to 58% of Anopheles 
blood meals. By examining mosquito exposure repeatedly in an area of pronounced 
seasonality, we demonstrate even more unequal exposure patterns across three 
timepoints in the season. Applying simple, well-established (14, 28) methods, we 
estimated that the observed degree of mosquito biting heterogeneity could be linked 
to a 3 fold or higher increase in malaria R0 compared to a random-mixing system. This 
suggests that in settings with considerable variation in mosquito exposure, 
heterogeneity in biting is likely to a major determinant of the coverage of vector 
control interventions required to reduce and interrupt transmission (14). These R0-
focused calculations however have limitations. Firstly, although there is a positive 
relationship between R0 and variability in Anopheles biting, in finite populations 
increasing aggregation in exposure does not necessarily equate to increasing 
community-wide infection burden, since in areas with highly heterogeneous mosquito 
biting a high proportion of parasite inoculations will be on already-infected 
individuals. Additionally, the framework used here does not account for previously 
observed interactions between frequency of exposure to infected mosquitoes and rates 
of immunity acquisition (17, 18, 29), which could influence blood stage parasite 
burden, and potentially production of transmission stages, in highly exposed, highly 
immune individuals. Development of detailed mathematical models that explicitly 
incorporate immunity and spatial dependencies (see next paragraph) would allow 
more precise estimation of the long-term influence of the observed variation in 
mosquito exposure on malaria transmission dynamics.  
 
The fact that the majority of human-mosquito encounters in each survey involved only 
a few individuals is a consequence of both between- and within-household variation 
in exposure. Indeed, at the peak of the transmission season, the household with the 
highest number of fed mosquitoes had ~150 times more than the household with the 
lowest number. Household characteristics, such as construction material, number of 
windows, eaves as well as geographical proximity to mosquito breeding sites have all 
been previously associated with increased exposure to mosquitoes indoors and explain 
some of the between-household variation in mosquito abundance. The significant 
differences in vector biting between study houses also imply that malaria control 
programmes could target households with high mosquito densities. However, 
quantification of the temporal variation in household-level vector densities as well as 
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estimations of the scale of transmission (30), i.e. the distance range within which 
mosquitoes infected by a single infectious individual circulate and cause secondary 
human infections, would be necessary to determine the feasibility and relevance of 
these strategies. Data on geographical clustering of Anopheles exposure, malaria 
infection and disease might be informative to understand spatial-temporal changes: a 
study in Kenya (17) showed that foci of clinical malaria are unstable and that one-
month surveillance data, for example, might only have predictive value of higher-than-
average transmission over short periods of time. This is consistent with our 
observation that the ranking of households according to the number of infected 
mosquito bites per individual varies over time (Figure 3) and poses considerable 
challenges to sustainably targeting high exposure households for maximum 
community benefit.  
 
We also found that household heterogeneity is compounded by inter-individual 
variation in frequency of sampling by mosquitoes for people in the same house. At the 
peak of the transmission season, the maximum difference in numbers of matched 
meals for participants in the same house ranged from 1 to 51, i.e. a difference of up to 
~10 mosquito bites per day. Age and body size can partially explain differences in 
attractiveness (4) yet we often noted age-matched individuals in the same house with 
dissimilar mosquito exposure. Other individual-level characteristics such as odours 
(21, 31), (effective) use of protective measures or behaviour will be relevant; in our 
study, bed net use and gametocyte carriage were not significantly associated with the 
number of mosquito bites an individual received though this study was not designed 
to assess the influence of these factors on mosquito exposure. Of note, the age 
distribution of our study population (Table 1) might not reflect the true demography 
of the region. Whilst our results are in agreement with previous studies, we cannot 
exclude that a difference in age composition related to the fact that only houses with 
at least one child were included in the study may have influenced our heterogeneity 
estimates. We also observed that blood meals from only 8.2% of tested mosquitoes 
did not amplify for human DNA. Although it is possible that some of these mosquitoes 
fed on domestic animals, since it is unlikely that non-human biting would divert bites 
from specific hosts, we do not expect this to bias our individual-level estimates. 
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A technical limitation of this study was that our analyses only used data from ~70% 
of all successfully typed mosquito meals. Of those not matched, 139/292 were single 
blood meals from individuals not in our study houses and 153/292 had evidence of 
multiple blood meals. The distribution of these bites, each representing at least two 
host-vector encounters, is likely to be an important determinant of Anopheles 
exposure, in particular if some individuals are over-represented in these mixed meals, 
for example due to frequent defensive behaviour that leads to interrupted mosquito 
feeding and multiple probing. However, in a conservative sensitivity analysis that 
assigned these meals to the individuals with lowest exposure in each household, most 
mosquito bites were still linked to a small proportion of the population. Those 
mosquitoes whose blood meals did not match residents of study houses are likely to 
have fed in neighbouring houses or outdoors before entering study houses. The genetic 
profiles of these unmatched blood meals also suggest a heterogeneous feeding pattern: 
in the three houses with more than 10 unmatched mosquitoes, 16/41, 8/13 and 31/33 
blood meals had the same profile. The only study house where a resident did not 
provide blood sample for matching had 8/10 unmatched meals presumably from the 
same human source. Concurrent collection of fed mosquitoes indoors and outdoors 
would help to understand how biting behaviour influences overall exposure. 
 
Broad differences in anthropophily between mosquito species are well recognised (32) 
however there are fewer data (33) on whether different Anopheles species have 
different feeding preferences with regards to individual humans. In this study, we 
analysed blood meals in mosquitoes from three species: A. gambiae s. s., A. coluzzii 
and Anopheles arabiensis. Although seasonal differences in species abundance were 
evident, we observed aggregation in human biting irrespective of vector species and 
exposure to one species was positively associated with exposure to the others. Though 
we only collected endophagic mosquitoes, it suggests that where vectors are 
anthropophilic heterogeneity in exposure to anopheline mosquitoes is a common 
epidemiological phenomenon including in areas with mixed vector species. 
Additionally, we observed that the most numerous species in our study area, A. coluzzii 
and A. gambiae s. s., differed in two key parameters that influence the transmission 
potential of mosquitoes: the likelihood of feeding on multiple individuals and the 
prevalence of sporozoites. There is evidence from membrane feeding experiments 
performed in Senegal (34) that A. gambiae s. s. mosquitoes might be more susceptible 
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to malaria infection, although this association was not observed in another 
transmission study (35). Another possible explanation for the observed species-related 
difference in sporozoite prevalence could be variation in mosquito survival and 
consequently age structure. The higher frequency of falciparum infection in A. 
gambiae s.s. mosquitoes confirms, together with its relatively high abundance, the 
prime importance of this species for malaria transmission in the study setting. The 
contributions of the different Anopheles species to the mosquito infectious reservoir 
also depend on the number of potential parasite inoculations per mosquito-time: 
mosquitoes with multiple blood meals are more likely to infect more than one 
individual on a single night compared to mosquitoes with single-source blood meals, 
assuming sufficient quantities of sporozoites are inoculated during the probing of the 
different hosts. The higher proportion of blood meals with multiple human DNA 
sources suggests that A. coluzzii mosquitoes also contribute significantly to the 
incidence of infection in humans. Importantly, as species composition of local vector 
populations varies in the course of the rainy season (36), these differences might 
impact the rate of infection propagartion in human populations over the course of a 
single transmission season as relative abundances of the different vector species 
change.  
 
We also determined how the frequency of host-vector contacts might influence 
malaria infection risk in human populations. In our study area, there was considerable 
variation in household-specific exposure to sporozoite-positive mosquitoes (Figure 
3). At the individual level, few individuals received multiple potentially infective bites 
while between 75 and 90% of the study participants were not matched to feeding by 
infected mosquitoes during the three study periods. Whilst this does not represent all 
infected mosquito bites these individuals receive during an entire transmission season, 
it does highlight the degree of heterogeneity in likely parasite inoculations and the 
limitations of using population- or region-wide entomological measures of 
transmission that do not capture this small-scale variation. These results also indicate 
that the use of blood meal genotyping with concurrent assessment of mosquito 
sporozoite carriage during epidemiological studies could improve our understanding 
of the heterogeneity in clinical malaria risk (37-39). Furthermore, whilst we observed 
a positive association between the total number of mosquito bites and the number of 
bites from sporozoite infected mosquitoes at the individual level, our data suggest 
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clustering of sporozoite-positive mosquito bites at the household level that was not 
related to local mosquito abundance. This phenomenon could be linked to i) a 
correlation between prevalence of infection in mosquitoes and in humans in the same 
households assuming limited mixing of mosquitoes and humans (40) (e.g. due to the 
presence of breeding sites near houses, reducing the distances travelled by mosquitoes 
between consecutive blood meals) or possibly to ii) factors which affect mosquito 
survival on a very local scale, since mosquito age is associated with cumulative risk 
of sporozoite infection (41). 
 
In summary, although studies have assessed natural exposure to vectors of other 
infections, such as Aedes (42, 43) and Culex (44), only limited data are available for 
Anopheles mosquitoes (24, 27). In our field site, characterized by high malaria 
transmission intensity, we show significant heterogeneity both between and within 
households in terms of the number of mosquito blood meals and the distribution of 
potentially infectious mosquito feedings; these patterns are consistent with the 20/80 
rule and support the design of interventions that aim to reduce transmission by 
targeting a small proportion of the population. A quantitative understanding of the 
processes leading to heterogeneity in mosquito exposure and its temporal variability 
would inform at which level such interventions may be targeted in different settings; 
this would require quantification of the relative contributions of household-level 
factors, differential attractiveness to mosquitoes and human behavioural factors. 
 
Materials and Methods 
Study area and mosquito collections 
This study was conducted in Balonghin (health district of Saponé, Burkina Faso). The 
main economic activity in this area is subsistence farming and livestock keeping. 
Malaria transmission is seasonal, occurring between August and December following 
rainfall between June and September (45), and falciparum parasite prevalence is high, 
above 80% by 18S qPCR, during the transmission season (11). At the time of this 
study, seasonal malaria chemoprophylaxis was not part of national guidelines in 
Burkina Faso. Indoor mosquito collections were performed at the end of the 2013 
transmission season (October – December), and at the start (July 2014) and peak 
(September 2014) of the following wet season. Every week mosquito collections were 
performed in five households. Forty households with at least one household member 
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< 15 years of age were included in the first survey. For each household, mosquitoes 
were collected between 7 and 9 AM by mouth aspiration from walls and ceilings for 
a maximum of 15 minutes per sampling morning for seven days or until 30 bloodfed 
Anopheles mosquitoes were collected. In 2014, mosquito collections were performed 
in 20 of these 40 initial households over 10 days (5 days in July, and 5 in September). 
Bloodfed mosquitoes had their head-thoraces stored for speciation and malaria 
infection assessment by PCR (see below), and their abdomens containing blood meal 
material squeezed onto filter paper that was stored with desiccant until DNA extraction 
and further analyses.  
 
Parasite detection in humans 
Finger prick blood samples were collected at enrolment and stored in RNAprotect Cell 
Reagent. 18S qPCR and Pfs25 mRNA qRT-PCR were used to detect falciparum 
parasites and gametocytes, respectively. 
 
Mosquito blood meal typing 
Genetic typing of blood meal samples has been described in detail elsewhere (11). 
Briefly, bloodfed mosquitoes’ abdomens were processed using Boom extraction 
method (46). The AuthentifilerTM PCR Amplification kit (Applied Biosystems®), 
with nine human microsatellite markers and one gender marker, was used to compare 
human DNA in blood meals and in blood samples collected from study participants. 
Capillary electrophoresis was used to determine DNA profiles. Mosquito blood meals 
with more than two alleles in at least three loci were considered to have multiple 
human sources.  
 
Mosquito speciation assay and malaria parasite detection by PCR 
DNA was extracted from individual head-thoraces using the DNAzol procedure 
(Invitrogen). Mosquito speciation was performed using a single PCR-RFLP assay as 
described by Fanello and colleagues (47), and nested PCR (48) was used for 
Plasmodium falciparum detection.  
 
Statistical analysis 
Stata version 14 (Stata Corporation, College Station, TX, USA) was used for statistical 
analysis. Demographic data were not available for five houses where no bloodfed 
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mosquitoes were collected; study participants living in these households are not 
included in the analyses presented here. We used the number of bloodfed Anopheles 
mosquitoes collected per day per household when comparing different surveys. 
Wilcoxon signed-rank test was used to assess within-household changes in Anopheles 
abundance. To estimate household-specific exposure to infected mosquitoes (Figure 
3), we only considered singly matched mosquitoes and mosquitoes with blood meals 
that had multiple human DNA sources, and excluded from these calculations 
mosquitoes whose blood meals did not match house residents; for individuals with at 
least one matched mosquito that was not tested for sporozoite status, the number of 
infected bites was estimated based on total number of matched meals and proportion 
of tested mosquitoes that were positive. A mixed effects logistic model was used to 
assess the association between mosquito falciparum infection status and mosquito 
species; the analysis was adjusted for survey time (fixed effect), and household of 
collection was used as random effect. To describe the temporal variation in relative 
abundance of the different Anopheles species, data from all mosquitoes with speciation 
results were used. In other analyses, that assessed Anopheles species-specific 
proportions of blood meals with multiple human sources and prevalences of 
sporozoites, only data from mosquitoes with both blood meal and head-thorax 
molecular assays were included (645/666 singly matched, 151/153 multiple, and 
132/139 non-matched meals).  
 
To generate Figure 1b and estimate the highest proportion of singly matched mosquito 
meals linked to 20% of study participants, only individuals who were present in at 
least 3 collection days were considered. Mixed effects negative binomial models (49, 
50) were used to assess overdispersion in exposure to mosquitoes, after adjustment for 
variability linked to age categories and survey time (fixed effects) and household-level 
variation (random effect). These models were also used in Anopheles species-specific 
analysis. Likelihood-ratio test compared mixed effects negative binomial models and 
mixed effects Poisson models.  
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Supporting Information  
Figure S1. Sensitivity analyses. In Figure 1, only singly-matched mosquitoes were 
included. A total of 153 mosquito blood meals were likely to have at least two human 
DNA sources. In this graph, two different scenarios were assumed: in Scenario 1, each 
mosquito blood meal with multiple sources was assigned to the two individuals with 
most singly-matched meals in each household; in Scenario 2, each blood meal with 
multiple human DNA sources was assigned to the two individuals with lowest 
numbers of singly-matched mosquito meals in each household. The cumulative 
proportion of blood meals (y-axis) matched to study participants (x-axis) sorted by 
number of mosquito bites received is presented for the three different surveys and two 
different scenarios. Only individuals present in at least 3 mosquito collection days 
were included in this graph.   
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Figure S2. Relationship between household- and individual-level exposures to Anopheles mosquitoes. The y-axis represents the number 
of mosquito blood meals linked to each study participant (left column) and the total number of blood meals matched to individuals living 
in each study household (right column). In each panel, individuals living in the same household are represented by circles of the same 
colour and linked to their household. Only houses with at least 10 (start and peak of transmission season) or 5 (end of transmission season) 
matched mosquitoes are included in this graph; in all other houses, all individuals had 5 mosquito bites or fewer at the start or peak of the 
wet season, and 3 or fewer bites at the end of the transmission season.  
 
  
326 
 
Figure S3. Cumulative proportion of Anopheles species-specific blood meals (y-axes) 
matched to study participants (x-axes) sorted by number of mosquito bites received. 
Only individuals present in at least 3 mosquito collection days were included in this 
graph. a, A. gambiae s. s.; b, A. coluzzii. Only a few (7 – 20) A. arabiensis mosquitoes 
were matched to study participants. 
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Figure S4. Correlations between vector species-specific numbers of matched blood 
meals. Both y- and x-axes represent the number of mosquito blood meals matched to 
study participants; each circle corresponds to a study participant. Axes limits vary to 
allow better visualisation of patterns in different surveys. 
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Answers to reviewers’ comments 
 
Manuscript: Variation in natural exposure to anopheles mosquitoes and its effects on 
malaria transmission 
 
Reviewers’ comment 
 
SUMMARY:  
This is a well-written manuscript that quantifies the uneven distribution of bites 
by malaria vectors within and between households in a village in Burkina Faso. 
With the specific exceptions noted below it appears to be a well-done study that 
is one of only few to document this phenomenon in the field using a large survey 
and capturing the detail (vector species, infected vs total bites, within and 
between households, demographic predictors). The phenomenon has been shown 
theoretically to be important, so documenting how large it is makes a significant 
contribution to the field, which will be interesting to anyone concerned about 
malaria and to others interested in the role of heterogeneity in infectious diseases. 
Revisions below are requested to improve the understanding of readers 
(including nonspecialists) of the context and precise implications of the finding. 
 
Answer to Reviewers’ comment 
 
We would like to thank the reviewers for their detailed comments and valuable 
suggestions. It is gratifying that they recognise the importance of these data. We have 
revised the manuscript to address the points raised and to clarify the implications of 
our results. 
 
Reviewers’ comment 
 
ESSENTIAL REVISIONS (these are approximately in the order they appear in 
the paper, but may be not exactly so as the Reviewing Editor has combined the 
three reviews into a single list of revisions) 
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1. The discussion and some of the results presentation should be modified to 
consider the following perspectives: 
  
The authors cite compelling theoretical demonstrations that R0 is massively 
inflated with this level of heterogeneity, compared to all behavior being average 
(random biting). It is not clear to me for an infection with slowly-developing 
immunity that R0 is the best measure of impact. Suppose in the extreme case that 
all the mosquitoes exclusively bit 2 people of the 100 in a community. That would 
certainly make for a high R0 and make control by say mass vaccination or 
mosquito control challenging (in proportion to R0 inflation). It wouldn't however 
increase the burden of disease much and might decrease it, as these people would 
rapidly become immune, making bites on them less productive of gametocytes 
and further transmission (to the extent that immunity impacts transmission). 
Moreover (as in STI models) extreme specialization of this sort increases R0 but 
not necessarily prevalence because some "nonspecialized" bloodfeeding is 
necessary to disperse infection into the wider community. This is an important 
limitation of the R0-focused presentation. This paper is not the place to develop 
the theory further, but I think emphasizing the impact on R0 means the 
discursive parts of the MS should focus on the difficulty of control (which is 
proportional to R0) not "transmission" or "endemicity" generally, which does 
not follow in a simple way.  
 
Answer to Reviewers’ comment 
 
We agree that the fold-changes in R0, presented in Figure 4, do not necessarily reflect 
the true relationship between heterogeneity in exposure to mosquitoes and local 
human infection burden, defined as community-wide parasite prevalence or incidence 
of infections in uninfected individuals. We agree with the reviewers that highly 
heterogenous transmission can result in an extreme scenario where the infection 
burden is concentrated in, or even confined to, a very small fraction of the population. 
In a detailed theoretical analysis (Revisiting the basic reproductive number for malaria 
and its implications for malaria control. PLoS Biology 2007), Smith and colleagues 
showed that in finite populations the number of different individuals whose parasites 
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originate from a single infected individual might decrease with increasing levels of 
heterogeneity, depending on the human population size. In this context, rather than 
being a direct measure of community-wide malaria burden, R0 determines the 
coverage level of non-targeted vector control interventions required to interrupt 
parasite circulation.  
 
To address this and the next comment, we have modified the following paragraph in 
the Discussion section: 
 
“Applying simple, well-established (24, 25) methods, for assessing the influence of 
observed mosquito biting heterogeneity on local malaria R0epidemiology, we 
estimated that the observed degree of mosquito biting heterogeneity could be linked 
to a at least 3-times fold or higher increase in malaria R0 than compared to it would 
have been in a random-mixing system. contributed significantly to the high 
transmission intensity in our study area. This suggests that in settings with 
considerable variation in mosquito exposure, heterogeneity in biting is likely to be a 
major determinant of the coverage of vector control interventions required to reduce 
and interrupt transmission (25). These R0–focused calculations however have 
limitations. Firstly, although there is a positive relationship between R0 and variability 
in Anopheles biting, in finite populations increasing aggregation in exposure does not 
necessarily equate to increasing community-wide infection burden, since in areas with 
highly heterogeneous mosquito biting a high proportion of parasite inoculations will 
be on already-infected individuals. Additionally, the framework used here does not 
account for previously observed interactions between frequency of exposure to 
infected mosquitoes and rates of immunity acquisition (13, 14, 26), which could 
influence blood stage parasite burden and potentially the production of transmission 
stages in highly exposed, highly immune individuals. Development of detailed 
mathematical models that explicitly incorporate immunity and spatial dependencies 
(see next paragraph) would allow more precise estimation of the long-term influence 
of the observed variation in mosquito exposure on malaria transmission dynamics.” 
(Lines 299 – 303) 
 
We have also replaced the title of the subsection “Effect of exposure heterogeneity on 
transmission” (Results section) with “Effect of exposure heterogeneity on malaria R0”, 
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and modified its contents (some of the modifications in this paragraph relate to other 
comments): 
 
“The impact of biting heterogeneity on the resilience of vector-borne disease 
transmission to control interventions is most transparently can be demonstrated 
estimated using the methods described in (11, 12): compared to uniform biting, the 
basic reproduction number (R0) of a vector-borne disease, which corresponds to the 
number of secondary infections generated by an infectious individual in the absence 
of any control and any population immunity, is inflated by the factor (1 + α), where α 
is the squared coefficient of variation of the human biting rate. Figure 4 illustrates 
the impact that more extreme heterogeneity can have on the calculated R0 of malaria: 
In terms of all singly matched bloodfed mosquitoes: R0 is increased by a factor of 4.8, 
4.2 and 8.4 in settings where mosquito exposure and its variability are similar to those 
observed at the start, peak and end of the transmission season in our study area, 
respectively. This intensified transmission potential remains R0 amplification is high 
even when the skew is reduced by the conservative sensitivity analysis that allocates 
multiply fed mosquitoes’ meals to the least exposed individuals, yielding R0 increases 
by a factor of 3.3, 3.2 and 5.7 at the start, peak and end of the transmission season, 
respectively.” (Lines 244 – 256) 
 
Reviewers’ comment 
 
Another perspective on the same issue:It might be worthwhile to state that the 
absolute values of Ro, as calculated, are notional in the sense that these are the 
values that would pertain in the absence of any control and any population 
immunity. In the case of Burkina, there's plenty of both control effort and 
immunity, so the actual Ro is considerably less. The important lesson is that some 
means for better targeting control measures might be considered. Some of these 
are by now anodyne -- we can't merely target children, but adults must be 
included in our efforts. We are already know that poor housing and poverty are 
associated with higher prevalence of malaria. While this paper very convincingly 
tells us that there is individual level variability in transmission -- strongly 
associated with spatial factors -- we don't yet know whether the observed spatial 
heterogeneity in transmission is temporally stable. If it isn't, then targeting of 
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interventions will be hard to accomplish. But for the purposes of publication 
decision, this is not really of importance, as the paper presents splendid data 
confirming some long-held theoretical and field-based suspicions. 
 
Answer to Reviewers’ comment 
 
We agree that absolute values of R0 should be interpreted in the context of 
interventions that reduce the actual reproduction number. Because of this obvious 
discordance, we did not estimate local malaria R0, opting instead to present changes in 
R0 (relative to a homogenous-biting system) estimated from the new data on biting 
variation. 
 
As note in the response to the previous comment we have revised the Discussion to 
point out 1) that R0 calculations concern scenarios where no control measures are in 
place in a population of immunologically naïve individuals, 2) that malaria R0 might 
not be the best measure to assess the impact of biting heterogeneity on local malaria 
burden, 3) that R0 amplification due to variation in mosquito exposure determines 
requirements for control strategies to be effective, and 4) that more complex 
mathematical models that account for correlations between malaria exposure and rate 
of immunity acquisition might inform how the distribution of mosquito bites 
influences different human malaria metrics.  
 
In addition to these modifications related to R0, we also agree with the reviewers that 
characterising the temporal variation in the spatial distribution of mosquito bites is 
essential to determine the feasibility of spatially targeted interventions. Large 
population-based epidemiological studies could be informative in this respect. 
Analysing data on more than 1,000 homesteads in coastal Kenya, Bejon and 
colleagues showed that foci of clinical malaria are unstable and that one-month 
surveillance data, for example, might only have predictive value of future hotspots for 
short periods of time (A micro-epidemiological analysis of febrile malaria in Coastal 
Kenya showing hotspots within hotspots. eLife 2014). This is consistent with our 
observation that the ranking of houses according to the number of infected mosquito 
bites per individual varies over time (Figure 3). To this, we add that determining the 
spatial scale of malaria transmission is also important. The average distance between 
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locations where consecutive blood meals of the same mosquito take place (see Perkins 
et al. Heterogeneity, Mixing, and the Spatial Scales of Mosquito-Borne Pathogen 
Transmission. PLOS Computational Biology 2013 for a detailed discussion on spatial 
scale of malaria transmission; see McCall et al. Evidence for memorized site-fidelity 
in Anopheles arabiensis. Trans R Soc Trop Med Hyg. 2001 and Le Menach et al. The 
unexpected importance of mosquito oviposition behaviour for malaria: non-
productive larval habitats can be sources for malaria transmission. Malaria Journal 
2005 for two possible mechanisms influencing the scale of transmission) is likely to 
influence the contribution of different households to community-wide transmission, 
and consequently is a measure of the maximal efficacy of spatially targeted 
interventions.  
 
We modified the following paragraph to emphasize the need to quantify temporal 
variation in the spatial distribution of mosquito bites. These changes are equally 
relevant to comment 7.  
 
“The fact that the majority of human-mosquito encounters in each survey in our study 
involved only a few individuals is a consequence of both between- and within-
household variation in exposure. Indeed, at the peak of the transmission season, the 
household with the highest number of fed mosquitoes had ~150 times more than the 
household with the lowest number. Household characteristics, such as construction 
material, number of windows, eaves as well as geographical proximity to mosquito 
breeding sites have all been previously associated with increased exposure to 
mosquitoes indoors and explain some of the between-household variation in mosquito 
abundance. The significant differences in vector biting between study houses also 
imply that malaria control programmes could target households with high mosquito 
densities. However, quantification of the temporal variation in household-level vector 
densities as well as estimations of the scale of transmission (27), i.e. the distance range 
within which mosquitoes infected by a single infectious individual circulate and cause 
secondary human infections, would be necessary to determine the feasibility and 
relevance of these strategies. Data on geographical clustering of Anopheles exposure, 
malaria infection and disease might be informative to understand spatio-temporal 
changes: a study in Kenya (13) showed that foci of clinical malaria are unstable and 
that one-month surveillance data, for example, might only have predictive value of 
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higher-than-average transmission over short periods of time. This is consistent with 
our observation that the ranking of households according to the number of infected 
mosquito bites per individual varies over time (Figure 3) and poses considerable 
challenges to sustainably targeting high exposure households for maximum 
community benefit.  
 
We also found that household heterogeneity is compounded by inter-individual 
variation in frequency of sampling by mosquitoes for people in the same house. ….” 
(Lines 303 – 312) 
 
Reviewers’ comment 
 
2. Line 166 (Fig). The reviewers had divergent opinions on the figures. Two of us 
(ML and RP) found this figure in particular quite confusing. Another (WH) 
wrote "The figures are lovely, creative, and informative, once their code is 
understood." It is up to the authors to consider whether greater clarity can be 
achieved without sacrificing information or readability. Also it would be helpful 
to describe Fig 2 more explicitly in the text 
 
Answer to Reviewers’ comment 
 
We have now modified Figure 2 to present temporal variation in exposure in one 
single panel. This information is now represented in linear scale (see figure below). 
We have also modified the Results section and the Methods section where the 
calculations used to create the previous panels a and b were described. 
 
“Figure 2. Temporal (a and b) and within-household (b) variation in exposure to 
malaria vectors. In a and b, individuals were ranked (y-axis) according to the number 
of matched mosquito blood meals per collection day at the peak of the transmission 
season. The left and right, symmetrical, x-axes represent the number of mosquito bites 
each individual received at the peak (orange bars), and at the start (blue bars) and 
end (red circles) of the transmission season, respectively. Only individuals present 
during at least 3 collection days per survey in all surveys and matched to at least one 
blood meal (N=62) are included in this panel. ; each green circle represents a study 
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participant and the distance between a green circle and the centre of the panel is 
proportional to the loge-transformed number of mosquito bites received per collection 
day (see Supporting Information for details). Each red circle corresponds to the 
number of singly matched blood meals at the peak (a) or end (b) of the transmission 
season for the individual represented by the radially aligned green circle. The dotted 
inner circle corresponds to no mosquito bites, and the dotted outer circle, to 5 bites 
per day. In b, each group of the three columns corresponds to a different survey (S, 
Start of transmission season; P, Peak of transmission season; E, End of transmission 
season) for a select number of households. Individuals in the same household are 
denoted by different colours, which are consistent in the different surveys. The 
proportions of matched blood meals linked to each individual by household and survey 
are on the y-axis; only the 8 households with at least 5 matched mosquitoes at the start 
of the transmission season and three or more study participants are shown. The 
numbers of individuals living in the households included in panel c are shown above 
the columns.” 
 
“However, some individuals with highest numbers of matched blood meals at the peak 
of the transmission season received few or no mosquito bites in other surveys (Figure 
2a and b).” (Lines 151 – 153) 
 
“Within-household heterogeneity in mosquito exposure was observed (Figure 2b): 
considering data from houses with at least three study participants and five matched 
mosquitoes in single surveys, in 4/8, 14/15 and 7/7 households with at least three study 
participants and five matched mosquitoes at the start, peak and end of the transmission 
season respectively, the most exposed individual was the source of at least 50% of 
matched mosquito blood meals.” (Lines 167 – 170)
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Reviewers’ comment 
 
3, Fig 4 line 258ff. We don't understand how there are 3 different curves since 
1/k should give a single curve. This must be because the fold increase depends on 
more than 1/k, and I just don't follow the figure legend, which should provide the 
formula. 
  
Answer to Reviewers’ comment 
 
The different curves in Figure 4 represent the effect of aggregation (1/k) on malaria 
R0 in areas with mosquito exposure levels (i.e. average number of mosquito bites) 
similar to those observed in our study (i.e. start [blue], peak [orange] and end [green] 
of transmission season). These calculations are not intended to reflect seasonal biting 
variation, but rather to provide estimates of R0 amplification in theoretical settings 
with vector densities and biting variation similar to those observed at different times 
in our study area. To clarify this, we have modified the legend of Figure 4 and the 
Results section (see below).  
 
In addition to addressing this comment, we wish to draw the reviewers’ attention to an 
error that occurred in calculating the R0 inflations. A coding error meant that the 
coefficient of variation was miscalculated as the variance divided by the mean bite 
rate when it should have been the standard deviation divided by the mean. While the 
biting variation recorded in the field still inflates R0 considerably, the inflations are 
attenuated (now resulting in 4 to 8-fold increases in R0 relative to homogenous 
mixing). We have corrected the sub-section “Effect of exposure heterogeneity on 
malaria R0” in the Results section to reflect this change and apologise for not noticing 
this mistake sooner. These rectifications do not change the overall message of the 
manuscript or the large majority of the presented results. The corrected R0 calculation 
resulted in changes in the last paragraph of the Results section and one paragraph in 
the Discussion section, the actual presentation of all entomological data is unaltered 
and correct. 
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“Figure 4. The relationship between the fold increase in R0 and the level of 
aggregation in mosquito bites. This relation depends on the mean mosquito biting rate 
(see below), and the different curves represent the shape of this effect for different 
mosquito exposure levels: blue, orange and green lines correspond to settings where 
host-vector contact rates (mean numbers of matched mosquito bites) are similar to 
those observed at the start, peak and end of the transmission season, respectively for 
each survey, based on the mean numbers of mosquito bites recorded. Aggregation 
level increases along with the inverse of the aggregation parameter k from the 
negative binomial distribution, where k can be calculated as the squared mean number 
of mosquito bites (μ2) divided by the variance in bite number (σ2) minus the mean, i.e.  
  = 

  	 . R0 is inflated by factor (1+α) whereby α = 




 in other words, α is the 
squared coefficient of variation (14). In the special case whereby bites are perfectly 
homogenous, the coefficient of variation is zero, and the standard formulation for R0 
is regained (15, 16). The fold increases in R0 for the levels of aggregation observed in 
our surveys are represented by the coloured crossed-lines.” 
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“The impact of biting heterogeneity on the resilience of vector-borne disease 
transmission to control interventions is most transparently can be demonstrated 
estimated using the methods described in (11, 12): compared to uniform biting, the 
basic reproduction number (R0) of a vector-borne disease, which corresponds to the 
number of secondary infections generated by an infectious individual in the absence 
of any control and any population immunity, is inflated by the factor (1 + α), where α 
is the squared coefficient of variation of the human biting rate. Figure 4 illustrates 
the impact that more extreme heterogeneity can have on the calculated R0 of malaria: 
In terms of all singly matched bloodfed mosquitoes: R0 is increased by a factor of 4.8, 
4.2 and 8.4 in settings where mosquito exposure and its variability are similar to those 
observed at the start, peak and end of the transmission season in our study area, 
respectively. This intensified transmission potential remains R0 is high even when the 
skew is reduced by the conservative sensitivity analysis that allocates multiply fed 
mosquitoes’ meals to the least exposed individuals, yielding R0 increases by a factor 
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of 3.3, 3.2 and 5.7 at the start, peak and end of the transmission season, respectively.” 
(Lines 244 – 256) 
 
 
Reviewers’ comment 
 
4. Line 319 and following. This result should not be presented for the first time 
in the Discussion. A p value with no mention of effect size or CIs is bad statistical 
practice. More generally, the list of factors considered as potential risk factors 
should be presented with univariate association measures provided (point and 
CI); as it is we don't know what the authors tried and only know that one 
association was null, but not whether it was convincingly close to null or just 
underpowered (narrow or wide CI respectively). 
  
Answer to Reviewers’ comment 
 
We previously showed that age influences mosquito exposure in this area (Gonçalves 
et al. Examining the human infectious reservoir for Plasmodium falciparum malaria 
in areas of differing transmission intensity. Nature Communications 2017). Here, we 
also assessed the effect of bed net use on mosquito exposure, although as we 
mentioned in the Discussion section, the study was not designed for this. We modified 
the Results section to describe the analysis that include bed net use. Additionally, to 
address another comment (see “Optional major revision”), we have now included a 
statement on the effect of parasite carriage on mosquito biting.  
 
“Throughout the study, a small number of individuals, mostly adults, were matched to 
considerably higher numbers of blood meals compared to the rest of the population. 
Conversely, 32.0 – 76.2% of study participants were not linked to bloodfed mosquitoes 
during the surveys, including 15/77 individuals present in all surveys who were never 
matched to collected fed mosquitoes. Reported bed net use and parasite and 
gametocyte carriage at enrolment were not significantly associated with mosquito 
exposure during our study (incidence rate ratio of 0.70 [95% confidence interval, CI, 
0.22 – 2.20, P = 0.55] for reported bed net use versus no net use in a model adjusted 
for survey and of 3.42 and 0.99 [95% CI 0.50 – 23.45 and 0.33 – 3.10, P = 0.21 and 
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0.99] for parasite and gametocyte carriage at enrolment respectively in models that 
only included data from the first survey). In an analysis of data from all surveys, 
negative binomial regression with mixed effects better explained the distribution of 
mosquito bite counts than mixed effects Poisson models (P < 0.001), after adjustments 
for age, which influences Anopheles exposure in this population (11), survey and 
intra-household data correlation.” (Lines 117 – 124) 
 
We have also modified the Discussion section: 
 
“....; in our study, bed net use and gametocyte carriage were not significantly 
associated with the number of mosquito bites an individual received (P = 0.72) though 
this study was not designed to assess the influence of these factors on mosquito 
exposure.” (Lines 318 – 320) 
 
 
Reviewers’ comment 
 
5. Paragraph starting line 369 is hard to understand -- could not identify the main 
point.  
 
Answer to Reviewers’ comment 
 
In this paragraph, we discuss the effect of the heterogeneity described on the 
distribution of potentially infectious bites from mosquitoes. As with total mosquito 
counts, most sporozoite-positive mosquito blood meals were matched to a small 
proportion of participants. An unexpected finding was that infected bites clustered at 
the household level after adjustment for the number of mosquitoes collected. We 
believe this observation is important since it might be linked to previously 
unrecognized epidemiological phenomena. Indeed, possible explanations for this 
include 1) household-level differences in mosquito survival and average age, where 
mosquito age is associated with cumulative risk of infection (Lines et al. Human 
malaria infectiousness measured by age-specific sporozoite rates in Anopheles 
gambiae in Tanzania. Parasitology 1991), and 2) a time-lagged correlation between 
prevalences of infection in mosquitoes and in humans in corresponding households. 
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Explanation 2 implies limited movement of mosquitoes in some areas, i.e. the distance 
travelled by mosquitoes between consecutive blood meals is small. This might occur 
for example in houses located near breeding sites, which allow oviposition after blood 
feeding and might increase the probability that mosquitoes feed in the same house 
afterwards. Another mechanism could involve feeding site-fidelity as previously 
described (McCall et al. Evidence for memorized site-fidelity in Anopheles arabiensis. 
Trans R Soc Trop Med Hyg. 2001). 
 
We have improved the clarity of this paragraph. We have removed the statement that 
contrasted the proportion of the study population linked to potentially infective blood 
meals and the prevalence of infection in this population, since these two quantities are 
not directly comparable (we assessed exposure to infected mosquitoes during one 
week at the end of the transmission season, while infections in humans can last several 
months [Felger et al. The Dynamics of Natural Plasmodium falciparum Infections. 
PLoS ONE 2012]). We also included additional information about the clustering of 
infected mosquitoes at the household level.  
 
 
“We also determined how the frequency of host-vector contacts might influence 
malaria infection risk in human populations. In our study area, there was considerable 
variation in household-specific exposure to sporozoite-positive mosquitoes (Figure 
3). At the individual level, few individuals received multiple potentially infective bites 
while For example, at the end of the 2013 transmission season, only 8/35 study houses 
had infected bloodfed mosquitoes whilst 79.2% (99/125) of the study participants had 
falciparum parasites detected by PCR. Overall, between 75 and 90% of the study 
participants were not matched to feeding by infected mosquitoes during the three study 
periods. Whilst this does not represent all infected mosquito bites these individuals 
receives during an entire transmission season, it does highlight the degree of 
heterogeneity in likely parasite inoculations and the limitations of using population- 
or region-wide entomological measures of transmission that do not capture this small-
scale variation. These results also indicate that the use of blood meal genotyping with 
concurrent assessment of mosquito sporozoite carriage during epidemiological 
studies could improve our understanding of the heterogeneity in clinical malaria risk 
(33-35). Furthermore, whilst we observed a positive association between the total 
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number of mosquito bites and the number of bites from sporozoite infected mosquitoes 
at the individual level, there was no evidence that the proportion of potentially 
infective bites varies from individual to individual within a household. On the other 
hand, our data also suggest clustering of sporozoite-positive mosquito bites at the 
household level that was not related to local mosquito abundance. This phenomenon 
could be linked to i) a correlation between prevalence of infection in mosquitoes and 
in humans in the same households household-specific parasite prevalence in humans, 
assuming some fidelity in mosquito-host interaction, i.e. assuming limited mixing of 
mosquitoes and humans (31) (e.g. due to the presence of breeding sites near houses, 
reducing the distances travelled by mosquitoes between consecutive blood meals), or 
possibly to ii) factors which affect mosquito survival on a very local scale, since 
mosquito age is associated with cumulative risk of sporozoite infection (38). Whether 
individuals who received multiple infected bites developed infections and how 
different inoculations and ongoing blood-stage infections interacted with each other 
(32) are not known. Studies that combine mosquito blood meal typing and 
parasitological and clinical follow-up of human populations would be informative to 
understand heterogeneity in clinical malaria risk (33-35).” (Lines 369 – 391) 
 
Reviewers’ comment 
 
6. LInes 407 ff. We would like more information. I don't understand what was 
done. How were households chosen and individuals in them identified? Was 
sleeping in the household the night of the mosquito collection necessary for 
inclusion (if not, maybe some heterogeneity is just because someone wasn't there). 
What is the mosquito trapping protocol (I don't know about mouth aspiration 
but want more detail anyway about how long, where, what kind of traps etc) 
  
Answer to Reviewers’ comment 
 
Households with at least one child were eligible for inclusion in the first entomological 
survey. Residents in study houses were enrolled and asked to provide a finger prick 
blood sample that was used to match mosquito blood meals to humans. In the second 
and third surveys, twenty houses from the first survey with no changes in the number 
of residents (e.g., no births or deaths) were sampled again for bloodfed mosquitoes; 
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priority was given to houses with highest mosquito exposure in the first survey. For 
the duration of catching in each survey we recorded whether each participant was 
present in the study house during the nights preceding mosquito collections. We used 
this information as exposure variable in statistical models of mosquito biting, 
including in the negative binomial models, and to exclude individuals with limited 
exposure data from some of the figures (Figure 1, Figure 2 and Figure S1).  
 
We have now modified the Methods section to give more details about mosquito 
collections:  
 
“This study was conducted in Balonghin (health district of Saponé, Burkina Faso). 
The main economic activity in this area is subsistence farming and livestock keeping. 
Malaria transmission is seasonal, occurring between August and December following 
rainfall between June and September (39), and falciparum parasite prevalence is high, 
above 80% by 18S qPCR, during the transmission season (11). At the time of this 
study, seasonal malaria chemoprophylaxis was not part of national guidelines in 
Burkina Faso. Indoor mosquito collections were performed at the end of the 2013 
transmission season (October – December), and at the start (July 2014) and peak 
(September 2014) of the following wet season. Every week mosquito collections were 
performed in five households. Forty households with at least one household member 
< 15 years of age were included in the first survey. For each household, mosquitoes 
were collected between 7 and 9 AM by mouth aspiration from walls and ceilings for a 
maximum of 15 minutes per sampling morning for seven days or until 30 bloodfed 
Anopheles mosquitoes were collected. In 2014, mosquito collections were performed 
in 20 of these 40 initial households over 10 days (5 days in July, and 5 in September). 
Bloodfed mosquitoes had their head-thoraces stored for species confirmation and 
malaria infection assessment by PCR (see below), and their abdomens containing 
blood meal material squeezed onto filter paper that was stored with desiccant until 
DNA extraction and further analyses.” (Lines 408 – 419) 
 
Reviewers’ comment 
 
7. The paper's penultimate sentence looms over this effort: "...support the design 
of interventions that aim to reduce transmission by a targeting a small proportion 
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of the population." The theoretical literature already admonishes us to do this, 
but your data help us to grapple with the question - should we be targeting 
households or individuals? I think the data clearly support the former, and would 
suggest that your discussion say so. Figures 3a, S2, and your regression analysis 
- line 214 "there was no evidence of individual level clustering after adjustment 
for household related variability (p = 0.50) all support the conclusion that the 
challenge to programs it to identify houses that attract the most mosquitoes, and 
not, thankfully, the most attractive individuals within houses. To gain this 
understanding, you advocate for (line 389) "studies that combine mosquito blood 
meal typing and parasitological and clinical follow up"; in an earlier phrase (line 
386) "factors which affect mosquito survival on a very local scale" are mentioned. 
What about the distribution and productivity of larval habitats? In a paper about 
heterogeneity, this is an essential and extremely heterogeneous (spatially and 
temporally) fact of nature that should be considered if we are to figure out how 
to target the individuals living in high transmission houses. Even if you don't 
agree with my interpretation of your data, I think it would be worthwhile to 
address the 'what do we need to target? - individuals or households?' question 
more directly if the intent is to inform research of programmatic usefulness. 
  
Answer to Reviewers’ comment 
 
Indeed, our results indicate that exposure to infected mosquitoes is highly variable at 
the household level. In particular, at the start of the transmission season, a period 
which may determine the malaria burden during the subsequent transmission season, 
only a few houses had infected mosquitoes collected. As the reviewer suggests, more 
effective targeting a fraction of households could have a significant impact on 
potential transmission. The issue of the identification of households associated with 
high exposure to mosquitoes is obviously key. As mentioned by the reviewer, the 
spatial distribution of larval breeding sites is one likely factor determining spatial 
heterogeneity in transmission, as it determines both abundance and feeding after 
oviposition, which has an effect on the scale of transmission (see Le Menach et al. The 
unexpected importance of mosquito oviposition behaviour for malaria: non-
productive larval habitats can be sources for malaria transmission. Malaria Journal 
2005 for a detailed discussion).  However, we strongly suspect that other factors such 
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as household construction and adherence to existing vector control will also play key 
roles in this and that identification of factors will be ecotype dependent.  We have now 
modified the following paragraph to address this comment and the related comment 
1: 
 
“The fact that the majority of human-mosquito encounters in each survey in our study 
involved only a few individuals is a consequence of both between- and within-
household variation in exposure. Indeed, at the peak of the transmission season, the 
household with the highest number of fed mosquitoes had ~150 times more than the 
household with the lowest number. Household characteristics, such as construction 
material, number of windows, eaves as well as geographical proximity to mosquito 
breeding sites have all been previously associated with increased exposure to 
mosquitoes indoors and explain some of the between-household variation in mosquito 
abundance. The significant differences in vector biting between study houses also 
imply that malaria control programmes could target households with high mosquito 
densities. However, quantification of the temporal variation in household-level vector 
densities as well as estimations of the scale of transmission (27), i.e. the distance range 
within which mosquitoes infected by a single infectious individual circulate and cause 
secondary human infections, would be necessary to determine the feasibility and 
relevance of these strategies. Data on geographical clustering of Anopheles exposure, 
malaria infection and disease might be informative to understand spatio-temporal 
changes: a study in Kenya (13) showed that foci of clinical malaria are unstable and 
that one-month surveillance data, for example, might only have predictive value of 
higher-than-average transmission over short periods of time. This is consistent with 
our observation that the ranking of households according to the number of infected 
mosquito bites per individual varies over time (Figure 3) and poses considerable 
challenges to sustainably targeting high exposure households for maximum 
community benefit.”  
   
In our opinion, targeting demographic groups should be considered in some settings. 
In a related analysis, we estimated that adults contribute ~50% of mosquito infections 
in this study area after accounting for the age structure of the population, relative 
infectivity and heterogeneity in exposure. One potential advantage of this approach 
compared to spatial targeting is the easier identification of demographic groups that 
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on average are more likely to contribute to transmission. Furthermore, there is 
considerable transmission outside hotspots of asymptomatic and clinical malaria, and 
by targeting for example all adults living in an endemic area transmission might be 
reduced in both highly exposed and less exposed households. We have included some 
of these ideas in the final paragraph of the Discussion section: 
 
“In summary, although studies have assessed natural exposure to vectors of other 
infections, such as Aedes (36, 37) and Culex (38), only limited data are available for 
Anopheles mosquitoes (20, 23). In our field site, characterized by high malaria 
transmission intensity, we show significant heterogeneity both between and within 
households in terms of the number of mosquito blood meals and the distribution of 
potentially infectious mosquito feedings; these patterns are consistent with the 20/80 
rule and support the design of interventions that aim to reduce transmission by 
targeting a small proportion of the population. Opportunities to specifically target 
high-exposure households depend on the operational feasibility to identify these 
households and the stability in exposure over time. A quantitative understanding of 
the processes leading to the heterogeneity in mosquito exposure and its temporal 
variability would inform at which level such interventions may be targeted household 
or individual, in different settings; this would require quantification of the relative 
contributions of household-level factors, differential attractiveness to mosquitoes and 
human behavioural factors.” 
 
Reviewers’ comment 
 
8. It would be helpful to summarize key features of malaria transmission in this 
area: what is the prevalence of parasitemia or other measures of transmission, 
and what is the nature and extent of interventions in place? 
 
 Answer to Reviewers’ comment 
 
Data from a recent epidemiological study showed that the prevalence of falciparum 
parasites during malaria transmission season was 83.8% by molecular methods, which 
is similar to the prevalence of 79.2% during the first mosquito collection survey. While 
seasonal chemoprophylaxis was not recommended in Burkina Faso at the time of this 
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study, reported bed net use was high (90.0%, 87.1% and 88.6% for children < 5 years, 
schoolchildren and adults, as we previously described [Gonçalves et al. Examining the 
human infectious reservoir for Plasmodium falciparum malaria in areas of differing 
transmission intensity. Nature Communications 2017]). We now mention this 
information in the Methods and Results sections.  
     
“This study was conducted in Balonghin (health district of Saponé, Burkina Faso). 
The main economic activity in this area is subsistence farming and livestock keeping. 
Malaria transmission is seasonal, occurring between August and December following 
rainfall between June and September (39), and falciparum parasite prevalence is high, 
above 80% by 18S qPCR, during the transmission season (11). At the time of this 
study, seasonal malaria chemoprophylaxis was not part of national guidelines in 
Burkina Faso. Indoor mosquito collections were performed at the end of the 2013 
transmission season (October – December), and at the start (July 2014) and peak 
(September 2014) of the following wet season. Every week mosquito collections were 
performed in five households. Forty households with at least one household member 
< 15 years of age were included in the first survey. For each household, mosquitoes 
were collected between 7 to 9 AM by mouth aspiration from walls and ceilings for a 
maximum of 15 minutes per sampling morning for seven days or until 30 bloodfed 
Anopheles mosquitoes were collected. In 2014, mosquito collections were performed 
in 20 of these 40 initial households over 10 days (5 days in July, and 5 in September). 
Bloodfed mosquitoes had their head-thoraces stored for speciation and malaria 
infection assessment by PCR (see below), and their abdomens containing blood meal 
material squeezed onto filter paper that was stored with desiccant until DNA 
extraction and further analyses.” (Lines 408 – 419) 
 
 
“We performed indoor resting collections of anopheline mosquitoes in an area with 
seasonal malaria transmission in Burkina Faso. Thirty-five households were included 
in this analysis. The median number of individuals living in each study household was 
3 (range, 2 – 5). Reported bed net use among the study participants was high (111/126, 
88.1%).” (Lines 81 – 83)  
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OPTIONAL MAJOR REVISION 
  
Reviewers’ comment 
 
The most surprising absence, given that people were bled for human genotyping 
and given that LaCroix et al. (cited ref 19) showed an increased attractiveness of 
parasite infected people to mosquitoes, is that there is no information given on 
the parasite prevalence in the population at an individual or even general level 
(how much malaria is there and when). The mosquitoes were examined for 
parasite sporozoite stages, but if the bloodmeals were squeezed out for typing and 
the abdomens remained, then surely the mosquito bloodmeal could have been 
checked for parasites. 
  
Answer to Reviewers’ comment 
 
In response to the reviewer comment, we have now included parasitology data for the 
first season when samples were available for this purpose. We tested these human 
samples, stored in RNAprotect cell reagent, for parasite and gametocyte detection 
using 18S qPCR and Pfs25 qRT-PCR and results are now included in the Results 
section and in Table 1 (see below). We observed high parasite and gametocyte 
prevalence in human samples and, potentially because of this, no association between 
mosquito exposure and parasite carriage in humans. We do agree that this is an 
interesting phenomenon and highly valuable to explore in the context of natural 
mosquito exposure. Given the estimated effect sizes (~2-fold higher mosquito 
exposure as a consequence of gametocyte carriage (Busula et al. J Infect 2017; Lacroix 
et al. PLoS Biol 2005) and body surface/age (up to 21-fold higher exposure, Gonçalves 
et al. Examining the human infectious reservoir for Plasmodium falciparum malaria 
in areas of differing transmission intensity. Nature Communications 2017) it may be 
challenging to reliably detect and quantify an impact of human parasite status on 
mosquito exposure in natural settings. 
 
“We performed indoor resting collections of anopheline mosquitoes in an area with 
seasonal malaria transmission in Burkina Faso. Thirty-five households were included 
in this analysis. The median number of individuals living in each study household was 
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3 (range, 2 – 5). Reported bed net use among the study participants was high (111/126, 
88.1%). At enrolment (October – December 2013), most (79.2%) individuals were 
parasite-positive by 18S qPCR; in 21/35 houses, all individuals were infected. We 
collected 325, 620 and 190 bloodfed Anopheles mosquitoes at the start (2014), peak 
(2014) and end (2013) of the transmission season, respectively (Table 1).” 
 
“Throughout the study, a small number of individuals, mostly adults, were matched to 
considerably higher numbers of blood meals compared to the rest of the population. 
Conversely, 32.0 – 76.2% of study participants were not linked to bloodfed mosquitoes 
during the surveys, including 15/77 individuals present in all surveys who were never 
matched to collected fed mosquitoes. Reported bed net use and parasite and 
gametocyte carriage at enrolment were not significantly associated with mosquito 
exposure during our study (incidence rate ratio of 0.70 [95% confidence interval, CI, 
0.22 – 2.20, P = 0.55] for reported bed net use versus no net use in a model adjusted 
for survey and of 3.42 and 0.99 [95% CI 0.50 – 23.45 and 0.33 – 3.10, P = 0.21 and 
0.99] for parasite and gametocyte carriage at enrolment respectively in models that 
only included data from the first survey). In an analysis of data from all surveys, 
negative binomial regression with mixed effects better explained the distribution of 
mosquito bite counts than mixed effects Poisson models (P < 0.001), after adjustments 
for age, which influences Anopheles exposure in this population (11), survey and 
intra-household data correlation.” (Lines 117 – 124) 
 
 
“....; in our study, bed net use and gametocyte carriage were not significantly 
associated with the number of mosquito bites an individual received (P = 0.72) though 
this study was not designed to assess the influence of these factors on mosquito 
exposure.” (Lines 318 – 320) 
 
“Parasite detection in humans 
Finger prick blood samples were collected at enrolment and stored in RNAprotect Cell 
Reagent. 18S qPCR and Pfs25 mRNA qRT-PCR were used to detect falciparum 
parasites, and gametocytes, respectively.” (new sub-section in the Methods section) 
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“Table 1. Study surveys 
 
  First Survey Second Survey Third Survey 
     
Start Date October, 2013 June, 2014 
September, 
2014 
Number of sampling days 54 20 20 
     
Timing 
End of transmission 
season 
Start of transmission 
season 
Peak of 
transmission 
season 
     
Number of households 35* 20 20 
     
Number of participants 127 81 77 
     
  N (%) N (%) N (%) 
Age categories**    
< 5 years 20 (15.9) 12 (14.8) 12 (15.6) 
5 - 15 years 62 (49.2) 39 (48.2) 37 (48.0) 
> 15 years 44 (34.9) 30 (37.0) 28 (36.4) 
     
Gender    
Male 41 (32.5) 22 (27.2) 21 (27.3) 
Female 85 (67.5) 59 (72.8) 56 (72.7) 
    
Prevalence of falciparum parasites 99 (79.2) - - 
Prevalence of falciparum gametocytes  79 (64.2) - - 
    
Number of bloodfed mosquitoes 
collected 190 325 620 
    
     
*Demographic information not available for individuals living in 5/40 households (first survey only); **Age 
at enrolment (first survey) 
” 
 
MINOR REVISIONS 
 
Reviewers’ comment 
 
1. Line 68: I don't think 9,10 focus on endemicity levels but rather on R0/growth 
of an epidemic in a naive population. Havent reread them but this wording should 
be checked for accuracy 
 
 
Answer to Reviewers’ comment 
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We have now corrected the sentence in line 68, and merged this paragraph with the 
following paragraph. Indeed, while Woolhouse and colleagues analysed data on a 
wide range of infectious agents, including some which are commonly associated with 
endemic transmission, such as schistosomiasis and leishmaniasis, all calculations 
involved R0, i.e. spread of these infections in naïve populations (Heterogeneities in the 
transmission of infectious agents: implications for the design of control programs. 
PNAS 1997). 
 
“The multifactorial nature of mosquito exposure in malaria endemic areas indicates 
that, while experimental and quasi-experimental, e.g. involving modified tents and 
huts, entomological studies are valuable, they will not accurately capture inter-
individual variation in actual exposure. Identifying transmission heterogeneities, 
especially extreme heterogeneities, is however critical to better inform infectious 
disease epidemiology. It is not unusual for a small proportion of individuals to 
contribute disproportionately to transmission, and well-established theory has 
elucidated how even small numbers of super-spreaders can trigger large outbreaks or 
perpetuate high levels of endemicity  their implications for pathogen spread and 
control measures (9, 10). Here, we describe the variability in natural exposure to 
malaria vectors by linking, through DNA fingerprinting, blood meals of wild-caught 
mosquitoes to humans living in the households where they were collected. Previously 
we have shown that these mosquitoes fed more often on adults (11). We now extend 
this analysis to assess the degree of heterogeneity in the distribution of mosquito bites 
in the population at different times during the transmission season. We also present 
the frequency of Anopheles species-specific mosquito bites, and potential parasite 
inoculations (i.e., sporozoite-positive mosquito bites) per individual.” (Lines 61 – 77) 
 
Reviewers’ comment 
 
2. Line 258 ff. Is the inflation relative to uniform biting (everyone gets the same 
number of bites) or Poisson biting (more realistic)? I thin it is relative to Poisson, 
since in this situation the dispersion parameter would be infinite and the inflation 
would be 0. But I think the null is inflation of 1, so I am confused. 
 
Answer to Reviewers’ comment 
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In our analysis, we used a formula developed by Dye & Hasibeder (Population 
dynamics of mosquito-borne disease: effects of flies which bite some people more 
frequently than others. Trans R Soc Trop Med Hyg. 1986), where R0 amplification 
due to variable exposure to mosquitoes is estimated and compared to the theoretical 
situation of uniform biting. A similar approach was adopted by Woolhouse and 
colleagues (see comment above). In other words, the null is achieved when the 
coefficient of variation equals zero and R0 reverts to the standard (homogenous 
mixing) assumption. 
  
Reviewers’ comment 
 
3. Line 356 please elaborate on these differences and why you found them 
interesting  
 
Answer to Reviewers’ comment 
 
In general, malaria vector species occur in different combinations and this influences 
vectorial capacity of any transmission system. This natural variation in species 
composition of vector populations together with the fact that different species are 
affected by control measures differently highlights the importance of understanding 
the factors influencing vector species-specific contribution to malaria transmission. In 
this study, bloodfed A. gambiae s. s. mosquitoes were more likely to carry sporozoites, 
and A. coluzzii mosquitoes had a higher percentage of blood meals with multiple 
human sources, which implies blood feeding on at least two individuals in a single 
night. The relevance of these results lies in their influence on the contribution of 
different mosquito species to transmission. Whilst the number of mosquito bites from 
different vector species depends primarily on their abundance and degree of 
anthropophily, the non-negligible frequency of multiple blood meals (14.3% in our 
study), which could represent two independent transmission events, suggests that this 
phenomenon needs to be considered in models of malaria transmission. Additionally, 
the probability of infecting a human host during a single blood feeding, another 
parameter that determines vector species-specific contribution to transmission, has as 
upper limit the prevalence of sporozoites. In our setting, this prevalence varies in 
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different vector species, and this could be linked to variability in mosquito 
susceptibility to falciparum infection, as mentioned in the Results section; another 
explanation could be related to species-specific mosquito survival and age structure, 
as older mosquitoes are likely to have acquired infection in previous blood meals (see 
answer to previous comments). 
  
As the species composition of local vector populations varies in the course of the rainy 
season (see Results section, and Dao et al. Signatures of aestivation and migration in 
Sahelian malaria mosquito populations. Nature 2014 for detailed discussion of vector 
species-specific population dynamics in another seasonal setting), these differences 
might impact infection propagation in the human population during the transition from 
dry to wet season and cause temporal variation in human force of infection during a 
single transmission season.  
 
We have now modified this paragraph to mention mosquito age structure as one of the 
possible causes of variation in sporozoite prevalence, and to explicitly state these 
observations are relevant to understand local malaria epidemiology: 
  
“Additionally, we observed that the most numerous species in our study area, A. 
coluzzii and A. gambiae s. s., differed in two key parameters that influence the 
transmission potential of mosquitoes: the likelihood of feeding on multiple individuals 
and the prevalence of sporozoites. There is evidence from membrane feeding 
experiments performed in Senegal (29) that A. gambiae s. s. mosquitoes might be more 
susceptible to malaria infection, although this association was not observed in another 
transmission study (30). Another possible explanation for the observed species-related 
difference in sporozoite prevalence could be variation in mosquito survival and 
consequently age structure. The higher frequency of falciparum infection in A. 
gambiae s. s. mosquitoes confirms, together with its relatively high abundance, the 
prime importance of this species for malaria transmission in the study setting. The 
contributions of the different Anopheles species to the mosquito infectious reservoir 
also depend on the number of potential parasite inoculations per mosquito-time: 
mosquitoes with multiple blood meals are more likely to infect more than one 
individual on a single night compared to mosquitoes with single-source blood meals, 
assuming sufficient quantities of sporozoites are inoculated during the probing of the 
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different hosts. The higher proportion of blood meals with multiple human DNA 
sources suggests that A. coluzzii mosquitoes also contribute significantly to the 
incidence of infection in humans. Importantly, as species composition of local vector 
populations varies in the course of the rainy season, these differences might impact 
the rate of infection propagation in human populations over the course of a single 
transmission season as relative abundances of the different vector species change.” 
 
Reviewers’ comment 
 
4. A map showing the location of houses and individuals sampled would be useful, 
including the distribution of those not sampled. Some description of the 
landscape and economy of the study area would be useful. This might explain 
why the sex ratio of the study population is so strongly skewed in favor of females. 
Were domestic animals present? If so, was screening done for non-human 
bloodmeals and what were the results? 
 
Answer to Reviewers’ comment 
 
The main economic activity in the health district of Saponé is subsistence farming and 
livestock keeping (Ouédraogo et al. Malaria Morbidity in High and Seasonal Malaria 
Transmission Area of Burkina Faso. PLOS One 2013). This is now mentioned in the 
Methods section:  
 
“This study was conducted in Balonghin (health district of Saponé, Burkina Faso). 
The main economic activity in this area is subsistence farming and livestock keeping. 
Malaria transmission is seasonal, occurring between August and December following 
rainfall between June and September (39), and falciparum parasite prevalence is high, 
above 80% by 18S qPCR, during the transmission season (11).” (Lines 408 – 410)” 
 
Regarding non-human blood meals, we observed that blood meals from only 8.2% 
(N=88) of tested mosquitoes did not amplify for human DNA. It is possible that some 
of these mosquitoes fed on domestic animals, however evidence from indoor 
collection studies demonstrates that Anopheles gambiae mosquitoes are highly 
anthropophilic (see Figure 1 of a summary of different studies. Takken & Verhulst. 
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Host preferences of blood-feeding mosquitoes. Annu Rev Entomol. 2013). 
Importantly, since our main objective was to assess the distribution of mosquito bites 
in human populations, and since it is unlikely that non-human biting would divert bites 
from specific hosts, we do not expect this to bias our individual-level estimates. We 
have now mentioned the possibility of non-human biting in the Discussion section:   
 
“Of note, the age distribution of our study population (Table 1) might not reflect the 
true demography of the region. Whilst our results are in agreement with previous 
studies, we cannot exclude that a difference in age composition related to the fact that 
only houses with at least one child were included in the study may have influenced our 
heterogeneity estimates. Furthermore, we observed that blood meals from 8.2% of 
tested mosquitoes did not amplify for human DNA. Although it is possible that some 
of these mosquitoes fed on domestic animals, since it is unlikely that non-human biting 
would divert bites from specific hosts, we do not expect this to bias our individual-
level estimates.” (Lines 320 – 324) 
 
Reviewers’ comment 
 
5. There seems to be an inconsistency between figure 2c and the sentence 
beginning on line 167 - "Within-household heterogeneity in mosquito exposure 
was observed: in 4/8, 14/15 and 7/7 houses with at least three study participants 
and five matched mosquitoes at the start, peak and end of the transmission season 
respectively, the most exposed individual was the source of more than 50% of 
mosquito blood meals (Figure 2c)." If figure 2c represents the 8 houses, then 
according to [reviewer WH's] inspection of the figure, the correct numbers 
should be 4/8 (we agree there), 3/8 (we are far off here - where does the 
denominator of 15 come from?), and 6/7 (though for the last house to be included 
in the numerator you'd need to specify "50% or more" in the interpretive 
sentence as in this house it seems that exactly 50% of bloodmeals came from a 
single individual). 
 
Answer to Reviewers’ comment 
 
In Figure 2c (now 2b), only the 8 houses with at least 5 matched mosquitoes at the 
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start of the transmission season were included; of these 8 houses, 6 also had 5 or more 
matched mosquitoes at the peak of the transmission season. The reason why we only 
present data for this subset of houses in this figure is because they had sufficient 
numbers of matched mosquitoes on which to base our calculations for at least two 
surveys. In the statement starting in line 167 (Results section), the survey-specific 
denominators comprise any houses with at least 5 matched mosquitoes in the 
corresponding survey. We have now modified this sentence to clarify this difference 
and also to mention that it corresponds to “50% or more”:  
 
“Within-household heterogeneity in mosquito exposure was observed (Figure 2b): 
considering data from houses with at least three study participants and five matched 
mosquitoes in single surveys, in 4/8, 14/15 and 7/7 households with at least three study 
participants and five matched mosquitoes at the start, peak and end of the transmission 
season respectively, the most exposed individual was the source of at least 50% of 
matched mosquito blood meals.” 
 
 
 
 
 
 
 
 
 
